ACADIA Pharmaceuticals Inc.
Perkenalan
Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di Felix Baker. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.
Profitabilitas Perdagangan Rata-rata
Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.
Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.
Frekuensi Pembaruan: Harian
Perusahaan dengan Posisi Insider yang Dilaporkan
Pengajuan SEC menunjukkan Felix Baker telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:
Bagaimana Menafsirkan Grafik
Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh Felix Baker. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.
Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.
Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.
Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.
Pembelian Insider ACAD / ACADIA Pharmaceuticals Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider ACAD / ACADIA Pharmaceuticals Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider BCRX / BioCryst Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider CELC / Celcuity Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider CELC / Celcuity Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider KALA / KALA BIO, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider KALA / KALA BIO, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider KNSA / Kiniksa Pharmaceuticals International, plc - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider KNSA / Kiniksa Pharmaceuticals International, plc - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider KOD / Kodiak Sciences Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider KOD / Kodiak Sciences Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider KYMR / Kymera Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider KYMR / Kymera Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider MDGL / Madrigal Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider MDGL / Madrigal Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider NTLA / Intellia Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider NTLA / Intellia Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider PRLD / Prelude Therapeutics Incorporated - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider PRLD / Prelude Therapeutics Incorporated - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider REPL / Replimune Group, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider REPL / Replimune Group, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider SERA / Sera Prognostics, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider SERA / Sera Prognostics, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider SYRE / Spyre Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider SYRE / Spyre Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider TCRX / TScan Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider TCRX / TScan Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider TRDA / Entrada Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider TRDA / Entrada Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider VTVT / vTv Therapeutics Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider VTVT / vTv Therapeutics Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider XOMAO / XOMA Royalty Corporation - Preferred Stock - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider XOMAO / XOMA Royalty Corporation - Preferred Stock - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Pembelian Insider ZYME / Zymeworks Inc. - Analisis Keuntungan Jangka Pendek
Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada ACAD / ACADIA Pharmaceuticals Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Pengembalian Maksimal (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Penjualan Insider ZYME / Zymeworks Inc. - Analisis Kerugian Jangka Pendek
Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di ACAD / ACADIA Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .
Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.
| Tanggal Perdagangan | Kode | Insider | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari ke Minimal |
Harga di Minimal |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
|---|---|---|---|---|---|---|---|
| Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini |
Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.
Riwayat Insider Trading
Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh Felix Baker sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).
| Tanggal Berkas | Tanggal Trans | Formulir | Kode | Keamanan | Kode | Saham | Sisa Saham | Persen Mengubah |
Saham Harga |
Trans Nilai |
Tersisa Nilai |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6.408 | 3.422.366 | 0,19 | ||||
| 2026-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6.408 | 343.275 | 1,90 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6.078 | 2.744.894 | 0,22 | ||||
| 2026-06-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 6.078 | 143.277 | 4,43 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.622 | 39.384.587 | 0,05 | ||||
| 2026-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.622 | 3.677.357 | 0,51 | ||||
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.756 | 142.570 | -1,90 | 23,79 | -65.567 | 3.391.812 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.756 | 142.566 | -1,90 | 23,79 | -65.567 | 3.391.716 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.743 | 145.326 | -1,85 | 23,85 | -65.424 | 3.466.199 | |
| 2026-05-27 |
|
4 | ONC |
BeOne Medicines Ltd.
Ordinary Shares |
S - Sale | -2.743 | 145.322 | -1,85 | 23,85 | -65.424 | 3.466.104 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 28.203.718 | 0,05 | 84,53 | 1.267.950 | 2.384.060.283 | |
| 2026-05-11 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 2.833.039 | 0,53 | 84,53 | 1.267.950 | 239.476.787 | |
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 28.188.718 | 0,00 | ||||
| 2026-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 421 | 2.818.039 | 0,01 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19.000 | 10.018.674 | 0,19 | ||||
| 2026-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 19.000 | 10.018.674 | 0,19 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28.188.297 | 0,00 | ||||
| 2026-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 328 | 28.188.297 | 0,00 | ||||
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.391.268 | 18.358.772 | 14,98 | 23,00 | 54.999.164 | 422.251.756 | |
| 2025-12-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 217.428 | 1.560.414 | 16,19 | 23,00 | 5.000.844 | 35.889.522 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1.838.621 | 7.955.916 | 30,06 | 86,00 | 158.121.406 | 684.208.776 | |
| 2025-12-11 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 167.192 | 701.326 | 31,30 | 86,00 | 14.378.512 | 60.314.036 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 13.082 | 4.691.392 | 0,28 | 9,07 | 118.690 | 42.564.061 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1.186 | 381.338 | 0,31 | 9,07 | 10.760 | 3.459.803 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 13.386 | 4.678.310 | 0,29 | 9,07 | 121.395 | 42.426.658 | |
| 2025-11-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1.213 | 380.152 | 0,32 | 9,07 | 11.000 | 3.447.522 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 11.494 | 4.664.924 | 0,25 | 7,95 | 91.431 | 37.108.071 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1.040 | 378.939 | 0,28 | 7,95 | 8.273 | 3.014.346 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 80.881 | 4.653.430 | 1,77 | 7,73 | 625.331 | 35.977.994 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.321 | 377.899 | 1,98 | 7,73 | 56.602 | 2.921.726 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30.879 | 4.572.549 | 0,68 | 7,54 | 232.812 | 34.474.733 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.795 | 370.578 | 0,76 | 7,54 | 21.073 | 2.793.973 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 11.701 | 4.541.670 | 0,26 | 7,39 | 86.481 | 33.567.029 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1.059 | 367.783 | 0,29 | 7,39 | 7.827 | 2.718.247 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.947 | 4.529.969 | 0,07 | 7,22 | 21.290 | 32.726.308 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 267 | 366.724 | 0,07 | 7,22 | 1.929 | 2.649.361 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 25.364 | 4.527.022 | 0,56 | 7,21 | 182.973 | 32.657.484 | |
| 2025-11-12 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.296 | 366.457 | 0,63 | 7,21 | 16.563 | 2.643.584 | |
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 28.187.969 | 0,00 | ||||
| 2025-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 388 | 2.817.290 | 0,01 | ||||
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -462.967 | 425.006 | -52,14 | 1,38 | -640.654 | 588.123 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -50.640 | 46.480 | -52,14 | 1,38 | -70.076 | 64.319 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -195.425 | 887.973 | -18,04 | 1,60 | -311.879 | 1.417.116 | |
| 2025-10-02 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
S - Sale | -21.376 | 97.120 | -18,04 | 1,60 | -34.114 | 154.994 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 4.212 | 7.211.484 | 0,06 | 58,02 | 244.395 | 418.436.263 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 388 | 704.308 | 0,06 | 58,02 | 22.513 | 40.866.486 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 151.524 | 7.207.272 | 2,15 | 56,22 | 8.518.679 | 405.192.832 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 13.976 | 703.920 | 2,03 | 56,22 | 785.731 | 39.574.382 | |
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46.692 | 135.946 | 52,31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4.308 | 12.368 | 53,45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.128 | 1.859.091 | 0,55 | 372,16 | 3.769.209 | 691.874.287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194.625 | 0,48 | 372,16 | 347.223 | 72.431.115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.494 | 1.848.963 | 0,30 | 371,00 | 2.038.301 | 685.974.518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193.692 | 0,26 | 371,00 | 187.729 | 71.860.700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.747 | 1.843.469 | 0,15 | 369,34 | 1.014.563 | 680.857.623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193.186 | 0,13 | 369,34 | 93.442 | 71.350.351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.419 | 1.840.722 | 0,08 | 368,84 | 523.384 | 678.931.902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192.933 | 0,07 | 368,84 | 48.318 | 71.161.408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.798 | 1.839.303 | 0,26 | 367,77 | 1.764.565 | 676.442.304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192.802 | 0,23 | 367,77 | 162.555 | 70.906.984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.289 | 1.834.505 | 0,12 | 366,30 | 838.459 | 671.977.714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192.360 | 0,11 | 366,30 | 77.289 | 70.461.314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.772 | 1.832.216 | 0,15 | 363,75 | 1.008.308 | 666.463.806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192.149 | 0,13 | 363,75 | 92.756 | 69.893.699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.587 | 1.829.444 | 0,31 | 362,39 | 2.024.662 | 662.968.735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191.894 | 0,27 | 362,39 | 186.630 | 69.540.102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.443 | 1.823.857 | 0,30 | 361,37 | 1.966.957 | 659.093.770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191.379 | 0,26 | 361,37 | 181.410 | 69.159.318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.514 | 1.818.414 | 0,47 | 359,39 | 3.059.873 | 653.525.445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190.877 | 0,41 | 359,39 | 281.764 | 68.599.877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.472 | 1.809.900 | 0,14 | 358,21 | 885.495 | 648.324.279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190.093 | 0,12 | 358,21 | 81.672 | 68.093.214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.328 | 1.807.428 | 0,46 | 357,02 | 2.973.289 | 645.293.728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189.865 | 0,41 | 357,02 | 273.837 | 67.786.210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1.799.100 | 0,05 | 355,00 | 325.180 | 638.680.500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189.098 | 0,04 | 355,00 | 29.820 | 67.129.790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.923 | 1.798.184 | 0,11 | 353,88 | 680.503 | 636.333.262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189.014 | 0,09 | 353,88 | 62.636 | 66.887.424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.362 | 1.947.968 | 0,48 | 392,24 | 3.672.178 | 764.076.617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202.813 | 0,43 | 392,24 | 338.113 | 79.551.959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.506 | 1.938.606 | 0,13 | 389,89 | 977.059 | 755.838.828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201.951 | 0,11 | 389,89 | 90.064 | 78.738.231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1.936.100 | 0,02 | 389,00 | 142.374 | 753.142.900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201.720 | 0,02 | 389,00 | 13.226 | 78.469.080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.441 | 1.935.734 | 0,23 | 387,07 | 1.718.969 | 749.260.688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201.686 | 0,20 | 387,07 | 158.311 | 78.066.197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.545 | 1.931.293 | 0,71 | 385,06 | 5.215.601 | 743.658.468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.248 | 201.277 | 0,62 | 385,06 | 480.552 | 77.503.178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.049 | 1.917.748 | 0,21 | 383,79 | 1.553.954 | 736.007.135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200.029 | 0,19 | 383,79 | 143.153 | 76.768.570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.838 | 1.913.699 | 0,15 | 382,82 | 1.086.447 | 732.604.739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199.656 | 0,13 | 382,82 | 100.299 | 76.432.569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.136 | 1.910.861 | 0,06 | 382,29 | 434.280 | 730.501.332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199.394 | 0,05 | 382,29 | 40.140 | 76.226.153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.477 | 1.909.725 | 0,50 | 381,12 | 3.611.889 | 727.837.448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199.289 | 0,44 | 381,12 | 332.719 | 75.953.343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.919 | 1.900.248 | 0,10 | 380,78 | 730.717 | 723.576.433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198.416 | 0,09 | 380,78 | 67.017 | 75.552.844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.209 | 1.898.329 | 0,28 | 380,44 | 1.981.694 | 722.193.641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198.240 | 0,24 | 380,44 | 182.610 | 75.417.732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.325 | 1.893.120 | 0,39 | 374,43 | 2.742.728 | 708.848.115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197.760 | 0,34 | 374,43 | 252.743 | 74.048.028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.704 | 1.885.795 | 1,44 | 372,87 | 9.957.102 | 703.155.062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.460 | 197.085 | 1,26 | 372,87 | 917.258 | 73.486.946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3.763.362 | 0 | -100,00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357.048 | 0 | -100,00 | ||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689.944 | ||||||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7.055.748 | ||||||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28.187.581 | 0,00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28.187.581 | 0,00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.763.362 | 0,03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.763.362 | 0,03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600.309 | 6.117.295 | 10,88 | 44,00 | 26.413.596 | 269.160.980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55.191 | 534.134 | 11,52 | 44,00 | 2.428.404 | 23.501.896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.430 | 1.796.261 | 0,08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.430 | 1.796.261 | 0,08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.518 | 28.187.089 | 0,01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.518 | 28.187.089 | 0,01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326.302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3.405.393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10.565 | 3.415.958 | 0,31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10.565 | 3.415.958 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8.397 | 2.738.816 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8.397 | 2.738.816 | 0,31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16.214 | 39.365.965 | 0,04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16.214 | 39.365.965 | 0,04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21.970 | 148.069 | 17,42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21.970 | 148.065 | 17,42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28.184.571 | 0,00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2.813.892 | 0,02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.762.409 | 0,03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356.095 | 0,27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92.349 | 2.144.060 | 4,50 | 29,56 | 2.729.864 | 63.379.057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8.589 | 178.596 | 5,05 | 29,56 | 253.893 | 5.279.351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646.290 | 2.051.711 | 45,99 | 29,74 | 19.221.699 | 61.021.168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60.110 | 170.007 | 54,70 | 29,74 | 1.787.768 | 5.056.280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929.241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10.116.095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671.976 | 8.068.411 | -7,69 | 260,00 | -174.713.760 | 2.097.786.860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60.851 | 730.642 | -7,69 | 260,00 | -15.821.260 | 189.966.920 | |
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432.434 | ||||||||
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5.065.736 | ||||||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4.400 | 9.999.674 | 0,04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4.400 | 918.483 | 0,48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28.184.084 | 0,00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28.184.084 | 0,00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.761.456 | 0,05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 355.142 | 0,56 | ||||
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279.939 | 1.083.398 | 34,84 | 6,44 | 1.802.807 | 6.977.083 | |
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30.620 | 118.496 | 34,84 | 6,44 | 197.193 | 763.114 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457.631 | 9.995.274 | 4,80 | 15,34 | 7.020.883 | 153.345.495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42.369 | 914.083 | 4,86 | 15,34 | 650.017 | 14.023.679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566.814 | 9.537.643 | 6,32 | 13,80 | 7.824.300 | 131.657.624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52.656 | 871.714 | 6,43 | 13,80 | 726.863 | 12.033.140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244.587 | 8.970.829 | 2,80 | 13,72 | 3.356.761 | 123.117.451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22.722 | 819.058 | 2,85 | 13,72 | 311.841 | 11.240.916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59.995 | 8.726.242 | 0,69 | 13,63 | 817.660 | 118.928.207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5.573 | 796.336 | 0,70 | 13,63 | 75.953 | 10.853.104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30.241 | 8.666.247 | 0,35 | 13,50 | 408.190 | 116.976.135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2.809 | 790.763 | 0,36 | 13,50 | 37.916 | 10.673.640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916.964 | 8.740.387 | -9,49 | 186,50 | -171.013.786 | 1.630.082.176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83.036 | 791.493 | -9,49 | 186,50 | -15.486.214 | 147.613.444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33.943 | 9.657.351 | -0,35 | 208,01 | -7.060.609 | 2.008.861.314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3.074 | 874.529 | -0,35 | 208,01 | -639.434 | 181.914.013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4.730 | 2.730.419 | 0,17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4.730 | 2.730.419 | 0,17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28.183.638 | 0,00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2.812.959 | 0,02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.759.462 | 0,05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 353.148 | 0,57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5.516.986 | 0,00 | 46,41 | 46 | 256.043.320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28.183.142 | 0,00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28.183.142 | 0,00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.757.468 | 0,05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.757.468 | 0,05 | ||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87.876 | ||||||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803.459 | ||||||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.428 | 1.794.831 | 0,08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.428 | 1.794.831 | 0,08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2.186.686 | 8.636.006 | 33,91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196.098 | 787.954 | 33,13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5.283.206 | 28.182.605 | -15,79 | 60,00 | -316.992.360 | 1.690.956.300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175.977 | 2.811.926 | -5,89 | 60,00 | -10.558.620 | 168.715.560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.830 | 33.465.811 | 0,01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.830 | 33.465.811 | 0,01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32.682 | 126.099 | 34,99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32.682 | 126.099 | 34,99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6.346 | 2.725.689 | 0,23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6.346 | 2.725.689 | 0,23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.774 | 39.349.751 | 0,05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.774 | 39.349.751 | 0,05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109.897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1.405.421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 33.462.981 | 0,04 | 49,01 | 735.150 | 1.640.020.699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 2.985.073 | 0,51 | 49,01 | 735.150 | 146.298.428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12.000 | 6.449.320 | 0,19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12.000 | 6.449.320 | 0,19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579.856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6.437.320 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.755.474 | 0,05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.755.474 | 0,05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33.447.981 | 0,00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2.970.073 | 0,02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89.407 | 3.753.480 | 2,44 | 9,62 | 860.042 | 36.106.226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8.066 | 347.166 | 2,38 | 9,62 | 77.590 | 3.339.529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8.439 | 3.664.073 | 0,23 | 9,27 | 78.207 | 33.956.064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339.100 | 0,22 | 9,27 | 7.052 | 3.142.541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17.101 | 3.655.634 | 0,47 | 9,22 | 157.683 | 33.707.504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1.543 | 338.339 | 0,46 | 9,22 | 14.228 | 3.119.722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247.656 | 3.638.533 | 7,30 | 8,26 | 2.046.159 | 30.061.923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22.344 | 336.796 | 7,11 | 8,26 | 184.608 | 2.782.642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12.836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142.135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52.881 | 89.254 | -37,20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4.776 | 8.060 | -37,21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33.447.438 | 0,00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33.447.438 | 0,00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3.390.877 | 0,02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3.390.877 | 0,02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42.977.301 | 0 | -100,00 | 229,00 | -9.841.801.929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1.731.202 | 0 | -100,00 | 229,00 | -396.445.258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23.277 | 0 | -100,00 | 229,00 | -5.330.433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23.280 | 0 | -100,00 | 229,00 | -5.331.120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214.025 | 3.390.323 | 6,74 | 6,60 | 1.412.565 | 22.376.132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17.066 | 313.898 | 5,75 | 6,60 | 112.636 | 2.071.727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52.528 | 3.176.298 | 1,68 | 6,37 | 334.399 | 20.220.631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4.188 | 296.832 | 1,43 | 6,37 | 26.661 | 1.889.662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3.123.770 | 0,01 | 6,36 | 1.176 | 19.851.558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292.644 | 0,01 | 6,36 | 95 | 1.859.753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145.749 | 3.123.585 | 4,89 | 6,50 | 947.602 | 20.308.300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11.621 | 292.629 | 4,14 | 6,50 | 75.555 | 1.902.557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71.219 | 2.977.836 | 2,45 | 5,99 | 426.751 | 17.843.491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5.679 | 281.008 | 2,06 | 5,99 | 34.029 | 1.683.828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9.649 | 2.906.617 | 0,33 | 5,76 | 55.567 | 16.738.626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275.329 | 0,28 | 5,76 | 4.429 | 1.585.565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.857 | 1.699.129 | 0,23 | 221,24 | 853.330 | 375.918.358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178.461 | 0,17 | 221,24 | 68.142 | 39.483.033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.408 | 1.695.272 | 0,26 | 220,65 | 972.645 | 374.069.565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178.153 | 0,20 | 220,65 | 77.670 | 39.310.279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.005 | 1.690.864 | 0,90 | 219,24 | 3.289.711 | 370.706.714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.195 | 177.801 | 0,68 | 219,24 | 261.993 | 38.981.269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.873 | 1.675.859 | 0,17 | 217,91 | 626.049 | 365.182.748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176.606 | 0,13 | 217,91 | 49.901 | 38.483.825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1.672.986 | 0,01 | 217,90 | 40.312 | 364.543.649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176.377 | 0,01 | 217,90 | 3.268 | 38.432.548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.769 | 1.672.801 | 0,11 | 216,67 | 383.286 | 362.442.949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176.362 | 0,08 | 216,67 | 30.550 | 38.212.055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1.671.032 | 0,04 | 214,72 | 143.434 | 358.807.834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176.221 | 0,03 | 214,72 | 11.380 | 37.838.578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1.670.364 | 0,03 | 213,80 | 110.107 | 357.122.821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176.168 | 0,02 | 213,80 | 8.766 | 37.664.613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1.669.849 | 0,01 | 213,62 | 39.521 | 356.721.493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176.127 | 0,01 | 213,62 | 3.204 | 37.625.130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1.669.664 | 0,04 | 212,04 | 137.403 | 354.037.892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176.112 | 0,03 | 212,04 | 11.026 | 37.343.035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1.669.016 | 0,01 | 209,76 | 19.508 | 350.101.141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176.060 | 0,00 | 209,76 | 1.468 | 36.931.226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1.668.923 | 0,02 | 208,69 | 77.216 | 348.289.710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176.053 | 0,02 | 208,69 | 6.261 | 36.740.729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1.668.553 | 0,04 | 206,93 | 134.092 | 345.277.176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176.023 | 0,03 | 206,93 | 10.760 | 36.424.809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1.667.905 | 0,04 | 205,60 | 145.565 | 342.921.268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175.971 | 0,03 | 205,60 | 11.514 | 36.179.638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1.667.197 | 0,01 | 205,32 | 19.095 | 342.308.888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175.915 | 0,00 | 205,32 | 1.437 | 36.118.868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.960 | 1.793.403 | 0,22 | 229,86 | 910.264 | 412.240.043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185.979 | 0,17 | 229,86 | 72.637 | 42.750.007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.204 | 1.789.443 | 0,12 | 228,79 | 504.252 | 409.405.411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185.663 | 0,09 | 228,79 | 40.267 | 42.477.708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11.602 | 1.787.239 | 0,65 | 227,86 | 2.643.597 | 407.234.917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185.487 | 0,50 | 227,86 | 210.768 | 42.264.511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.343 | 1.775.637 | 0,08 | 226,97 | 304.822 | 403.018.106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184.562 | 0,06 | 226,97 | 24.286 | 41.890.222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.594 | 1.774.294 | 0,32 | 224,91 | 1.258.156 | 399.059.480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184.455 | 0,24 | 224,91 | 100.311 | 41.486.088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1.768.700 | 0,02 | 223,94 | 81.289 | 396.078.079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184.009 | 0,02 | 223,94 | 6.494 | 41.206.497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.262 | 1.768.337 | 0,53 | 222,68 | 2.062.425 | 393.766.210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183.980 | 0,40 | 222,68 | 164.335 | 40.967.930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.532 | 1.759.075 | 0,26 | 221,78 | 1.005.101 | 390.125.367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183.242 | 0,20 | 221,78 | 80.062 | 40.639.173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.518 | 1.754.543 | 0,26 | 219,87 | 993.351 | 385.762.948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182.881 | 0,20 | 219,87 | 79.151 | 40.209.168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29.738 | 1.750.025 | 1,73 | 218,46 | 6.496.513 | 382.307.486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.373 | 182.521 | 1,32 | 218,46 | 518.402 | 39.873.227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.894 | 1.720.287 | 0,64 | 217,52 | 2.369.611 | 374.188.571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180.148 | 0,48 | 217,52 | 189.021 | 39.184.928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.264 | 1.709.393 | 0,60 | 216,70 | 2.224.203 | 370.424.437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179.279 | 0,46 | 216,70 | 177.260 | 38.849.652 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1.941.607 | 2.168.818 | 854,54 | 0,00 | 194 | 217 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174.742 | 196.654 | 797,47 | 0,00 | 17 | 20 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.917 | 1.667.104 | 0,48 | 190,14 | 1.505.308 | 316.976.653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175.908 | 0,37 | 190,14 | 124.539 | 33.446.461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.620 | 1.659.187 | 0,95 | 188,70 | 2.947.539 | 313.093.399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.291 | 175.253 | 0,74 | 188,70 | 243.615 | 33.070.749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.505 | 1.643.567 | 0,83 | 188,46 | 2.545.218 | 309.754.690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.117 | 173.962 | 0,65 | 188,46 | 210.515 | 32.785.731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.011 | 1.630.062 | 0,80 | 188,32 | 2.450.273 | 306.978.492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.076 | 172.845 | 0,63 | 188,32 | 202.636 | 32.550.724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.712 | 1.617.051 | 0,29 | 187,27 | 882.420 | 302.826.273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171.769 | 0,23 | 187,27 | 72.661 | 32.167.301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.124 | 1.612.339 | 0,13 | 187,24 | 397.706 | 301.900.642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171.381 | 0,10 | 187,24 | 32.955 | 32.090.047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.385 | 1.610.215 | 0,09 | 186,59 | 258.431 | 300.454.847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171.205 | 0,07 | 186,59 | 21.458 | 31.945.655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1.608.830 | 0,04 | 186,32 | 120.547 | 299.752.540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171.090 | 0,03 | 186,32 | 9.875 | 31.876.993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1.608.183 | 0,02 | 183,16 | 67.586 | 294.554.798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171.037 | 0,02 | 183,16 | 5.678 | 31.327.137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1.607.814 | 0,01 | 185,94 | 27.148 | 298.963.688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171.006 | 0,01 | 185,94 | 2.231 | 31.797.574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.022 | 1.607.668 | 0,19 | 189,70 | 573.267 | 304.971.083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170.994 | 0,15 | 189,70 | 47.424 | 32.437.186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.147 | 1.604.646 | 0,07 | 188,84 | 216.595 | 303.014.772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170.744 | 0,06 | 188,84 | 17.939 | 32.242.597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.895 | 1.603.499 | 0,31 | 187,34 | 917.054 | 300.407.520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170.649 | 0,24 | 187,34 | 75.875 | 31.970.237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.206 | 1.598.604 | 0,08 | 185,86 | 224.153 | 297.124.532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170.244 | 0,06 | 185,86 | 18.586 | 31.642.401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.010 | 1.597.398 | 0,44 | 183,40 | 1.285.633 | 292.962.633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170.144 | 0,34 | 183,40 | 106.189 | 31.204.393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.847 | 1.590.388 | 0,12 | 181,93 | 336.025 | 289.339.289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169.565 | 0,09 | 181,93 | 27.835 | 30.848.960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.715 | 1.588.541 | 0,68 | 175,82 | 1.883.889 | 279.293.943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169.412 | 0,54 | 175,82 | 158.764 | 29.785.662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.923 | 1.577.826 | 0,31 | 175,72 | 865.062 | 277.253.218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168.509 | 0,25 | 175,72 | 72.923 | 29.610.149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18.125 | 1.572.903 | 1,17 | 174,87 | 3.169.606 | 275.061.098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.528 | 168.094 | 0,92 | 174,87 | 267.209 | 29.395.405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1.554.778 | 0,06 | 174,67 | 170.827 | 271.572.762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166.566 | 0,05 | 174,67 | 14.323 | 29.094.050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.660 | 1.553.800 | 0,11 | 173,75 | 288.422 | 269.969.798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166.484 | 0,08 | 173,75 | 24.325 | 28.926.279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.151 | 1.552.140 | 0,27 | 173,20 | 718.960 | 268.833.131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166.344 | 0,21 | 173,20 | 60.621 | 28.811.047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1.547.989 | 0,03 | 171,79 | 79.195 | 265.929.030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165.994 | 0,02 | 171,79 | 6.700 | 28.516.109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.107 | 1.547.528 | 0,07 | 168,78 | 186.842 | 261.195.645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165.955 | 0,06 | 168,78 | 15.697 | 28.010.300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1.546.421 | 0,04 | 167,63 | 108.289 | 259.226.552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165.862 | 0,03 | 167,63 | 9.052 | 27.803.447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.548 | 1.500.227 | 0,91 | 154,78 | 2.096.961 | 232.205.285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.142 | 161.969 | 0,71 | 154,78 | 176.759 | 25.069.578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.098 | 1.486.679 | 0,55 | 153,97 | 1.246.878 | 228.909.318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160.827 | 0,43 | 153,97 | 105.164 | 24.763.112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.877 | 1.478.581 | 0,19 | 153,25 | 440.907 | 226.595.939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160.144 | 0,15 | 153,25 | 37.087 | 24.542.436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1.475.704 | 0,04 | 152,21 | 98.330 | 224.621.185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159.902 | 0,03 | 152,21 | 8.219 | 24.339.147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6.022 | 1.475.058 | 0,41 | 152,48 | 918.235 | 224.916.844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159.848 | 0,32 | 152,48 | 77.307 | 24.373.623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.542 | 1.469.036 | 0,24 | 154,60 | 547.582 | 227.108.412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159.341 | 0,19 | 154,60 | 46.224 | 24.633.625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.426 | 1.465.494 | 1,84 | 146,21 | 3.863.756 | 214.270.464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.228 | 159.042 | 1,42 | 146,21 | 325.757 | 23.253.594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.994 | 1.439.068 | 0,21 | 145,98 | 437.057 | 210.071.549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156.814 | 0,16 | 145,98 | 36.786 | 22.891.316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6.369 | 1.436.074 | 0,45 | 145,46 | 926.430 | 208.890.175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156.562 | 0,34 | 145,46 | 78.112 | 22.773.383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.291 | 1.429.705 | 0,09 | 142,86 | 184.429 | 204.244.082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156.025 | 0,07 | 142,86 | 15.571 | 22.289.341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.790 | 1.428.414 | 0,76 | 141,44 | 1.526.192 | 202.042.018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155.916 | 0,59 | 141,44 | 128.715 | 22.053.539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.072 | 1.417.624 | 0,36 | 140,90 | 714.657 | 199.746.624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155.006 | 0,28 | 140,90 | 60.165 | 21.840.717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.631 | 1.412.552 | 0,33 | 137,69 | 637.622 | 194.487.928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154.579 | 0,25 | 137,69 | 53.697 | 21.283.287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.693 | 1.407.921 | 0,26 | 136,91 | 505.605 | 192.756.915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154.189 | 0,20 | 136,91 | 42.579 | 21.109.846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.144 | 1.404.228 | 0,22 | 136,18 | 428.151 | 191.228.471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153.878 | 0,17 | 136,18 | 36.088 | 20.955.183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14.018 | 1.545.775 | 0,92 | 161,97 | 2.270.439 | 250.362.994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.181 | 165.808 | 0,72 | 161,97 | 191.282 | 26.855.259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31.530 | 1.531.757 | 2,10 | 156,42 | 4.932.061 | 239.604.170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.658 | 164.627 | 1,64 | 156,42 | 415.776 | 25.751.680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1.008.660 | 9.691.294 | -9,43 | 180,50 | -182.063.130 | 1.749.278.567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91.340 | 877.603 | -9,43 | 180,50 | -16.486.870 | 158.407.342 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251.902 | 2.971.128 | -7,82 | 0,40 | -101.391 | 1.195.879 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22.837 | 286.893 | -7,37 | 0,40 | -9.192 | 115.474 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535.601 | 1.658.190 | 47,71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57.049 | 155.874 | 57,73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33.446.882 | 0,00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2.968.974 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.968 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274.560 | 0,20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61.134 | 5.612.949 | 1,10 | 0,69 | 42.354 | 3.888.651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5.041 | 494.133 | 1,03 | 0,69 | 3.492 | 342.335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93.091 | 5.551.815 | 1,71 | 0,69 | 64.456 | 3.844.077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7.676 | 489.092 | 1,59 | 0,69 | 5.315 | 338.647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4.434 | 5.458.724 | 0,08 | 0,68 | 3.028 | 3.727.217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481.416 | 0,08 | 0,68 | 250 | 328.711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207.676 | 5.454.290 | 3,96 | 0,68 | 141.324 | 3.711.644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17.124 | 481.050 | 3,69 | 0,68 | 11.653 | 327.355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4.342 | 5.246.614 | 0,08 | 0,66 | 2.887 | 3.488.998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463.926 | 0,08 | 0,66 | 238 | 308.511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1.740.581 | 5.242.272 | 49,71 | 0,63 | 1.097.958 | 3.306.825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143.519 | 463.568 | 44,84 | 0,63 | 90.532 | 292.419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33.446.372 | 0,00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33.446.372 | 0,00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.414 | 0,02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.414 | 0,02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148.821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1.396.292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.792 | 1.401.084 | 0,34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.792 | 1.401.084 | 0,34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25.844 | 93.417 | 38,25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25.844 | 93.417 | 38,25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.505 | 33.445.860 | 0,01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.505 | 33.445.860 | 0,01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8.746 | 2.719.343 | 0,32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8.746 | 2.719.343 | 0,32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13.304 | 39.330.977 | 0,03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13.304 | 39.330.977 | 0,03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2.044 | 42.977.301 | 0,00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2.044 | 42.977.301 | 0,00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259.109 | 39.317.673 | 0,66 | 25,65 | 6.646.146 | 1.008.498.312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.113 | 3.610.443 | 0,67 | 25,65 | 618.498 | 92.607.863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.878 | 39.058.564 | 0,07 | 25,51 | 736.788 | 996.532.390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.688 | 3.586.330 | 0,08 | 25,51 | 68.581 | 91.500.906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218.171 | 39.029.686 | 0,56 | 25,27 | 5.513.683 | 986.369.933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20.304 | 3.583.642 | 0,57 | 25,27 | 513.129 | 90.566.876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74.582 | 38.811.515 | 0,19 | 25,54 | 1.904.824 | 991.246.093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6.941 | 3.563.338 | 0,20 | 25,54 | 177.273 | 91.007.653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116.672 | 38.736.933 | 0,30 | 25,33 | 2.955.325 | 981.214.260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10.858 | 3.556.397 | 0,31 | 25,33 | 275.035 | 90.084.247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12.500 | 38.620.261 | 0,03 | 17,01 | 212.625 | 656.930.640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12.500 | 38.620.261 | 0,03 | 17,01 | 212.625 | 656.930.640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40.632 | 38.607.761 | 0,11 | 24,80 | 1.007.674 | 957.472.473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.781 | 3.533.039 | 0,11 | 24,80 | 93.769 | 87.619.367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82.148 | 38.567.129 | 0,21 | 24,46 | 2.009.373 | 943.367.402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.645 | 3.529.258 | 0,22 | 24,46 | 187.000 | 86.327.062 | |
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21.912 | ||||||||
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227.211 | ||||||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209.175 | 23.277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209.175 | 23.277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209.175 | 232.452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209.175 | 232.452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2.368.357 | 1.729.158 | -57,80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8.750 | 42.975.257 | 0,02 | 36,70 | 321.125 | 1.577.191.932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8.750 | 42.975.257 | 0,02 | 36,70 | 321.125 | 1.577.191.932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33.443.355 | 0,00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33.443.355 | 0,00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.895.860 | 0,02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.895.860 | 0,02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.442.926 | 0,06 | 22,74 | 454.800 | 760.492.137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.442.926 | 0,06 | 22,74 | 454.800 | 760.492.137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15.000 | 38.484.981 | 0,04 | 5,22 | 78.300 | 200.891.601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15.000 | 38.484.981 | 0,04 | 5,22 | 78.300 | 200.891.601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33.422.926 | 0,00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33.422.926 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33.422.529 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33.422.529 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33.422.072 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33.422.072 | 0,00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10.000 | 2.710.597 | 0,37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10.000 | 2.710.597 | 0,37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33.384 | 67.573 | 97,65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33.384 | 67.569 | 97,66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.144 | 33.421.639 | 0,01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.144 | 33.421.639 | 0,01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10.622.568 | 14.575.984 | 268,69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1.252.432 | 1.585.054 | 376,53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17.104 | 38.469.981 | 0,04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17.104 | 38.469.981 | 0,04 | ||||
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26.450 | 4.501.658 | 0,59 | 6,42 | 169.849 | 28.907.397 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3.118 | 364.161 | 0,86 | 6,42 | 20.022 | 2.338.460 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.815 | 4.475.208 | 0,17 | 6,35 | 49.654 | 28.434.129 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361.043 | 0,26 | 6,35 | 5.852 | 2.293.959 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.364 | 4.467.393 | 0,05 | 5,82 | 13.759 | 26.001.121 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360.122 | 0,08 | 5,82 | 1.624 | 2.095.982 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170.549 | 15.967.504 | 1,08 | 7,78 | 1.327.008 | 124.239.955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20.108 | 1.342.986 | 1,52 | 7,78 | 156.456 | 10.449.505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101.315 | 15.796.955 | 0,65 | 7,75 | 785.070 | 122.407.445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.945 | 1.322.878 | 0,91 | 7,75 | 92.559 | 10.250.717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78.271 | 15.695.640 | 0,50 | 7,95 | 622.466 | 124.822.716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.224 | 1.310.933 | 0,71 | 7,95 | 73.356 | 10.425.457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.155 | 15.617.369 | 0,08 | 7,93 | 104.363 | 123.897.273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.550 | 1.301.709 | 0,12 | 7,93 | 12.297 | 10.326.848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138.122 | 15.604.214 | 0,89 | 7,68 | 1.060.680 | 119.829.441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16.278 | 1.300.159 | 1,27 | 7,68 | 125.004 | 9.984.311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.585 | 15.466.092 | 0,07 | 7,51 | 79.540 | 116.218.402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.247 | 1.283.881 | 0,10 | 7,51 | 9.370 | 9.647.595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88.046 | 15.455.507 | 0,57 | 6,92 | 609.278 | 106.952.108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.386 | 1.282.634 | 0,82 | 6,92 | 71.871 | 8.875.827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51.082 | 15.367.461 | 0,33 | 6,78 | 346.367 | 104.200.606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.026 | 1.272.248 | 0,48 | 6,78 | 40.860 | 8.626.605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15.316.379 | 0,00 | 6,64 | 2.375 | 101.624.175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1.266.222 | 0,00 | 6,64 | 279 | 8.401.383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15.316.021 | 0,01 | 6,76 | 6.647 | 103.459.722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1.266.180 | 0,01 | 6,76 | 784 | 8.553.046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53.401 | 15.315.037 | 0,35 | 6,75 | 360.521 | 103.394.878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.299 | 1.266.064 | 0,50 | 6,75 | 42.526 | 8.547.451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.090 | 15.261.636 | 0,19 | 6,71 | 195.089 | 102.350.636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.432 | 1.259.765 | 0,27 | 6,71 | 23.016 | 8.448.488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42.250 | 15.232.546 | 0,28 | 6,60 | 279.002 | 100.589.641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.984 | 1.256.333 | 0,40 | 6,60 | 32.912 | 8.296.321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48.222 | 15.190.296 | 0,32 | 6,53 | 315.058 | 99.245.799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.688 | 1.251.349 | 0,46 | 6,53 | 37.163 | 8.175.689 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19.789 | 4.465.029 | 0,45 | 5,74 | 113.619 | 25.635.964 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.334 | 359.843 | 0,65 | 5,74 | 13.401 | 2.066.039 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1.521 | 4.445.240 | 0,03 | 5,93 | 9.020 | 26.360.273 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357.509 | 0,05 | 5,93 | 1.061 | 2.120.028 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.010 | 4.443.719 | 0,16 | 5,99 | 41.972 | 26.606.323 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357.330 | 0,23 | 5,99 | 4.952 | 2.139.478 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.772 | 4.436.709 | 0,18 | 5,84 | 45.405 | 25.919.698 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356.503 | 0,27 | 5,84 | 5.527 | 2.082.726 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.248 | 4.428.937 | 0,16 | 5,84 | 42.335 | 25.868.978 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355.557 | 0,25 | 5,84 | 5.158 | 2.076.773 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.489 | 15.142.074 | 0,05 | 5,97 | 44.701 | 90.381.525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1.245.661 | 0,07 | 5,97 | 5.444 | 7.435.226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182.827 | 15.134.585 | 1,22 | 5,97 | 1.091.221 | 90.332.284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.266 | 1.244.749 | 1,82 | 5,97 | 132.897 | 7.429.409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.157 | 14.951.758 | 0,06 | 5,95 | 54.518 | 89.018.282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.115 | 1.222.483 | 0,09 | 5,95 | 6.638 | 7.278.297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90.674 | 14.942.601 | 0,61 | 5,99 | 542.929 | 89.471.812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.043 | 1.221.368 | 0,91 | 5,99 | 66.122 | 7.313.185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.118 | 14.851.927 | 0,05 | 5,99 | 48.599 | 88.912.546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1.210.325 | 0,08 | 5,99 | 5.921 | 7.245.732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.154 | 14.843.809 | 0,10 | 5,75 | 87.098 | 85.314.792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.846 | 1.209.336 | 0,15 | 5,75 | 10.610 | 6.950.659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93.690 | 14.828.655 | 0,64 | 5,71 | 534.979 | 84.673.103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.410 | 1.207.490 | 0,95 | 5,71 | 65.152 | 6.894.889 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30.003 | 4.421.689 | 0,68 | 6,00 | 180.018 | 26.530.134 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3.654 | 354.674 | 1,04 | 6,00 | 21.924 | 2.128.044 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4.391.686 | 0,02 | 5,92 | 4.095 | 25.989.998 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351.020 | 0,02 | 5,92 | 497 | 2.077.336 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16.501 | 4.390.994 | 0,38 | 6,13 | 101.153 | 26.917.232 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.010 | 350.936 | 0,58 | 6,13 | 12.322 | 2.151.273 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16.937 | 4.374.493 | 0,39 | 5,83 | 98.673 | 25.485.359 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.063 | 348.926 | 0,59 | 5,83 | 12.019 | 2.032.808 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3.676 | 3.676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.503 | 42.966.507 | 0,00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.503 | 42.966.507 | 0,00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22.983 | 2.528.583 | 0,92 | 1,99 | 45.628 | 5.019.996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2.882 | 256.209 | 1,14 | 1,99 | 5.722 | 508.652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758.094 | 2.505.600 | 43,38 | 1,95 | 1.478.283 | 4.885.920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95.060 | 253.327 | 60,06 | 1,95 | 185.367 | 493.988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101.831 | 1.747.506 | 6,19 | 1,93 | 196.962 | 3.380.026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12.769 | 158.267 | 8,78 | 1,93 | 24.698 | 306.120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325.373 | 1.645.675 | 24,64 | 1,70 | 553.134 | 2.797.648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40.800 | 145.498 | 38,97 | 1,70 | 69.360 | 247.347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2.592.497 | 4.674.392 | 124,53 | 23,00 | 59.627.431 | 107.511.016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233.590 | 421.532 | 124,29 | 23,00 | 5.372.570 | 9.695.236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33.419.495 | 0,00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33.419.495 | 0,00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29.497 | 29.497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 42.965.004 | 0,04 | 20,06 | 351.050 | 861.877.980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 42.965.004 | 0,04 | 20,06 | 351.050 | 861.877.980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175.795 | 33.419.055 | 0,53 | 73,31 | 12.887.303 | 2.449.907.477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14.490 | 2.941.147 | 0,50 | 73,31 | 1.062.243 | 215.611.663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.017 | 33.243.260 | 0,00 | 71,95 | 73.177 | 2.391.975.557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2.926.657 | 0,00 | 71,95 | 6.044 | 210.583.800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25.107 | 33.242.243 | 0,08 | 71,90 | 1.805.126 | 2.390.027.518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.070 | 2.926.573 | 0,07 | 71,90 | 148.827 | 210.412.697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65.147 | 33.217.136 | 0,20 | 71,72 | 4.672.408 | 2.382.366.211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.370 | 2.924.503 | 0,18 | 71,72 | 385.142 | 209.748.280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92.385 | 33.151.989 | 0,28 | 70,68 | 6.529.310 | 2.343.016.823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.615 | 2.919.133 | 0,26 | 70,68 | 538.190 | 206.309.725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.059.604 | 0,06 | 22,05 | 441.000 | 728.964.268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.059.604 | 0,06 | 22,05 | 441.000 | 728.964.268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92.234 | 33.039.604 | 0,28 | 68,07 | 6.278.507 | 2.249.055.404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.566 | 2.891.518 | 0,26 | 68,07 | 515.029 | 196.829.968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22.178 | 32.947.370 | 0,07 | 68,43 | 1.517.656 | 2.254.611.592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.827 | 2.883.952 | 0,06 | 68,43 | 125.023 | 197.350.854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100.731 | 32.925.192 | 0,31 | 68,37 | 6.886.696 | 2.251.003.187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.296 | 2.882.125 | 0,29 | 68,37 | 567.174 | 197.042.816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285.672 | 32.824.461 | 0,88 | 67,74 | 19.352.821 | 2.223.689.828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.300 | 32.538.789 | 0,02 | 67,40 | 491.984 | 2.192.951.685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271.997 | 14.734.965 | 1,88 | 54,57 | 14.843.883 | 804.141.559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.403 | 1.196.080 | 1,91 | 54,57 | 1.222.615 | 65.274.511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.174 | 14.462.968 | 0,04 | 53,82 | 278.457 | 778.376.690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1.173.677 | 0,04 | 53,82 | 22.927 | 63.165.653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64.119 | 14.457.794 | 0,45 | 54,26 | 3.479.200 | 784.503.035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.281 | 1.173.251 | 0,45 | 54,26 | 286.556 | 63.662.476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23.804 | 14.393.675 | 0,17 | 53,73 | 1.279.048 | 773.408.142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.961 | 1.167.970 | 0,17 | 53,73 | 105.369 | 62.757.948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.359 | 14.369.871 | 0,04 | 54,16 | 290.217 | 778.200.364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1.166.009 | 0,04 | 54,16 | 23.882 | 63.145.217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182.326 | 32.531.489 | 0,56 | 66,04 | 12.040.390 | 2.148.304.711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320.526 | 32.349.163 | 1,00 | 66,02 | 21.159.973 | 2.135.575.284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10.985 | 32.028.637 | 0,03 | 66,95 | 735.433 | 2.144.278.813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265.522 | 32.017.652 | 0,84 | 66,81 | 17.740.295 | 2.139.192.181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772.751 | 31.752.130 | 2,49 | 67,54 | 52.192.839 | 2.144.589.664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.100 | 30.979.379 | 0,02 | 67,20 | 409.899 | 2.081.705.841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40.164 | 30.973.279 | 0,13 | 66,57 | 2.673.577 | 2.061.782.777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27.841 | 14.364.512 | 0,19 | 57,22 | 1.593.076 | 821.944.559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.307 | 1.165.568 | 0,20 | 57,22 | 132.008 | 66.694.384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.526 | 14.336.671 | 0,08 | 51,61 | 594.898 | 739.967.202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1.163.261 | 0,08 | 51,61 | 49.188 | 60.040.088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17.119 | 14.325.145 | 0,12 | 50,56 | 865.460 | 724.214.868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.414 | 1.162.308 | 0,12 | 50,56 | 71.485 | 58.761.062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.395 | 14.308.026 | 0,16 | 49,70 | 1.113.056 | 711.124.631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.851 | 1.160.894 | 0,16 | 49,70 | 91.997 | 57.697.709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54.024 | 14.285.631 | 0,38 | 51,67 | 2.791.490 | 738.157.125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.465 | 1.159.043 | 0,39 | 51,67 | 230.712 | 59.889.259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117.291 | 14.231.607 | 0,83 | 51,59 | 6.050.820 | 734.181.565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86.479 | 14.114.316 | 0,62 | 52,04 | 4.500.497 | 734.530.176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.500 | 14.027.837 | 0,04 | 58,90 | 323.934 | 826.198.919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57.547 | 14.022.337 | 0,41 | 58,87 | 3.387.844 | 825.507.599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.350 | 13.964.790 | 0,07 | 58,76 | 549.368 | 820.513.805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132.367 | 13.955.440 | 0,96 | 58,13 | 7.693.938 | 811.171.114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25.900 | 13.823.073 | 0,19 | 57,59 | 1.491.519 | 796.037.599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116.083 | 13.797.173 | 0,85 | 56,86 | 6.601.060 | 784.576.243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.200 | 13.681.090 | 0,01 | 56,60 | 67.914 | 774.281.289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19.750 | 13.679.890 | 0,14 | 56,39 | 1.113.649 | 771.372.061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31.207 | 13.660.140 | 0,23 | 57,53 | 1.795.292 | 785.847.364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102.207 | 13.628.933 | 0,76 | 56,57 | 5.782.279 | 771.045.981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30.933.115 | 0,00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30.933.115 | 0,00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193.997 | 30.932.696 | 0,63 | 72,91 | 14.144.224 | 2.255.287.399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881.875 | 30.738.699 | 2,95 | 72,77 | 64.177.924 | 2.236.990.377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29.703 | 29.856.824 | 0,10 | 72,00 | 2.138.616 | 2.149.691.328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139.612 | 29.827.121 | 0,47 | 71,96 | 10.045.795 | 2.146.213.474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288.368 | 29.687.509 | 0,98 | 71,91 | 20.736.197 | 2.134.793.147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.382 | 29.399.141 | 0,02 | 71,03 | 382.302 | 2.088.323.882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.893 | 29.393.759 | 0,03 | 70,24 | 694.840 | 2.064.485.360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36.476 | 29.383.866 | 0,12 | 69,63 | 2.539.700 | 2.045.898.684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.352 | 29.347.390 | 0,03 | 68,52 | 640.841 | 2.011.015.226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29.338.038 | 0,00 | 67,90 | 58.460 | 1.991.999.972 | |
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346.863 | ||||||||
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4.357.556 | ||||||||
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51.399 | 42.947.504 | -0,12 | 161,39 | -8.295.146 | 6.931.181.712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4.738 | 4.069.762 | -0,12 | 161,39 | -764.653 | 656.807.901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8.332 | 42.998.903 | -0,02 | 161,34 | -1.344.327 | 6.937.658.005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4.074.500 | -0,02 | 161,34 | -123.913 | 657.400.202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25.833 | 43.007.235 | -0,06 | 160,80 | -4.154.029 | 6.915.701.011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2.381 | 4.075.268 | -0,06 | 160,80 | -382.872 | 655.316.135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.007 | 43.033.068 | 0,00 | 165,68 | -166.844 | 7.129.895.142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4.077.649 | 0,00 | 165,68 | -15.409 | 675.601.605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9.618 | 43.034.075 | -0,02 | 164,82 | -1.585.266 | 7.092.996.737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4.077.742 | -0,02 | 164,82 | -146.033 | 672.104.854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.337 | 43.043.693 | 0,00 | 163,39 | -218.449 | 7.032.809.999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4.078.628 | 0,00 | 163,39 | -20.097 | 666.397.648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20.154 | 43.045.030 | -0,05 | 160,96 | -3.243.986 | 6.928.523.724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.858 | 4.078.751 | -0,05 | 160,96 | -299.063 | 656.515.353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29.432 | 43.065.184 | -0,07 | 160,53 | -4.724.631 | 6.913.124.792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2.713 | 4.080.609 | -0,07 | 160,53 | -435.510 | 655.047.921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5.860 | 43.094.616 | -0,01 | 160,08 | -938.044 | 6.898.400.822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4.083.322 | -0,01 | 160,08 | -86.441 | 653.640.627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208.597 | 43.100.476 | -0,48 | 160,00 | -33.375.520 | 6.896.076.160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19.226 | 4.083.862 | -0,47 | 160,00 | -3.076.160 | 653.417.920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50.000 | 7.053.176 | 0,71 | 4,36 | 218.250 | 30.787.113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29.337.177 | 0,00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29.337.177 | 0,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86.932 | 13.526.726 | 0,65 | 95,83 | 8.330.572 | 1.296.247.215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138.815 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11.184 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13.439.794 | 0,00 | 102,00 | -1.428 | 1.370.858.988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138.815 | 13.439.808 | 1,04 | 0,01 | 1.388 | 134.398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1.154.578 | 0,00 | 102,00 | -204 | 117.766.956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11.184 | 1.154.580 | 0,98 | 0,01 | 112 | 11.546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.153 | 13.300.993 | 0,01 | 94,59 | 109.064 | 1.258.164.870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.299.840 | 0,00 | 94,48 | 37.791 | 1.256.535.634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30.285 | 13.299.440 | 0,23 | 94,38 | 2.858.425 | 1.255.257.005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52.201 | 13.269.155 | 0,39 | 93,35 | 4.872.948 | 1.238.671.639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.300 | 13.216.954 | 0,04 | 92,88 | 492.279 | 1.227.629.017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73.635 | 13.211.654 | 0,56 | 87,61 | 6.451.464 | 1.157.527.175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.396 | 13.138.019 | 0,02 | 87,48 | 209.607 | 1.149.341.492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.649 | 13.135.623 | 0,04 | 87,07 | 404.793 | 1.143.731.830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.968 | 13.130.974 | 0,02 | 86,94 | 258.033 | 1.141.587.183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.128.006 | 0,00 | 89,66 | 35.863 | 1.177.008.444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.100 | 13.127.606 | 0,01 | 88,16 | 96.982 | 1.157.395.383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.186 | 13.126.506 | 0,06 | 87,91 | 719.659 | 1.153.995.773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12.898 | 13.118.320 | 0,10 | 87,79 | 1.132.303 | 1.151.644.194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.764 | 13.105.422 | 0,06 | 85,95 | 667.333 | 1.126.439.853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.097.658 | 0,00 | 84,80 | 33.921 | 1.110.714.143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.097.258 | 0,00 | 88,82 | 35.526 | 1.163.232.969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16.269 | 13.096.858 | 0,12 | 88,76 | 1.444.017 | 1.162.461.400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21.595 | 13.080.589 | 0,17 | 88,59 | 1.913.036 | 1.158.770.138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.086 | 13.058.994 | 0,05 | 88,01 | 535.634 | 1.149.333.815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.600 | 13.052.908 | 0,04 | 86,44 | 397.646 | 1.128.354.716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13.048.308 | 0,00 | 85,58 | 25.674 | 1.116.674.199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.500 | 13.048.008 | 0,03 | 88,00 | 395.990 | 1.148.195.998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44.700 | 13.043.508 | 0,34 | 86,07 | 3.847.481 | 1.122.699.081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12.998.808 | 0,00 | 85,72 | 51.434 | 1.114.295.518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.723 | 12.998.208 | 0,03 | 84,39 | 314.185 | 1.096.922.673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3.960.811 | 3.960.811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3.960.811 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315.777 | 315.777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315.777 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1.320.302 | 1.320.302 | 15,00 | 19.804.530 | 19.804.530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104.698 | 104.698 | 15,00 | 1.570.470 | 1.570.470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29.336.784 | 0,00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29.336.784 | 0,00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66.474 | 66.474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7.368 | 7.368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121.612 | 12.994.485 | 0,94 | 92,75 | 11.279.014 | 1.205.185.206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.009 | 12.872.873 | 0,05 | 91,64 | 642.276 | 1.179.617.303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.353 | 12.865.864 | 0,17 | 90,20 | 2.016.332 | 1.160.553.683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.603 | 12.843.511 | 0,04 | 89,74 | 413.070 | 1.152.566.402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30.221 | 12.838.908 | 0,24 | 90,70 | 2.741.157 | 1.164.536.460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.200 | 12.808.687 | 0,01 | 90,40 | 108.474 | 1.157.841.261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.731 | 12.807.487 | 0,09 | 90,39 | 1.060.378 | 1.157.682.838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.847 | 12.795.756 | 0,03 | 89,90 | 345.828 | 1.150.282.163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.079 | 12.791.909 | 0,06 | 89,87 | 636.196 | 1.149.620.375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.459 | 12.784.830 | 0,08 | 91,87 | 960.845 | 1.174.514.205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.445 | 12.774.371 | 0,18 | 91,80 | 2.060.393 | 1.172.654.044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.170 | 12.751.926 | 0,08 | 90,76 | 923.046 | 1.157.386.482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.200 | 12.741.756 | 0,04 | 90,27 | 469.420 | 1.150.237.814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23.274 | 23.274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12.782 | 38.452.877 | 0,03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12.782 | 38.452.877 | 0,03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23.344 | 23.344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34.996 | 34.996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15.600 | 34.189 | 83,92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15.600 | 34.189 | 83,92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40.000 | 40.000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8.010 | 8.010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.923 | 29.336.439 | 0,01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.923 | 29.336.439 | 0,01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3.462 | 3.462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.402 | 43.309.073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.402 | 43.309.073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 43.307.671 | 0,04 | 19,02 | 332.850 | 823.711.902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 43.307.671 | 0,04 | 19,02 | 332.850 | 823.711.902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.334.516 | 0,07 | 18,97 | 379.400 | 556.475.769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 2.870.749 | 0,70 | 18,97 | 379.400 | 54.458.109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.314.516 | 0,00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.314.516 | 0,00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47.200 | 47.200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315.516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3.094.590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6.423 | 6.423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6.427.576 | 27.511.741 | 30,49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536.438 | 2.345.481 | 29,65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7.286.794 | 21.084.165 | 52,81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536.414 | 1.809.043 | 42,15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1.941 | 5.420 | 55,79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6.654.603 | 13.797.371 | 93,17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598.860 | 1.272.629 | 88,88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7.142.768 | 7.142.768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673.769 | 673.769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3.479 | 3.479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9.191.433 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767.106 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10.420.117 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767.072 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2.776 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9.516.082 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856.370 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10.214.159 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963.490 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4.975 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5.792.538 | 7.003.176 | 478,47 | 16,00 | 92.680.608 | 112.050.816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457.462 | 571.659 | 400,59 | 16,00 | 7.319.392 | 9.146.544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9.191.433 | 9.191.433 | 8,55 | 78.586.752 | 78.586.752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767.106 | 767.106 | 8,55 | 6.558.756 | 6.558.756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158.456 | 23.277 | -87,19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158.460 | 23.280 | -87,19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114.197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1.210.638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.188 | 41.500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.188 | 41.500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5.188 | 9.252.951 | 0,06 | 12,85 | 66.666 | 118.900.420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5.188 | 9.252.951 | 0,06 | 12,85 | 66.666 | 118.900.420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.833 | 2.527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.833 | 2.527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.377 | 6.723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.377 | 6.723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.833 | 2.895.306 | 0,20 | 40,27 | 234.895 | 116.593.973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.833 | 2.895.306 | 0,20 | 40,27 | 234.895 | 116.593.973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.377 | 2.889.473 | 0,19 | 16,00 | 86.032 | 46.231.568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.377 | 2.889.473 | 0,19 | 16,00 | 86.032 | 46.231.568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154.222 | 5.212.371 | 3,05 | 60,00 | 9.253.320 | 312.742.260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12.444 | 509.480 | 2,50 | 60,00 | 746.640 | 30.568.800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332.622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3.953.416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1.200.369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13.413.895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111.094 | 10.699.954 | -1,03 | 220,50 | -24.496.227 | 2.359.339.857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10.060 | 968.943 | -1,03 | 220,50 | -2.218.230 | 213.651.932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.884.096 | 0,01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.884.096 | 0,01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29.314.152 | 0,00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29.314.152 | 0,00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518.555 | 10.283.888 | 5,31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38.974 | 1.199.122 | 3,36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394.360 | 3.501.691 | 12,69 | 15,25 | 6.013.990 | 53.400.788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29.640 | 320.049 | 10,21 | 15,25 | 452.010 | 4.880.747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616.846 | 616.846 | 89,99 | 55.509.972 | 55.509.972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49.820 | 49.820 | 89,99 | 4.483.302 | 4.483.302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1.386.033 | 10.811.048 | -11,36 | 220,50 | -305.620.276 | 2.383.836.084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125.513 | 979.003 | -11,36 | 220,50 | -27.675.616 | 215.870.162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13.516 | 10.418 | -56,47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13.516 | 10.418 | -56,47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.411.619 | 12.736.556 | 12,46 | 108,00 | 152.454.852 | 1.375.548.048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116.158 | 1.143.396 | 11,31 | 108,00 | 12.545.064 | 123.486.768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.873 | 0,01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.873 | 0,01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29.313.809 | 0,00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29.313.809 | 0,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382.884 | 5.058.149 | 8,19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382.884 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30.349 | 497.036 | 6,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30.349 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574.327 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45.524 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2.698.424 | 4.675.265 | 136,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2.698.424 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247.034 | 466.687 | 112,47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247.034 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4.047.634 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370.552 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1.976.841 | 1.976.841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1.976.841 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219.653 | 219.653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219.653 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2.965.263 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329.478 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1.474.319 | 9.247.763 | 18,97 | 19,00 | 28.012.061 | 175.707.497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104.628 | 870.873 | 13,65 | 19,00 | 1.987.932 | 16.546.587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574.327 | 7.773.444 | 7,98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45.524 | 766.245 | 6,32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4.047.634 | 7.199.117 | 128,44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370.552 | 720.721 | 105,82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2.965.263 | 3.151.483 | 1.592,34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329.478 | 350.169 | 1.592,37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46.688 | 46.688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957.211 | 957.211 | 14,52 | 13.898.321 | 13.898.321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75.873 | 75.873 | 14,52 | 1.101.646 | 1.101.646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3.373.029 | 3.373.029 | 3,93 | 13.264.099 | 13.264.099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308.793 | 308.793 | 3,93 | 1.214.298 | 1.214.298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.843 | 11.324.937 | 0,07 | 58,09 | 455.565 | 657.814.628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1.027.238 | 0,05 | 58,09 | 32.354 | 59.667.633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19.235 | 11.317.094 | 0,17 | 56,92 | 1.094.854 | 644.167.859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.365 | 1.026.681 | 0,13 | 56,92 | 77.696 | 58.438.580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.705 | 11.297.859 | 0,04 | 56,76 | 267.055 | 641.265.347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1.025.316 | 0,03 | 56,76 | 18.958 | 58.196.834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.153 | 11.293.154 | 0,12 | 55,35 | 728.057 | 625.108.824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1.024.982 | 0,09 | 55,35 | 51.644 | 56.735.726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.327 | 11.280.001 | 0,26 | 52,11 | 1.528.374 | 587.856.124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.081 | 1.024.049 | 0,20 | 52,11 | 108.451 | 53.368.211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.306 | 11.250.674 | 0,04 | 51,41 | 221.368 | 578.388.150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1.021.968 | 0,03 | 51,41 | 15.731 | 52.538.557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74.381 | 11.246.368 | 0,67 | 52,44 | 3.900.235 | 589.713.428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.278 | 1.021.662 | 0,52 | 52,44 | 276.757 | 53.571.766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.467 | 11.171.987 | 0,09 | 52,40 | 548.468 | 585.408.767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1.016.384 | 0,07 | 52,40 | 38.933 | 53.258.217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.120 | 11.161.520 | 0,01 | 51,97 | 58.206 | 580.064.194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1.015.641 | 0,01 | 51,97 | 4.158 | 52.782.863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.361 | 11.160.400 | 0,20 | 51,98 | 1.162.235 | 580.072.950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.587 | 1.015.561 | 0,16 | 51,98 | 82.486 | 52.784.799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36.647 | 11.138.039 | 0,33 | 50,15 | 1.837.909 | 558.591.591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.601 | 1.013.974 | 0,26 | 50,15 | 130.445 | 50.852.520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.983 | 11.101.392 | 0,10 | 49,72 | 546.102 | 551.988.964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1.011.373 | 0,08 | 49,72 | 38.734 | 50.287.994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20.691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186.220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.172 | 11.090.409 | 0,14 | 47,47 | 720.200 | 526.450.625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.220 | 1.010.594 | 0,12 | 47,47 | 57.912 | 47.971.887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76.473 | 11.075.237 | 0,70 | 47,39 | 3.623.857 | 524.826.686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.151 | 1.009.374 | 0,61 | 47,39 | 291.480 | 47.831.609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.807 | 10.998.764 | 0,14 | 47,04 | 743.482 | 517.326.865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.272 | 1.003.223 | 0,13 | 47,04 | 59.829 | 47.186.594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10.982.957 | 0,00 | 45,88 | 8.487 | 503.843.152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1.001.951 | 0,00 | 45,88 | 688 | 45.964.502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.101 | 10.982.772 | 0,08 | 47,50 | 432.281 | 521.661.901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1.001.936 | 0,07 | 47,50 | 33.819 | 47.590.157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26.238 | 10.973.671 | 0,24 | 47,26 | 1.239.984 | 518.605.815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.054 | 1.001.224 | 0,21 | 47,26 | 97.070 | 47.316.945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.319 | 10.947.433 | 0,27 | 46,62 | 1.366.767 | 510.337.579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.295 | 999.170 | 0,23 | 46,62 | 106.986 | 46.578.408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12.132 | 10.918.114 | 0,11 | 45,30 | 549.535 | 494.550.167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996.875 | 0,10 | 45,30 | 43.031 | 45.154.749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32.088 | 10.905.982 | 0,30 | 49,00 | 1.572.312 | 534.393.118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.512 | 995.925 | 0,25 | 49,00 | 123.088 | 48.800.325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77.456 | 10.873.894 | 0,72 | 47,60 | 3.686.658 | 517.562.558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.062 | 993.413 | 0,61 | 47,60 | 288.532 | 47.283.280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.987 | 10.796.438 | 0,03 | 47,45 | 141.725 | 512.260.753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987.351 | 0,02 | 47,45 | 11.103 | 46.847.040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.359 | 10.793.451 | 0,02 | 46,97 | 110.798 | 506.947.886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987.117 | 0,02 | 46,97 | 8.689 | 46.363.010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83.832 | 10.791.092 | 0,78 | 49,08 | 4.114.734 | 529.660.248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.645 | 986.932 | 0,68 | 49,08 | 326.157 | 48.441.682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.286 | 10.707.260 | 0,02 | 48,74 | 111.430 | 521.922.177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980.287 | 0,02 | 48,74 | 8.823 | 47.783.796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42.714 | 10.704.974 | 0,40 | 47,74 | 2.039.256 | 511.077.939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.386 | 980.106 | 0,35 | 47,74 | 161.655 | 46.792.319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10.662.260 | 0,01 | 47,82 | 36.058 | 509.896.995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976.720 | 0,01 | 47,82 | 2.869 | 46.709.290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41.155 | 10.661.506 | 0,39 | 47,72 | 1.963.970 | 508.780.926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.262 | 976.660 | 0,34 | 47,72 | 155.667 | 46.607.485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.640 | 10.620.351 | 0,10 | 46,50 | 494.716 | 493.802.778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973.398 | 0,09 | 46,50 | 39.196 | 45.259.016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.576 | 10.609.711 | 0,03 | 46,30 | 165.575 | 491.248.717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972.555 | 0,03 | 46,30 | 13.103 | 45.031.047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.585 | 10.606.135 | 0,03 | 46,99 | 168.447 | 498.345.162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972.272 | 0,03 | 46,99 | 13.344 | 45.683.658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.335.362 | 11.638.314 | 12,96 | 21,00 | 28.042.602 | 244.404.594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93.210 | 1.143.650 | 8,87 | 21,00 | 1.957.410 | 24.016.650 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728.370 | 6.173.327 | 13,38 | 16,00 | 11.653.920 | 98.773.232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52.880 | 542.114 | 10,81 | 16,00 | 846.080 | 8.673.824 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728.370 | 6.173.327 | 13,38 | 16,00 | 11.653.920 | 98.773.232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52.880 | 542.114 | 10,81 | 16,00 | 846.080 | 8.673.824 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13.589.904 | 18.840.379 | 258,83 | 14,23 | 193.395.206 | 268.113.665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994.276 | 1.021.851 | 3.605,72 | 14,23 | 14.149.343 | 14.541.757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.650 | 0,01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.650 | 0,01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7.106 | 7.106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29.313.492 | 0,00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29.313.492 | 0,00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11.158 | 11.158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6.118 | 38.440.095 | 0,02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6.118 | 38.440.095 | 0,02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90.766 | 90.766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4.135 | 4.135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29.313.198 | 0,00 | 102,55 | 103 | 3.006.068.455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29.313.198 | 0,00 | 102,55 | 103 | 3.006.068.455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10.514 | 10.514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.282 | 29.313.197 | 0,00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.282 | 29.313.197 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3.171 | 3.171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1.335 | 43.290.171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1.335 | 43.290.171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1.602.312 | 43.288.836 | -3,57 | 160,00 | -256.369.920 | 6.926.213.760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147.688 | 4.082.851 | -3,49 | 160,00 | -23.630.080 | 653.256.160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.465.603 | 10.302.952 | 16,58 | 18,25 | 26.747.255 | 188.028.874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134.397 | 1.050.440 | 14,67 | 18,25 | 2.452.745 | 19.170.530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.189 | 7.846.213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.189 | 7.846.213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.468 | 7.845.024 | 0,04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.468 | 7.845.024 | 0,04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9.000 | 9.000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457.803 | 44.891.148 | -1,01 | 158,50 | -72.561.776 | 7.115.246.958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42.197 | 4.230.539 | -0,99 | 158,50 | -6.688.224 | 670.540.432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.343 | 45.348.951 | -0,01 | 166,15 | -721.610 | 7.534.941.349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4.272.736 | -0,01 | 166,15 | -66.462 | 709.935.168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48.880 | 45.353.294 | -0,11 | 164,96 | -8.063.118 | 7.481.361.460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.505 | 4.273.136 | -0,11 | 164,96 | -743.133 | 704.885.404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84.663 | 45.402.174 | -0,19 | 164,19 | -13.901.157 | 7.454.764.558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7.805 | 4.277.641 | -0,18 | 164,19 | -1.281.534 | 702.362.986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16.159 | 45.486.837 | -0,04 | 163,41 | -2.640.610 | 7.433.195.079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1.489 | 4.285.446 | -0,03 | 163,41 | -243.324 | 700.302.730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41.072 | 45.502.996 | -0,09 | 166,62 | -6.843.564 | 7.581.873.004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3.786 | 4.286.935 | -0,09 | 166,62 | -630.837 | 714.304.543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91.613 | 45.544.068 | -0,20 | 165,70 | -15.180.641 | 7.546.834.244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8.444 | 4.290.721 | -0,20 | 165,70 | -1.399.205 | 710.989.633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178.862 | 45.635.681 | -0,39 | 164,60 | -29.440.041 | 7.511.468.804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16.485 | 4.299.165 | -0,38 | 164,60 | -2.713.372 | 707.627.082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45.606 | 45.814.543 | -0,10 | 164,06 | -7.482.107 | 7.516.320.180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.204 | 4.315.650 | -0,10 | 164,06 | -689.707 | 708.024.244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.311.915 | 0,07 | 13,34 | 266.800 | 391.020.946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.311.915 | 0,07 | 13,34 | 266.800 | 391.020.946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17.500 | 45.860.149 | 0,04 | 12,76 | 223.300 | 585.175.501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17.500 | 45.860.149 | 0,04 | 12,76 | 223.300 | 585.175.501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.427 | 0,01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.427 | 0,01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29.291.915 | 0,00 | 73,23 | 28.706 | 2.145.046.935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29.291.915 | 0,00 | 73,23 | 28.706 | 2.145.046.935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42.473 | 38.433.977 | 0,11 | 34,47 | 1.463.896 | 1.324.684.668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.837 | 3.470.609 | 0,11 | 34,47 | 132.248 | 119.619.745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33.464 | 38.391.504 | 0,09 | 33,63 | 1.125.465 | 1.291.186.902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.023 | 3.466.772 | 0,09 | 33,63 | 101.670 | 116.594.823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.201 | 38.358.040 | 0,01 | 32,85 | 72.302 | 1.260.053.942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3.463.749 | 0,01 | 32,85 | 6.537 | 113.783.462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46.225 | 38.355.839 | 0,12 | 32,61 | 1.507.268 | 1.250.676.513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.175 | 3.463.550 | 0,12 | 32,61 | 136.135 | 112.936.668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38.309.614 | 0,00 | 31,94 | 8.782 | 1.223.417.523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3.459.375 | 0,00 | 31,94 | 798 | 110.475.141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93.006 | 38.309.339 | 0,24 | 33,86 | 3.149.406 | 1.297.246.161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8.402 | 3.459.350 | 0,24 | 33,86 | 284.512 | 117.141.893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.223 | 38.216.333 | 0,06 | 32,32 | 782.873 | 1.235.128.953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.188 | 3.450.948 | 0,06 | 32,32 | 70.715 | 111.532.569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29.624 | 38.192.110 | 0,08 | 32,19 | 953.620 | 1.229.434.575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.676 | 3.448.760 | 0,08 | 32,19 | 86.143 | 111.018.343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.612 | 38.162.486 | 0,02 | 31,83 | 242.290 | 1.214.711.929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3.446.084 | 0,02 | 31,83 | 21.899 | 109.688.854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.212 | 38.154.874 | 0,11 | 31,74 | 1.371.359 | 1.210.867.819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.903 | 3.445.396 | 0,11 | 31,74 | 123.864 | 109.341.709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.913 | 38.111.662 | 0,01 | 31,00 | 121.285 | 1.181.290.020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3.441.493 | 0,01 | 31,00 | 10.941 | 106.670.796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631.281 | 38.107.749 | 1,68 | 31,51 | 19.893.937 | 1.200.912.359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57.022 | 3.441.140 | 1,68 | 31,51 | 1.796.968 | 108.442.710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.503 | 37.476.468 | 0,01 | 31,19 | 171.613 | 1.168.714.898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3.384.118 | 0,01 | 31,19 | 15.499 | 105.534.735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.172 | 10.602.550 | 0,09 | 38,38 | 352.019 | 406.922.688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971.988 | 0,09 | 38,38 | 31.778 | 37.304.608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.237 | 10.593.378 | 0,06 | 37,75 | 235.433 | 399.876.714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971.160 | 0,06 | 37,75 | 21.252 | 36.659.153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17.058 | 10.587.141 | 0,16 | 36,69 | 625.914 | 388.477.141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.542 | 970.597 | 0,16 | 36,69 | 56.581 | 35.614.407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.172 | 10.570.083 | 0,09 | 38,98 | 357.570 | 412.074.686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969.055 | 0,09 | 38,98 | 32.280 | 37.778.609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95.934 | 10.560.911 | 0,92 | 39,97 | 3.834.588 | 422.131.230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.666 | 968.227 | 0,90 | 39,97 | 346.390 | 38.701.098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14.731 | 7.841.556 | 0,19 | 83,14 | 1.224.797 | 651.979.900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.331 | 994.296 | 0,13 | 83,14 | 110.665 | 82.669.945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.321 | 7.826.825 | 0,02 | 82,92 | 109.537 | 648.995.633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992.965 | 0,01 | 82,92 | 9.867 | 82.336.062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.928 | 7.825.504 | 0,20 | 82,13 | 1.308.149 | 642.700.035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.439 | 992.846 | 0,15 | 82,13 | 118.183 | 81.541.350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25.640 | 7.809.576 | 0,33 | 81,79 | 2.097.003 | 638.717.107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.314 | 991.407 | 0,23 | 81,79 | 189.254 | 81.083.609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.203 | 7.783.936 | 0,05 | 81,47 | 342.438 | 634.193.850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989.093 | 0,04 | 81,47 | 30.960 | 80.586.055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12.815 | 7.779.733 | 0,16 | 81,09 | 1.039.177 | 630.863.995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.158 | 988.713 | 0,12 | 81,09 | 93.903 | 80.175.429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.298 | 7.766.918 | 0,04 | 80,91 | 266.845 | 628.431.432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987.555 | 0,03 | 80,91 | 24.112 | 79.904.359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.285 | 7.763.620 | 0,13 | 79,87 | 821.429 | 620.054.709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987.257 | 0,09 | 79,87 | 74.196 | 78.848.959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.022 | 7.753.335 | 0,34 | 79,72 | 2.074.362 | 618.062.527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.351 | 986.328 | 0,24 | 79,72 | 187.412 | 78.625.827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.888 | 7.727.313 | 0,04 | 79,29 | 228.980 | 612.673.148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983.977 | 0,03 | 79,29 | 20.694 | 78.016.289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.191 | 7.724.425 | 0,05 | 79,16 | 331.760 | 611.467.028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983.716 | 0,04 | 79,16 | 30.002 | 77.871.155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7.720.234 | 0,01 | 78,66 | 44.443 | 607.273.606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983.337 | 0,01 | 78,66 | 4.012 | 77.349.288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65.505 | 7.719.669 | 0,86 | 76,67 | 5.022.445 | 591.887.865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.917 | 983.286 | 0,61 | 76,67 | 453.672 | 75.391.192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27.866 | 7.654.164 | 0,37 | 76,10 | 2.120.480 | 582.448.202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.517 | 977.369 | 0,26 | 76,10 | 191.533 | 74.373.480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62.129 | 7.626.298 | 0,82 | 79,76 | 4.955.720 | 608.311.660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.612 | 974.852 | 0,58 | 79,76 | 447.641 | 77.759.070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133.042 | 7.564.169 | 1,79 | 79,14 | 10.529.170 | 598.641.194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12.017 | 969.240 | 1,26 | 79,14 | 951.046 | 76.707.301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.612 | 7.431.127 | 0,10 | 77,94 | 593.260 | 579.163.461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957.223 | 0,07 | 77,94 | 53.621 | 74.603.568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.309 | 7.423.515 | 0,11 | 77,89 | 647.203 | 578.230.946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956.535 | 0,08 | 77,89 | 58.419 | 74.506.233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32.228 | 7.415.206 | 0,44 | 75,66 | 2.438.422 | 561.046.350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.911 | 955.785 | 0,31 | 75,66 | 220.251 | 72.316.222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18.000 | 18.000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82.740 | 10.464.977 | 0,80 | 57,82 | 4.783.944 | 605.074.505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.460 | 959.561 | 0,78 | 57,82 | 431.330 | 55.480.857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.989 | 10.382.237 | 0,09 | 59,61 | 535.824 | 618.873.727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952.101 | 0,09 | 59,61 | 48.343 | 56.753.693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.631 | 10.373.248 | 0,14 | 59,99 | 877.642 | 622.240.319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.319 | 951.290 | 0,14 | 59,99 | 79.120 | 57.063.226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145.994 | 10.358.617 | 1,43 | 57,68 | 8.421.518 | 597.526.463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.164 | 949.971 | 1,41 | 57,68 | 759.352 | 54.798.127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.051 | 10.212.623 | 0,14 | 57,22 | 803.980 | 584.353.012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.267 | 936.807 | 0,14 | 57,22 | 72.496 | 53.602.879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.402 | 10.198.572 | 0,14 | 58,80 | 846.819 | 599.662.775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.298 | 935.540 | 0,14 | 58,80 | 76.321 | 55.008.536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.623 | 10.184.170 | 0,08 | 60,77 | 524.043 | 618.919.508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934.242 | 0,08 | 60,77 | 47.220 | 56.776.409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.788 | 10.175.547 | 0,07 | 58,54 | 397.393 | 595.711.118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933.465 | 0,07 | 58,54 | 35.829 | 54.648.215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.122 | 10.168.759 | 0,07 | 58,39 | 415.826 | 593.714.180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932.853 | 0,07 | 58,39 | 37.484 | 54.465.649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.577 | 10.161.637 | 0,04 | 57,62 | 206.108 | 585.517.589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932.211 | 0,03 | 57,62 | 18.611 | 53.714.371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21.301 | 10.158.060 | 0,21 | 56,69 | 1.207.513 | 575.841.121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.921 | 931.888 | 0,21 | 56,69 | 108.898 | 52.826.960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.804 | 10.136.759 | 0,06 | 56,62 | 328.631 | 573.958.500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929.967 | 0,06 | 56,62 | 29.613 | 52.656.126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.121 | 10.130.955 | 0,10 | 56,25 | 569.277 | 569.836.839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929.444 | 0,10 | 56,25 | 51.297 | 52.278.530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10.120.834 | 0,00 | 55,45 | 5.102 | 561.225.547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928.532 | 0,00 | 55,45 | 444 | 51.489.421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.813 | 10.120.742 | 0,02 | 55,77 | 101.117 | 564.468.192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928.524 | 0,02 | 55,77 | 9.147 | 51.786.940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29.291.523 | 0,00 | 87,32 | 27.593 | 2.557.735.788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29.291.523 | 0,00 | 87,32 | 27.593 | 2.557.735.788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9.765.333 | 9.765.333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1.160.148 | 1.161.048 | 128.905,33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9.765.333 | 3.107.331 | -75,86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1.160.148 | 290.409 | -79,98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2.767.505 | 12.872.664 | 27,39 | 8,40 | 23.247.042 | 108.130.378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250.037 | 1.450.557 | 20,83 | 8,40 | 2.100.311 | 12.184.679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.743.993 | 10.118.929 | 20,82 | 46,00 | 80.223.678 | 465.470.734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158.180 | 928.360 | 20,54 | 46,00 | 7.276.280 | 42.704.560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22.000 | 22.000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7.642.042 | 0,00 | 67,28 | 24.894 | 514.156.586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7.642.042 | 0,00 | 67,28 | 24.894 | 514.156.586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1.217.279 | 0,03 | 67,28 | 24.894 | 81.898.531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244.595 | 0,15 | 67,28 | 24.894 | 16.456.352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160.223 | 0,23 | 67,28 | 24.894 | 10.779.803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.291.207 | 0,00 | 74,23 | 27.020 | 2.174.286.296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.291.207 | 0,00 | 74,23 | 27.020 | 2.174.286.296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2.081.895 | 2.081.895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2.081.895 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187.942 | 187.942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187.942 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2.883.204 | 2.883.204 | 16,00 | 46.131.264 | 46.131.264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260.796 | 260.796 | 16,00 | 4.172.736 | 4.172.736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.494.025 | 37.470.965 | 4,15 | 40,00 | 59.761.000 | 1.498.838.600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68.475 | 3.383.621 | 2,07 | 40,00 | 2.739.000 | 135.344.840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138.815 | 0,00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8.374.936 | 0,00 | 0,01 | 0 | 83.749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12.100 | 12.100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95.289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95.289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8.341 | 95.289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8.340 | 95.289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8.866 | 43.361 | -16,98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7.815 | 165.610 | -4,51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50.436 | 10.105.159 | 0,50 | 3,15 | 159.020 | 31.860.556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.564 | 1.200.520 | 0,38 | 3,15 | 14.390 | 3.785.120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209.382 | 10.054.723 | 2,13 | 3,02 | 633.255 | 30.409.504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18.943 | 1.195.956 | 1,61 | 3,02 | 57.291 | 3.617.049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.869 | 9.845.341 | 0,06 | 2,96 | 17.358 | 29.118.581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1.177.013 | 0,05 | 2,96 | 1.570 | 3.481.134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65.568 | 9.839.472 | 0,67 | 2,85 | 186.666 | 28.011.993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.932 | 1.176.482 | 0,51 | 2,85 | 16.888 | 3.349.327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.445 | 9.773.904 | 0,10 | 2,83 | 26.756 | 27.687.515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1.170.550 | 0,07 | 2,83 | 2.422 | 3.315.934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7.641.672 | 0,01 | 58,86 | 24.957 | 449.788.814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7.641.672 | 0,01 | 58,86 | 24.957 | 449.788.814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1.390.806 | 0,03 | 58,86 | 24.957 | 81.862.841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418.122 | 0,10 | 58,86 | 24.957 | 24.610.661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333.750 | 0,13 | 58,86 | 24.957 | 19.644.525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226.124 | 0,19 | 58,86 | 24.957 | 13.309.659 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.964 | 4.290.995 | 0,07 | 2,61 | 7.736 | 11.199.497 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.964 | 4.290.995 | 0,07 | 2,61 | 7.736 | 11.199.497 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29.290.843 | 0,00 | 84,96 | 26.338 | 2.488.550.021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29.290.843 | 0,00 | 84,96 | 26.338 | 2.488.550.021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1.904.850 | 5.444.957 | 53,81 | 17,00 | 32.382.450 | 92.564.269 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95.150 | 489.234 | 24,14 | 17,00 | 1.617.550 | 8.316.978 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3.540.107 | 3.540.107 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3.540.107 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394.084 | 394.084 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394.084 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920.361 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89.878 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2.302.669 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219.852 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3.223.030 | 3.223.030 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309.730 | 309.730 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13.166 | 13.166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 7.641.248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 7.641.248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 1.390.382 | 0,14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 417.698 | 0,46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 333.326 | 0,58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 225.700 | 0,85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74.229 | 181.733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74.229 | 181.733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1.002.483 | 4.302.354 | -18,90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14.840 | 14.840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14.840 | 14.840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200.423 | 98.980 | -66,94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31.229 | 102.876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31.229 | 102.876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421.756 | 3.315.146 | -11,29 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1.660 | 1.660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1.660 | 1.660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6.256 | 6.256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6.256 | 6.256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6.009 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11.337 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42.724 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21.929 | 21.929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21.929 | 21.929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59.267 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178.967 | 347.757 | -33,98 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43.109 | 43.109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43.109 | 43.109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582.200 | 18.591 | -96,91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13.516 | 20.618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13.516 | 20.618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182.539 | 1.028.034 | -15,08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129.220 | 129.220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220.141 | 281.190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220.141 | 281.190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692.706 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1.603.238 | 2.826.766 | -36,19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24.747 | 24.747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22.720 | 7.382.978 | -0,31 | 120,77 | -2.743.928 | 891.653.328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2.729 | 952.874 | -0,29 | 120,77 | -329.585 | 115.080.022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13.213 | 7.405.698 | -0,18 | 122,31 | -1.616.054 | 905.775.370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.587 | 955.603 | -0,17 | 122,31 | -194.103 | 116.877.796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15.355 | 7.418.911 | -0,21 | 120,12 | -1.844.459 | 891.167.750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.845 | 957.190 | -0,19 | 120,12 | -221.623 | 114.978.716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35.796 | 7.434.266 | -0,48 | 122,37 | -4.380.432 | 909.746.742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4.300 | 959.035 | -0,45 | 122,37 | -526.200 | 117.359.127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30.766 | 7.470.062 | -0,41 | 123,06 | -3.786.036 | 919.259.107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3.696 | 963.335 | -0,38 | 123,06 | -454.826 | 118.547.138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39.732 | 7.500.828 | -0,53 | 121,37 | -4.822.189 | 910.359.743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4.772 | 967.031 | -0,49 | 121,37 | -579.168 | 117.366.522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71.819 | 7.540.560 | -0,94 | 127,06 | -9.125.258 | 958.096.767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8.627 | 971.803 | -0,88 | 127,06 | -1.096.139 | 123.476.415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22.886 | 7.612.379 | -0,30 | 125,05 | -2.861.901 | 951.930.278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2.749 | 980.430 | -0,28 | 125,05 | -343.763 | 122.603.066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15.541 | 7.635.265 | -0,20 | 126,25 | -1.962.085 | 963.969.004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.867 | 983.179 | -0,19 | 126,25 | -235.713 | 124.128.512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7.038 | 7.038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7.038 | 7.038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2.963 | 45.842.649 | 0,01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2.963 | 45.842.649 | 0,01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.726 | 7.650.806 | 0,04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.726 | 7.650.806 | 0,04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 45.839.686 | 0,02 | 8,38 | 83.800 | 384.136.569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 45.839.686 | 0,02 | 8,38 | 83.800 | 384.136.569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529.758 | 529.758 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529.758 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60.194 | 60.194 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60.194 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2.905.359 | 2.905.359 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2.905.359 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324.421 | 324.421 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324.421 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820.729 | 820.729 | 14,00 | 11.490.206 | 11.490.206 | ||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72.128 | 72.128 | 14,00 | 1.009.792 | 1.009.792 | ||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.232 | 7.639.338 | -0,12 | 65,32 | -603.070 | 499.031.352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.417 | 1.214.575 | -0,12 | 65,32 | -92.564 | 79.340.776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241.891 | -0,10 | 65,32 | -15.939 | 15.801.263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157.519 | -0,09 | 65,32 | -9.276 | 10.289.755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49.893 | -0,02 | 65,32 | -719 | 3.259.205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171.091 | -0,09 | 65,32 | -10.321 | 11.176.331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63.775 | 7.648.570 | -0,83 | 67,13 | -4.281.177 | 513.443.915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.791 | 1.215.992 | -0,80 | 67,13 | -657.264 | 81.628.813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.688 | 242.135 | -0,69 | 67,13 | -113.314 | 16.254.377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157.661 | -0,62 | 67,13 | -65.720 | 10.583.688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49.904 | -0,15 | 67,13 | -4.968 | 3.350.026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.093 | 171.249 | -0,63 | 67,13 | -73.372 | 11.495.843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173.085 | 7.712.345 | -2,19 | 64,62 | -11.184.701 | 498.369.420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26.575 | 1.225.783 | -2,12 | 64,62 | -1.717.269 | 79.209.730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.581 | 243.823 | -1,84 | 64,62 | -296.023 | 15.755.769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.656 | 158.640 | -1,65 | 64,62 | -171.630 | 10.251.269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49.978 | -0,40 | 64,62 | -13.053 | 3.229.563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.966 | 172.342 | -1,69 | 64,62 | -191.662 | 11.136.688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106.054 | 7.885.430 | -1,33 | 66,61 | -7.063.981 | 525.227.990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16.282 | 1.252.358 | -1,28 | 66,61 | -1.084.502 | 83.416.310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.807 | 248.404 | -1,12 | 66,61 | -186.967 | 16.545.545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.628 | 161.296 | -1,00 | 66,61 | -108.437 | 10.743.507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50.180 | -0,25 | 66,61 | -8.259 | 3.342.359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.817 | 175.308 | -1,03 | 66,61 | -121.026 | 11.676.810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60.618 | 7.991.484 | -0,75 | 67,42 | -4.086.914 | 538.792.244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.307 | 1.268.640 | -0,73 | 67,42 | -627.485 | 85.532.724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.604 | 251.211 | -0,63 | 67,42 | -108.143 | 16.936.847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162.924 | -0,57 | 67,42 | -62.701 | 10.984.466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50.304 | -0,14 | 67,42 | -4.787 | 3.391.536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.039 | 177.125 | -0,58 | 67,42 | -70.050 | 11.941.909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.832 | 8.052.102 | -0,13 | 69,12 | -748.735 | 556.581.420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.663 | 1.277.947 | -0,13 | 69,12 | -114.951 | 88.334.892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252.815 | -0,11 | 69,12 | -19.838 | 17.475.205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163.854 | -0,10 | 69,12 | -11.474 | 11.325.998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50.375 | -0,03 | 69,12 | -899 | 3.482.046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178.164 | -0,10 | 69,12 | -12.788 | 12.315.141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102.618 | 8.062.934 | -1,26 | 68,70 | -7.049.918 | 553.928.404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.755 | 1.279.610 | -1,22 | 68,70 | -1.082.378 | 87.909.975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.716 | 253.102 | -1,06 | 68,70 | -186.591 | 17.388.259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.575 | 164.020 | -0,95 | 68,70 | -108.203 | 11.268.272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50.388 | -0,24 | 68,70 | -8.244 | 3.461.686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.758 | 178.349 | -0,98 | 68,70 | -120.776 | 12.252.683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.543 | 8.165.552 | -0,19 | 67,68 | -1.051.888 | 552.611.897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.386 | 1.295.365 | -0,18 | 67,68 | -161.475 | 87.665.122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255.818 | -0,16 | 67,68 | -27.815 | 17.312.739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165.595 | -0,14 | 67,68 | -16.175 | 11.206.807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50.508 | -0,04 | 67,68 | -1.218 | 3.418.179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180.107 | -0,15 | 67,68 | -18.002 | 12.188.921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.813 | 8.181.095 | -0,02 | 67,87 | -123.047 | 555.244.373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1.297.751 | -0,02 | 67,87 | -18.868 | 88.077.322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256.229 | -0,02 | 67,87 | -3.258 | 17.390.057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165.834 | -0,02 | 67,87 | -1.900 | 11.255.021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50.526 | 0,00 | 67,87 | -136 | 3.429.159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180.373 | -0,02 | 67,87 | -2.104 | 12.241.771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.661 | 8.182.908 | -0,23 | 67,90 | -1.267.017 | 555.590.813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.865 | 1.298.029 | -0,22 | 67,90 | -194.523 | 88.131.626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256.277 | -0,19 | 67,90 | -33.541 | 17.400.311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165.862 | -0,17 | 67,90 | -19.418 | 11.261.449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50.528 | -0,04 | 67,90 | -1.494 | 3.430.674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180.404 | -0,18 | 67,90 | -21.727 | 12.248.800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.863 | 8.201.569 | -0,52 | 68,72 | -2.945.370 | 563.578.195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.581 | 1.300.894 | -0,50 | 68,72 | -452.219 | 89.392.102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.134 | 256.771 | -0,44 | 68,72 | -77.924 | 17.644.250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166.148 | -0,39 | 68,72 | -45.215 | 11.417.009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50.550 | -0,10 | 68,72 | -3.436 | 3.473.589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180.724 | -0,40 | 68,72 | -50.437 | 12.418.612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21.116 | 8.244.432 | -0,26 | 68,63 | -1.449.147 | 565.798.055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.242 | 1.307.475 | -0,25 | 68,63 | -222.492 | 89.729.264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257.905 | -0,22 | 68,63 | -38.363 | 17.699.479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166.806 | -0,19 | 68,63 | -22.235 | 11.447.545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50.600 | -0,05 | 68,63 | -1.716 | 3.472.572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181.458 | -0,20 | 68,63 | -24.843 | 12.453.081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66.784 | 8.265.548 | -0,80 | 66,64 | -4.450.459 | 550.812.813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.253 | 1.310.717 | -0,78 | 66,64 | -683.256 | 87.345.657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.768 | 258.464 | -0,68 | 66,64 | -117.819 | 17.223.938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.025 | 167.130 | -0,61 | 66,64 | -68.306 | 11.137.476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50.625 | -0,15 | 66,64 | -5.198 | 3.373.630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.145 | 181.820 | -0,63 | 66,64 | -76.302 | 12.116.412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80.146 | 8.332.332 | -0,95 | 68,90 | -5.521.963 | 574.087.676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.305 | 1.320.970 | -0,92 | 68,90 | -847.800 | 91.013.248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.121 | 260.232 | -0,81 | 68,90 | -146.134 | 17.929.673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.230 | 168.155 | -0,73 | 68,90 | -84.746 | 11.585.678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50.703 | -0,18 | 68,90 | -6.408 | 3.493.376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.374 | 182.965 | -0,75 | 68,90 | -94.667 | 12.606.069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 89.233 | 4,89 | 2,59 | 10.777 | 231.113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 89.233 | 4,89 | 2,59 | 10.777 | 231.113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 4.288.031 | 0,10 | 2,59 | 10.777 | 11.106.000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8.412.478 | 0,00 | 66,84 | 19.918 | 562.290.030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8.412.478 | 0,00 | 66,84 | 19.918 | 562.290.030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1.507.172 | 0,02 | 66,84 | 19.918 | 100.739.376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436.250 | 0,07 | 66,84 | 19.918 | 29.158.950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343.282 | 0,09 | 66,84 | 19.918 | 22.944.969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224.693 | 0,13 | 66,84 | 19.918 | 15.018.480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46.678 | 8.412.180 | -0,55 | 74,71 | -3.487.122 | 628.439.478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.167 | 1.332.977 | -0,53 | 74,71 | -535.417 | 99.581.246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.235 | 262.055 | -0,47 | 74,71 | -92.262 | 19.577.055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169.087 | -0,42 | 74,71 | -53.489 | 12.631.797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50.498 | -0,11 | 74,71 | -4.109 | 3.772.499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184.041 | -0,43 | 74,71 | -59.765 | 13.748.949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41.281 | 8.458.858 | -0,49 | 74,34 | -3.068.962 | 628.858.572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.338 | 1.340.144 | -0,47 | 74,34 | -471.187 | 99.630.593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.092 | 263.290 | -0,41 | 74,34 | -81.183 | 19.573.821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169.803 | -0,37 | 74,34 | -47.134 | 12.623.698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50.553 | -0,09 | 74,34 | -3.568 | 3.758.272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184.841 | -0,38 | 74,34 | -52.561 | 13.741.671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86.620 | 8.500.139 | -1,01 | 74,63 | -6.464.529 | 634.373.024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.298 | 1.346.482 | -0,98 | 74,63 | -992.442 | 100.489.163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.293 | 264.382 | -0,86 | 74,63 | -171.129 | 19.731.067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.329 | 170.437 | -0,77 | 74,63 | -99.184 | 12.719.867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50.601 | -0,20 | 74,63 | -7.538 | 3.776.398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.485 | 185.548 | -0,79 | 74,63 | -110.827 | 13.847.614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90.251 | 8.586.759 | -1,04 | 74,19 | -6.695.487 | 637.029.325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.856 | 1.359.780 | -1,01 | 74,19 | -1.027.941 | 100.878.543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.388 | 266.675 | -0,89 | 74,19 | -177.160 | 19.783.925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.385 | 171.766 | -0,80 | 74,19 | -102.750 | 12.742.873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50.702 | -0,21 | 74,19 | -7.864 | 3.761.450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.547 | 187.033 | -0,82 | 74,19 | -114.768 | 13.875.492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8.677.010 | 0,00 | 74,56 | -30.795 | 647.001.251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1.373.636 | 0,00 | 74,56 | -4.698 | 102.425.168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269.063 | 0,00 | 74,56 | -820 | 20.062.683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173.151 | 0,00 | 74,56 | -447 | 12.911.004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188.580 | 0,00 | 74,56 | -522 | 14.061.468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.124 | 8.677.423 | -0,48 | 74,50 | -3.138.238 | 646.468.014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.467 | 1.373.699 | -0,47 | 74,50 | -481.792 | 102.340.576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.115 | 269.074 | -0,41 | 74,50 | -83.068 | 20.046.013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173.157 | -0,37 | 74,50 | -48.202 | 12.900.196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50.808 | -0,10 | 74,50 | -3.650 | 3.785.196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188.587 | -0,38 | 74,50 | -53.789 | 14.049.732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.068 | 8.719.547 | -0,04 | 76,57 | -234.915 | 667.649.610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1.380.166 | -0,03 | 76,57 | -36.064 | 105.678.345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270.189 | -0,03 | 76,57 | -6.202 | 20.688.183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173.804 | -0,03 | 76,57 | -3.599 | 13.308.051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50.857 | -0,01 | 76,57 | -306 | 3.894.085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189.309 | -0,03 | 76,57 | -3.982 | 14.495.258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41.281 | 8.458.858 | -0,49 | 74,34 | -3.068.962 | 628.858.572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.338 | 1.340.144 | -0,47 | 74,34 | -471.187 | 99.630.593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.092 | 263.290 | -0,41 | 74,34 | -81.183 | 19.573.821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169.803 | -0,37 | 74,34 | -47.134 | 12.623.698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50.553 | -0,09 | 74,34 | -3.568 | 3.758.272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184.841 | -0,38 | 74,34 | -52.561 | 13.741.671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.648 | 8.722.615 | -0,02 | 76,03 | -125.301 | 663.197.864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.380.637 | -0,02 | 76,03 | -19.236 | 104.972.592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270.270 | -0,02 | 76,03 | -3.345 | 20.549.169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173.851 | -0,01 | 76,03 | -1.901 | 13.218.239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50.861 | 0,00 | 76,03 | -152 | 3.867.064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189.361 | -0,01 | 76,03 | -2.129 | 14.397.496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51.987 | 8.724.263 | -0,59 | 76,50 | -3.977.031 | 667.410.482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.982 | 1.380.890 | -0,57 | 76,50 | -610.627 | 105.638.775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.375 | 270.314 | -0,51 | 76,50 | -105.188 | 20.679.156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173.876 | -0,46 | 76,50 | -61.047 | 13.301.601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50.863 | -0,12 | 76,50 | -4.667 | 3.891.045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189.389 | -0,47 | 76,50 | -68.162 | 14.488.353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8.776.250 | 0,00 | 75,40 | -18.624 | 661.729.250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1.388.872 | 0,00 | 75,40 | -2.941 | 104.720.949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271.689 | 0,00 | 75,40 | -528 | 20.485.351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174.674 | 0,00 | 75,40 | -302 | 13.170.420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174.674 | 0,00 | 75,40 | -302 | 13.170.420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50.924 | 0,00 | 75,40 | -75 | 3.839.670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63.047 | 8.776.497 | -0,71 | 75,92 | -4.786.390 | 666.292.344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.679 | 1.388.911 | -0,69 | 75,92 | -734.808 | 105.443.068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.668 | 271.696 | -0,61 | 75,92 | -126.631 | 20.626.563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174.678 | -0,55 | 75,92 | -73.413 | 13.261.169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50.925 | -0,14 | 75,92 | -5.542 | 3.866.114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.080 | 190.284 | -0,56 | 75,92 | -81.991 | 14.445.943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.832 | 8.839.544 | -0,03 | 76,05 | -215.369 | 672.232.294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1.398.590 | -0,03 | 76,05 | -33.081 | 106.360.392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273.364 | -0,03 | 76,05 | -5.704 | 20.788.867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175.645 | -0,02 | 76,05 | -3.270 | 13.357.504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50.998 | -0,01 | 76,05 | -228 | 3.878.311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191.364 | -0,03 | 76,05 | -3.726 | 14.552.907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61.122 | 8.842.376 | -0,69 | 75,63 | -4.622.669 | 668.750.665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.384 | 1.399.025 | -0,67 | 75,63 | -709.714 | 105.808.541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.618 | 273.439 | -0,59 | 75,63 | -122.370 | 20.680.246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175.688 | -0,53 | 75,63 | -70.941 | 13.287.319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51.001 | -0,14 | 75,63 | -5.370 | 3.857.216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.047 | 191.413 | -0,54 | 75,63 | -79.185 | 14.476.603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.296 | 8.903.498 | -0,04 | 74,03 | -244.007 | 659.137.531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1.408.409 | -0,04 | 74,03 | -37.460 | 104.266.349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275.057 | -0,03 | 74,03 | -6.441 | 20.362.827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176.626 | -0,03 | 74,03 | -3.776 | 13.075.852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51.072 | -0,01 | 74,03 | -296 | 3.780.927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192.460 | -0,03 | 74,03 | -4.146 | 14.248.064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37.107 | 8.906.794 | -0,41 | 75,08 | -2.786.101 | 668.747.923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.697 | 1.408.915 | -0,40 | 75,08 | -427.747 | 105.785.424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275.144 | -0,36 | 75,08 | -73.731 | 20.658.609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176.677 | -0,32 | 75,08 | -42.722 | 13.265.422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51.076 | -0,08 | 75,08 | -3.229 | 3.834.934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192.516 | -0,33 | 75,08 | -47.828 | 14.454.660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.703 | 8.943.901 | -0,21 | 73,55 | -1.375.551 | 657.797.981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.872 | 1.414.612 | -0,20 | 73,55 | -211.227 | 104.040.610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276.126 | -0,18 | 73,55 | -36.406 | 20.308.267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177.246 | -0,16 | 73,55 | -21.108 | 13.035.929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51.119 | -0,04 | 73,55 | -1.618 | 3.759.654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193.153 | -0,17 | 73,55 | -23.609 | 14.205.843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.647 | 8.962.604 | -0,02 | 73,72 | -121.421 | 660.745.573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.417.484 | -0,02 | 73,72 | -18.652 | 104.500.464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276.621 | -0,02 | 73,72 | -3.244 | 20.393.192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177.533 | -0,01 | 73,72 | -1.843 | 13.088.177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51.141 | 0,00 | 73,72 | -147 | 3.770.242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193.474 | -0,01 | 73,72 | -2.138 | 14.263.387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.486 | 8.964.251 | -0,09 | 77,04 | -653.755 | 690.598.726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.303 | 1.417.737 | -0,09 | 77,04 | -100.382 | 109.221.324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276.665 | -0,08 | 77,04 | -17.334 | 21.314.050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177.558 | -0,07 | 77,04 | -10.015 | 13.678.926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51.143 | -0,02 | 77,04 | -770 | 3.940.016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193.503 | -0,08 | 77,04 | -11.248 | 14.907.316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22.914 | 8.972.737 | -0,25 | 76,49 | -1.752.680 | 686.320.167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.518 | 1.419.040 | -0,25 | 76,49 | -269.090 | 108.541.660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276.890 | -0,22 | 76,49 | -46.429 | 21.179.178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177.688 | -0,20 | 76,49 | -26.924 | 13.591.266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51.153 | -0,05 | 76,49 | -2.065 | 3.912.667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193.649 | -0,20 | 76,49 | -30.060 | 14.812.115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58.412 | 8.995.651 | -0,65 | 77,15 | -4.506.626 | 694.036.064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.968 | 1.422.558 | -0,63 | 77,15 | -691.903 | 109.753.764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.546 | 277.497 | -0,55 | 77,15 | -119.278 | 21.409.560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178.040 | -0,50 | 77,15 | -69.129 | 13.736.213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51.180 | -0,13 | 77,15 | -5.246 | 3.948.660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.001 | 194.042 | -0,51 | 77,15 | -77.230 | 14.970.806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.909 | 9.054.063 | -0,08 | 77,64 | -536.386 | 702.919.424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.060 | 1.431.526 | -0,07 | 77,64 | -82.294 | 111.137.666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279.043 | -0,07 | 77,64 | -14.207 | 21.663.727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178.936 | -0,06 | 77,64 | -8.307 | 13.891.840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51.248 | -0,02 | 77,64 | -621 | 3.978.679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195.043 | -0,06 | 77,64 | -9.161 | 15.142.319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9.060.972 | -0,01 | 76,20 | -37.565 | 690.423.414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1.432.586 | -0,01 | 76,20 | -5.791 | 109.159.472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279.226 | 0,00 | 76,20 | -991 | 21.276.323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179.043 | 0,00 | 76,20 | -610 | 13.642.629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.256 | 0,00 | 76,20 | -76 | 3.905.579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195.161 | 0,00 | 76,20 | -686 | 14.870.780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9.061.465 | -0,01 | 76,20 | -56.540 | 690.483.633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1.432.662 | -0,01 | 76,20 | -8.687 | 109.168.844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279.239 | -0,01 | 76,20 | -1.524 | 21.278.012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179.051 | -0,01 | 76,20 | -838 | 13.643.686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.257 | 0,00 | 76,20 | -76 | 3.905.783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195.170 | -0,01 | 76,20 | -991 | 14.871.954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31.482 | 9.062.207 | -0,35 | 76,66 | -2.413.501 | 694.735.069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.833 | 1.432.776 | -0,34 | 76,66 | -370.512 | 109.840.763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279.259 | -0,30 | 76,66 | -63.860 | 21.408.805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179.062 | -0,27 | 76,66 | -37.105 | 13.727.412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51.258 | -0,07 | 76,66 | -2.837 | 3.929.587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195.183 | -0,28 | 76,66 | -41.321 | 14.963.295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9.093.689 | -0,01 | 77,81 | -48.239 | 707.539.019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1.437.609 | -0,01 | 77,81 | -7.392 | 111.853.887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280.092 | -0,01 | 77,81 | -1.245 | 21.792.698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179.546 | -0,01 | 77,81 | -778 | 13.969.666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.295 | 0,00 | 77,81 | -78 | 3.991.033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195.722 | -0,01 | 77,81 | -856 | 15.228.248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.506 | 9.094.309 | -0,07 | 78,13 | -508.342 | 710.577.468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1.437.704 | -0,07 | 78,13 | -78.056 | 112.333.996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280.108 | -0,06 | 78,13 | -13.439 | 21.886.043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179.556 | -0,06 | 78,13 | -7.813 | 14.029.482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51.296 | -0,02 | 78,13 | -625 | 4.007.977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195.733 | -0,06 | 78,13 | -8.751 | 15.293.461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 9.100.815 | 0,09 | 17,59 | 145.118 | 160.083.336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 9.100.815 | 0,09 | 17,59 | 145.118 | 160.083.336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.288.793 | 0,07 | 2,80 | 56.000 | 82.008.620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.288.793 | 0,07 | 2,80 | 56.000 | 82.008.620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.818.475 | 8.837.349 | 25,91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181.525 | 916.043 | 24,71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.634 | 9.092.565 | -0,15 | 70,55 | -961.887 | 641.485.916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.093 | 1.430.453 | -0,15 | 70,55 | -147.662 | 100.919.317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280.280 | -0,13 | 70,55 | -25.469 | 19.773.922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179.656 | -0,12 | 70,55 | -14.816 | 12.674.839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51.304 | -0,03 | 70,55 | -1.129 | 3.619.528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195.845 | -0,12 | 70,55 | -16.509 | 13.816.982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24.660 | 9.106.199 | -0,27 | 71,35 | -1.759.553 | 649.750.064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.786 | 1.432.546 | -0,26 | 71,35 | -270.141 | 102.215.738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280.641 | -0,23 | 71,35 | -46.593 | 20.024.437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179.866 | -0,21 | 71,35 | -26.971 | 12.833.889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51.320 | -0,06 | 71,35 | -2.069 | 3.661.810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196.079 | -0,22 | 71,35 | -30.182 | 13.990.727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75.736 | 9.130.859 | -0,82 | 72,20 | -5.468.397 | 659.279.065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.627 | 1.436.332 | -0,80 | 72,20 | -839.509 | 103.708.054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.004 | 281.294 | -0,71 | 72,20 | -144.696 | 20.310.383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.162 | 180.244 | -0,64 | 72,20 | -83.900 | 13.014.230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51.349 | -0,17 | 72,20 | -6.426 | 3.707.572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.298 | 196.502 | -0,66 | 72,20 | -93.720 | 14.188.113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65.426 | 9.206.595 | -0,71 | 72,02 | -4.711.967 | 663.057.131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.044 | 1.447.959 | -0,69 | 72,02 | -723.367 | 104.281.718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.732 | 283.298 | -0,61 | 72,02 | -124.738 | 20.403.065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.004 | 181.406 | -0,55 | 72,02 | -72.308 | 13.064.824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51.438 | -0,15 | 72,02 | -5.474 | 3.704.554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.121 | 197.800 | -0,56 | 72,02 | -80.734 | 14.245.516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.648 | 9.272.021 | -0,02 | 73,46 | -121.054 | 681.076.303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.458.003 | -0,02 | 73,46 | -18.584 | 107.097.610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285.030 | -0,02 | 73,46 | -3.232 | 20.936.879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182.410 | -0,01 | 73,46 | -1.836 | 13.398.927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51.514 | 0,00 | 73,46 | -147 | 3.783.961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198.921 | -0,01 | 73,46 | -2.057 | 14.611.742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29.260 | 9.273.669 | -0,31 | 70,52 | -2.063.313 | 653.946.680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.492 | 1.458.256 | -0,31 | 70,52 | -316.760 | 102.831.109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285.074 | -0,27 | 70,52 | -54.580 | 20.102.421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182.435 | -0,25 | 70,52 | -31.732 | 12.864.678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51.516 | -0,07 | 70,52 | -2.398 | 3.632.728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198.949 | -0,25 | 70,52 | -35.399 | 14.029.187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.521 | 9.302.929 | -0,45 | 71,00 | -3.018.995 | 660.508.889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.529 | 1.462.748 | -0,44 | 71,00 | -463.560 | 103.855.254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.125 | 285.848 | -0,39 | 71,00 | -79.875 | 20.295.237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182.885 | -0,36 | 71,00 | -46.292 | 12.984.853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51.550 | -0,10 | 71,00 | -3.550 | 3.660.055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199.451 | -0,36 | 71,00 | -51.759 | 14.161.041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.547 | 9.345.450 | -0,11 | 71,61 | -755.298 | 669.251.973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.619 | 1.469.277 | -0,11 | 71,61 | -115.941 | 105.218.746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286.973 | -0,10 | 71,61 | -19.980 | 20.550.883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183.537 | -0,09 | 71,61 | -11.601 | 13.143.562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51.600 | -0,02 | 71,61 | -859 | 3.695.210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200.180 | -0,09 | 71,61 | -12.962 | 14.335.410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.595 | 9.355.997 | -0,15 | 72,23 | -981.964 | 675.781.792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.087 | 1.470.896 | -0,14 | 72,23 | -150.744 | 106.242.524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287.252 | -0,13 | 72,23 | -26.003 | 20.748.155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183.699 | -0,11 | 72,23 | -15.096 | 13.268.542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51.612 | -0,03 | 72,23 | -1.156 | 3.727.924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200.361 | -0,12 | 72,23 | -16.830 | 14.472.035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132.363 | 9.369.592 | -1,39 | 72,79 | -9.634.226 | 681.978.871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20.322 | 1.472.983 | -1,36 | 72,79 | -1.479.165 | 107.213.130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.503 | 287.612 | -1,20 | 72,79 | -254.971 | 20.934.242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.031 | 183.908 | -1,09 | 72,79 | -147.829 | 13.386.001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51.628 | -0,30 | 72,79 | -11.282 | 3.757.816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.268 | 200.594 | -1,12 | 72,79 | -165.080 | 14.600.515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149.754 | 9.501.955 | -1,55 | 70,79 | -10.601.295 | 672.656.697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22.991 | 1.493.305 | -1,52 | 70,79 | -1.627.565 | 105.713.152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.963 | 291.115 | -1,34 | 70,79 | -280.546 | 20.608.438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.298 | 185.939 | -1,22 | 70,79 | -162.679 | 13.162.882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51.783 | -0,34 | 70,79 | -12.388 | 3.665.791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.566 | 202.862 | -1,25 | 70,79 | -181.651 | 14.360.885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9.651.709 | -0,01 | 70,07 | -34.545 | 676.311.658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1.516.296 | -0,01 | 70,07 | -5.325 | 106.249.438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295.078 | 0,00 | 70,07 | -911 | 20.676.617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188.237 | 0,00 | 70,07 | -561 | 13.190.087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.958 | 0,00 | 70,07 | -70 | 3.640.785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205.428 | 0,00 | 70,07 | -631 | 14.394.689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23.462 | 9.652.202 | -0,24 | 70,22 | -1.647.574 | 677.807.546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.602 | 1.516.372 | -0,24 | 70,22 | -252.944 | 106.484.343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295.091 | -0,21 | 70,22 | -43.609 | 20.722.205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188.245 | -0,19 | 70,22 | -25.280 | 13.219.147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51.959 | -0,05 | 70,22 | -1.896 | 3.648.722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205.437 | -0,20 | 70,22 | -28.230 | 14.426.423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.392 | 9.675.664 | -0,09 | 70,28 | -589.772 | 679.985.347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.288 | 1.519.974 | -0,08 | 70,28 | -90.518 | 106.820.581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295.712 | -0,08 | 70,28 | -15.602 | 20.782.018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188.605 | -0,07 | 70,28 | -9.066 | 13.254.763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51.986 | -0,02 | 70,28 | -703 | 3.653.467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205.839 | -0,07 | 70,28 | -10.120 | 14.465.933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1.695.159 | 0,02 | 64,41 | 19.967 | 109.185.191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225.893 | 0,14 | 64,41 | 19.967 | 14.549.768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362.631 | 0,09 | 64,41 | 19.967 | 23.357.063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810.862 | 0,04 | 63,59 | 18.950 | 51.562.715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810.862 | 0,04 | 63,59 | 18.950 | 51.562.715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29.421.884 | 0,00 | 63,59 | 18.950 | 1.870.937.604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.243 | 9.683.746 | -0,16 | 73,09 | -1.114.047 | 707.744.323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.340 | 1.520.952 | -0,15 | 73,09 | -171.021 | 111.159.994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295.624 | -0,14 | 73,09 | -29.454 | 21.605.917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188.424 | -0,12 | 73,09 | -17.102 | 13.771.119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51.686 | -0,03 | 73,09 | -1.316 | 3.777.513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205.673 | -0,13 | 73,09 | -19.148 | 15.031.776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.627 | 9.698.989 | -0,13 | 71,81 | -906.797 | 696.524.166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.939 | 1.523.292 | -0,13 | 71,81 | -139.248 | 109.393.844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296.027 | -0,11 | 71,81 | -23.986 | 21.258.913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188.658 | -0,10 | 71,81 | -13.932 | 13.548.304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51.704 | -0,03 | 71,81 | -1.077 | 3.713.076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205.935 | -0,10 | 71,81 | -15.512 | 14.789.037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34.794 | 9.711.616 | -0,36 | 74,88 | -2.605.510 | 727.243.681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.342 | 1.525.231 | -0,35 | 74,88 | -400.030 | 114.215.246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296.361 | -0,31 | 74,88 | -68.968 | 22.192.667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188.852 | -0,28 | 74,88 | -39.988 | 14.141.974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51.719 | -0,08 | 74,88 | -3.070 | 3.872.920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206.151 | -0,29 | 74,88 | -44.706 | 15.437.391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.718 | 9.746.410 | -0,08 | 73,83 | -569.813 | 719.568.679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.185 | 1.530.573 | -0,08 | 73,83 | -87.487 | 113.000.827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297.282 | -0,07 | 73,83 | -15.061 | 21.948.063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189.386 | -0,06 | 73,83 | -8.712 | 13.982.198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51.760 | -0,02 | 73,83 | -664 | 3.821.394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206.748 | -0,06 | 73,83 | -9.745 | 15.264.019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84.418 | 9.754.128 | -0,86 | 76,15 | -6.428.768 | 742.815.864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.961 | 1.531.758 | -0,84 | 76,15 | -987.032 | 116.649.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.234 | 297.486 | -0,75 | 76,15 | -170.128 | 22.654.749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.296 | 189.504 | -0,68 | 76,15 | -98.696 | 14.431.488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51.769 | -0,19 | 76,15 | -7.539 | 3.942.416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.447 | 206.880 | -0,69 | 76,15 | -110.195 | 15.754.740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76.364 | 9.838.546 | -0,77 | 75,46 | -5.762.481 | 742.423.568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.724 | 1.544.719 | -0,75 | 75,46 | -884.701 | 116.565.577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.021 | 299.720 | -0,67 | 75,46 | -152.506 | 22.617.081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.172 | 190.800 | -0,61 | 75,46 | -88.440 | 14.397.902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51.868 | -0,17 | 75,46 | -6.716 | 3.913.996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.309 | 208.327 | -0,62 | 75,46 | -98.778 | 15.720.501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.538 | 9.914.910 | -0,03 | 77,75 | -197.318 | 770.839.635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1.556.443 | -0,03 | 77,75 | -30.321 | 121.006.439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301.741 | -0,02 | 77,75 | -5.209 | 23.459.005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191.972 | -0,02 | 77,75 | -3.032 | 14.924.959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51.957 | -0,01 | 77,75 | -233 | 4.039.423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209.636 | -0,02 | 77,75 | -3.343 | 16.298.256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.493 | 9.917.448 | -0,06 | 73,81 | -405.449 | 732.025.680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1.556.833 | -0,05 | 73,81 | -62.223 | 114.912.802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301.808 | -0,05 | 73,81 | -10.777 | 22.277.022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192.011 | -0,04 | 73,81 | -6.200 | 14.172.697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51.960 | -0,01 | 73,81 | -443 | 3.835.266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209.679 | -0,05 | 73,81 | -7.012 | 15.476.805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.604 | 9.922.941 | -0,19 | 75,83 | -1.410.758 | 752.465.547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.856 | 1.557.676 | -0,18 | 75,83 | -216.573 | 118.119.973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301.954 | -0,16 | 75,83 | -37.309 | 22.897.444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192.095 | -0,15 | 75,83 | -21.688 | 14.566.737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51.966 | -0,04 | 75,83 | -1.592 | 3.940.629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209.774 | -0,15 | 75,83 | -24.190 | 15.907.351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9.941.545 | 0,00 | 77,11 | -28.608 | 766.592.535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1.560.532 | 0,00 | 77,11 | -4.395 | 120.332.623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302.446 | 0,00 | 77,11 | -771 | 23.321.611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192.381 | 0,00 | 77,11 | -463 | 14.834.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192.381 | 0,00 | 77,11 | -463 | 14.834.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.987 | 0,00 | 77,11 | -77 | 4.008.718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1.569 | 1.569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1.569 | 1.569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10.731 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71.647 | 71.647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71.647 | 71.647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489.977 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.178.823 | 35.976.940 | 45,08 | 17,00 | 190.039.991 | 611.607.980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585.882 | 3.736.902 | 18,59 | 17,00 | 9.959.994 | 63.527.334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9.941.916 | 0,00 | 76,62 | -18.925 | 761.724.749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1.560.589 | 0,00 | 76,62 | -2.911 | 119.568.428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302.456 | 0,00 | 76,62 | -460 | 23.173.423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192.387 | 0,00 | 76,62 | -306 | 14.740.211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192.387 | 0,00 | 76,62 | -306 | 14.740.211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.988 | 0,00 | 76,62 | -77 | 3.983.191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32.598 | 9.942.163 | -0,33 | 77,52 | -2.527.147 | 770.762.210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.005 | 1.560.627 | -0,32 | 77,52 | -388.011 | 120.986.984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302.462 | -0,28 | 77,52 | -66.904 | 23.448.246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192.391 | -0,26 | 77,52 | -38.762 | 14.915.035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51.989 | -0,07 | 77,52 | -2.946 | 4.030.426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210.103 | -0,27 | 77,52 | -43.336 | 16.288.151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89.047 | 9.974.761 | -0,88 | 78,05 | -6.950.074 | 778.525.109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.671 | 1.565.632 | -0,87 | 78,05 | -1.067.015 | 122.196.795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.357 | 303.325 | -0,77 | 78,05 | -183.963 | 23.674.365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.367 | 192.891 | -0,70 | 78,05 | -106.694 | 15.055.046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52.027 | -0,20 | 78,05 | -8.117 | 4.060.681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.526 | 210.662 | -0,72 | 78,05 | -119.104 | 16.442.064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44.659 | 10.063.808 | -0,44 | 80,09 | -3.576.721 | 806.006.357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.856 | 1.579.303 | -0,43 | 80,09 | -549.094 | 126.485.746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.182 | 305.682 | -0,39 | 80,09 | -94.666 | 24.481.949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194.258 | -0,35 | 80,09 | -54.861 | 15.558.046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52.131 | -0,10 | 80,09 | -4.165 | 4.175.151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212.188 | -0,36 | 80,09 | -61.269 | 16.994.052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129.121 | 10.108.467 | -1,26 | 79,07 | -10.209.675 | 799.282.551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19.824 | 1.586.159 | -1,23 | 79,07 | -1.567.496 | 125.418.544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.417 | 306.864 | -1,10 | 79,07 | -270.184 | 24.263.921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.981 | 194.943 | -1,01 | 79,07 | -156.639 | 15.414.260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52.183 | -0,29 | 79,07 | -11.940 | 4.126.141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.214 | 212.953 | -1,03 | 79,07 | -175.062 | 16.838.321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39.591 | 10.237.588 | -0,39 | 79,63 | -3.152.536 | 815.194.562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.078 | 1.605.983 | -0,38 | 79,63 | -483.977 | 127.880.572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.048 | 310.281 | -0,34 | 79,63 | -83.450 | 24.706.931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196.924 | -0,31 | 79,63 | -48.414 | 15.680.586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52.334 | -0,09 | 79,63 | -3.663 | 4.167.231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215.167 | -0,31 | 79,63 | -53.988 | 17.133.232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30.257 | 10.277.179 | -0,29 | 77,61 | -2.348.376 | 797.656.054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.646 | 1.612.061 | -0,29 | 77,61 | -360.596 | 125.118.986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311.329 | -0,26 | 77,61 | -62.169 | 24.163.582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197.532 | -0,23 | 77,61 | -36.091 | 15.331.308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52.380 | -0,07 | 77,61 | -2.717 | 4.065.437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215.845 | -0,24 | 77,61 | -40.204 | 16.752.659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.994 | 10.307.436 | -0,12 | 78,80 | -945.149 | 812.244.510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.841 | 1.616.707 | -0,11 | 78,80 | -145.074 | 127.399.422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312.130 | -0,10 | 78,80 | -24.980 | 24.596.406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197.997 | -0,09 | 78,80 | -14.500 | 15.602.520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52.415 | -0,03 | 78,80 | -1.103 | 4.130.396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216.363 | -0,10 | 78,80 | -16.233 | 17.049.794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77.976 | 10.319.430 | -0,75 | 76,81 | -5.989.017 | 792.593.109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.972 | 1.618.548 | -0,73 | 76,81 | -919.520 | 124.314.036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.064 | 312.447 | -0,66 | 76,81 | -158.527 | 23.997.773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.197 | 198.181 | -0,60 | 76,81 | -91.937 | 15.221.470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52.429 | -0,17 | 76,81 | -6.989 | 4.026.857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.335 | 216.569 | -0,61 | 76,81 | -102.536 | 16.633.777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.595 | 10.397.406 | -0,13 | 74,01 | -1.006.150 | 769.499.541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.087 | 1.630.520 | -0,13 | 74,01 | -154.456 | 120.672.829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314.511 | -0,11 | 74,01 | -26.643 | 23.276.582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199.378 | -0,10 | 74,01 | -15.468 | 14.755.727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52.520 | -0,03 | 74,01 | -1.184 | 3.886.942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217.904 | -0,11 | 74,01 | -17.244 | 16.126.814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57.979 | 10.411.001 | -0,55 | 74,71 | -4.331.524 | 777.790.268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.901 | 1.632.607 | -0,54 | 74,71 | -664.980 | 121.969.620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.534 | 314.871 | -0,48 | 74,71 | -114.603 | 23.523.540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199.587 | -0,44 | 74,71 | -66.491 | 14.910.845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52.536 | -0,13 | 74,71 | -5.080 | 3.924.886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218.137 | -0,45 | 74,71 | -74.260 | 16.296.688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56.764 | 10.468.980 | -0,54 | 75,27 | -4.272.831 | 788.037.813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.715 | 1.641.508 | -0,53 | 75,27 | -656.009 | 123.562.217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.502 | 316.405 | -0,47 | 75,27 | -113.061 | 23.816.943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200.477 | -0,43 | 75,27 | -65.563 | 15.090.626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52.604 | -0,13 | 75,27 | -4.968 | 3.959.692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219.131 | -0,44 | 75,27 | -73.241 | 16.494.779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36.652 | 10.525.744 | -0,35 | 73,76 | -2.703.294 | 776.333.617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.627 | 1.650.223 | -0,34 | 73,76 | -415.023 | 121.713.353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317.907 | -0,30 | 73,76 | -71.543 | 23.447.453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201.348 | -0,28 | 73,76 | -41.524 | 14.850.563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52.670 | -0,08 | 73,76 | -3.171 | 3.884.713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220.104 | -0,28 | 73,76 | -46.319 | 16.233.925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77.558 | 10.562.396 | -0,73 | 74,24 | -5.758.092 | 784.177.629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.907 | 1.655.850 | -0,71 | 74,24 | -884.004 | 122.934.278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.052 | 318.877 | -0,64 | 74,24 | -152.345 | 23.674.194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.190 | 201.911 | -0,59 | 74,24 | -88.348 | 14.990.357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52.713 | -0,17 | 74,24 | -6.756 | 3.913.540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.329 | 220.732 | -0,60 | 74,24 | -98.668 | 16.387.673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.204 | 10.639.954 | -0,08 | 74,05 | -607.484 | 787.859.866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.260 | 1.667.757 | -0,08 | 74,05 | -93.300 | 123.492.903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320.929 | -0,07 | 74,05 | -16.068 | 23.763.926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203.101 | -0,06 | 74,05 | -9.330 | 15.039.081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52.804 | -0,02 | 74,05 | -740 | 3.909.994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222.061 | -0,06 | 74,05 | -10.441 | 16.443.017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24.487 | 10.648.158 | -0,23 | 74,36 | -1.820.848 | 791.794.899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.759 | 1.669.017 | -0,22 | 74,36 | -279.518 | 124.107.770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321.146 | -0,20 | 74,36 | -48.185 | 23.880.352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203.227 | -0,18 | 74,36 | -27.959 | 15.111.919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52.814 | -0,05 | 74,36 | -2.082 | 3.927.238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222.202 | -0,19 | 74,36 | -31.157 | 16.522.896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55.365 | 10.672.645 | -0,52 | 76,35 | -4.227.024 | 814.838.302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.499 | 1.672.776 | -0,51 | 76,35 | -648.884 | 127.713.604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.466 | 321.794 | -0,45 | 76,35 | -111.927 | 24.568.425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203.603 | -0,42 | 76,35 | -64.896 | 15.544.743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52.842 | -0,12 | 76,35 | -4.963 | 4.034.397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222.621 | -0,42 | 76,35 | -72.455 | 16.996.735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16.646 | 10.728.010 | -0,15 | 77,66 | -1.292.763 | 833.159.785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.556 | 1.681.275 | -0,15 | 77,66 | -198.504 | 130.571.347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323.260 | -0,14 | 77,66 | -34.171 | 25.105.050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204.453 | -0,12 | 77,66 | -19.804 | 15.878.249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52.907 | -0,04 | 77,66 | -1.476 | 4.108.869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223.570 | -0,13 | 77,66 | -22.134 | 17.362.916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38.330 | 10.744.656 | -0,36 | 79,13 | -3.033.110 | 850.240.746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.885 | 1.683.831 | -0,35 | 79,13 | -465.689 | 133.244.073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.014 | 323.700 | -0,31 | 79,13 | -80.239 | 25.614.867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204.708 | -0,29 | 79,13 | -46.529 | 16.198.851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52.926 | -0,08 | 79,13 | -3.561 | 4.188.114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223.855 | -0,29 | 79,13 | -51.989 | 17.713.982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.296 | 10.782.986 | -0,03 | 80,09 | -263.978 | 863.613.662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1.689.716 | -0,03 | 80,09 | -40.526 | 135.330.030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324.714 | -0,03 | 80,09 | -6.968 | 26.006.474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205.296 | -0,02 | 80,09 | -4.085 | 16.442.239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52.971 | -0,01 | 80,09 | -320 | 4.242.469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224.512 | -0,02 | 80,09 | -4.485 | 17.981.256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53.013 | 10.786.282 | -0,49 | 80,07 | -4.244.714 | 863.650.049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.139 | 1.690.222 | -0,48 | 80,07 | -651.684 | 135.334.892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.403 | 324.801 | -0,43 | 80,07 | -112.337 | 26.006.589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205.347 | -0,39 | 80,07 | -65.176 | 16.441.991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52.975 | -0,12 | 80,07 | -4.964 | 4.241.671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224.568 | -0,40 | 80,07 | -72.703 | 17.981.003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99.280 | 10.839.295 | -0,91 | 78,09 | -7.752.428 | 846.402.609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.242 | 1.698.361 | -0,89 | 78,09 | -1.190.194 | 132.619.066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.628 | 326.204 | -0,80 | 78,09 | -205.211 | 25.472.129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.524 | 206.161 | -0,73 | 78,09 | -119.004 | 16.098.391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53.037 | -0,22 | 78,09 | -8.980 | 4.141.474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.702 | 225.476 | -0,75 | 78,09 | -132.903 | 17.606.632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.014 | 10.938.575 | -0,14 | 81,26 | -1.220.038 | 888.868.604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.305 | 1.713.603 | -0,13 | 81,26 | -187.304 | 139.247.380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328.832 | -0,12 | 81,26 | -32.260 | 26.720.888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207.685 | -0,11 | 81,26 | -18.690 | 16.876.483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53.152 | -0,03 | 81,26 | -1.463 | 4.319.132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227.178 | -0,11 | 81,26 | -20.884 | 18.460.484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46.511 | 10.953.589 | -0,42 | 81,16 | -3.774.912 | 889.011.904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.140 | 1.715.908 | -0,41 | 81,16 | -579.495 | 139.266.010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.231 | 329.229 | -0,37 | 81,16 | -99.910 | 26.720.785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207.915 | -0,34 | 81,16 | -57.949 | 16.874.735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53.170 | -0,10 | 81,16 | -4.383 | 4.315.368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227.435 | -0,35 | 81,16 | -64.605 | 18.459.011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.533 | 11.000.100 | -0,07 | 80,51 | -606.473 | 885.604.851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.156 | 1.723.048 | -0,07 | 80,51 | -93.068 | 138.720.527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330.460 | -0,06 | 80,51 | -16.021 | 26.604.938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208.629 | -0,06 | 80,51 | -9.339 | 16.796.470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53.224 | -0,02 | 80,51 | -725 | 4.285.000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228.231 | -0,06 | 80,51 | -10.386 | 18.374.604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.877 | 11.007.633 | -0,11 | 80,38 | -954.711 | 884.828.765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.824 | 1.724.204 | -0,11 | 80,38 | -146.619 | 138.597.035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330.659 | -0,09 | 80,38 | -25.240 | 26.579.429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208.745 | -0,09 | 80,38 | -14.630 | 16.779.591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53.233 | -0,03 | 80,38 | -1.125 | 4.279.039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228.360 | -0,09 | 80,38 | -16.398 | 18.356.308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19.367 | 11.019.510 | -0,18 | 85,11 | -1.648.296 | 937.853.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.973 | 1.726.028 | -0,17 | 85,11 | -253.028 | 146.899.654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330.973 | -0,15 | 85,11 | -43.661 | 28.168.616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208.927 | -0,14 | 85,11 | -25.277 | 17.781.464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53.247 | -0,04 | 85,11 | -1.957 | 4.531.772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228.564 | -0,15 | 85,11 | -28.256 | 19.452.739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112.010 | 11.038.877 | -1,00 | 82,06 | -9.191.025 | 905.799.468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17.198 | 1.729.001 | -0,98 | 82,06 | -1.411.189 | 141.873.869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.964 | 331.486 | -0,89 | 82,06 | -243.212 | 27.200.216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.720 | 209.224 | -0,82 | 82,06 | -141.135 | 17.167.959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53.270 | -0,24 | 82,06 | -10.585 | 4.371.091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.919 | 228.896 | -0,83 | 82,06 | -157.464 | 18.782.153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.157 | 11.150.887 | -0,07 | 82,55 | -673.321 | 920.452.198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.252 | 1.746.199 | -0,07 | 82,55 | -103.347 | 144.140.346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334.450 | -0,06 | 82,55 | -17.830 | 27.607.242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210.944 | -0,06 | 82,55 | -10.318 | 17.412.415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53.399 | -0,02 | 82,55 | -743 | 4.407.831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230.815 | -0,06 | 82,55 | -11.556 | 19.052.670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.120 | 11.159.044 | -0,04 | 83,90 | -345.678 | 936.271.689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1.747.451 | -0,04 | 83,90 | -53.110 | 146.615.508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334.666 | -0,03 | 83,90 | -9.145 | 28.079.314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211.069 | -0,03 | 83,90 | -5.286 | 17.709.217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.408 | -0,01 | 83,90 | -420 | 4.481.065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230.955 | -0,03 | 83,90 | -5.957 | 19.377.702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62.929 | 11.163.164 | -0,56 | 83,20 | -5.235.598 | 928.758.500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.661 | 1.748.084 | -0,55 | 83,20 | -803.781 | 145.437.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.665 | 334.775 | -0,49 | 83,20 | -138.526 | 27.852.778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211.132 | -0,46 | 83,20 | -80.370 | 17.565.866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53.413 | -0,14 | 83,20 | -6.157 | 4.443.881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.078 | 231.026 | -0,46 | 83,20 | -89.688 | 19.221.017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17.602 | 11.226.093 | -0,16 | 85,87 | -1.511.565 | 964.036.246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.702 | 1.757.745 | -0,15 | 85,87 | -232.033 | 150.945.649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336.440 | -0,14 | 85,87 | -40.018 | 28.891.650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212.098 | -0,13 | 85,87 | -23.186 | 18.213.831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53.487 | -0,04 | 85,87 | -1.803 | 4.593.175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232.104 | -0,13 | 85,87 | -25.934 | 19.931.838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.120 | 11.243.695 | -0,04 | 82,00 | -337.840 | 921.982.990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1.760.447 | -0,04 | 82,00 | -51.906 | 144.356.654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336.906 | -0,03 | 82,00 | -8.938 | 27.626.292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212.368 | -0,03 | 82,00 | -5.166 | 17.414.176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.508 | -0,01 | 82,00 | -410 | 4.387.656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232.406 | -0,03 | 82,00 | -5.822 | 19.057.292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.565 | 11.247.815 | -0,01 | 83,85 | -131.227 | 943.138.286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1.761.080 | -0,01 | 83,85 | -20.124 | 147.667.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337.015 | -0,01 | 83,85 | -3.522 | 28.258.977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212.431 | -0,01 | 83,85 | -2.012 | 17.812.509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53.513 | 0,00 | 83,85 | -168 | 4.487.108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232.477 | -0,01 | 83,85 | -2.264 | 19.493.382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.301 | 11.249.380 | -0,08 | 84,84 | -789.121 | 954.426.648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.428 | 1.761.320 | -0,08 | 84,84 | -121.155 | 149.434.968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337.057 | -0,07 | 84,84 | -20.871 | 28.596.792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212.455 | -0,07 | 84,84 | -12.132 | 18.025.235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53.515 | -0,02 | 84,84 | -933 | 4.540.352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232.504 | -0,07 | 84,84 | -13.490 | 19.726.244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21.423 | 11.258.681 | -0,19 | 89,34 | -1.913.901 | 1.005.834.798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.289 | 1.762.748 | -0,19 | 89,34 | -293.835 | 157.481.438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337.303 | -0,17 | 89,34 | -50.655 | 30.134.178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212.598 | -0,15 | 89,34 | -29.392 | 18.993.208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53.526 | -0,05 | 89,34 | -2.233 | 4.781.938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232.663 | -0,16 | 89,34 | -32.787 | 20.785.787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30.555 | 11.280.104 | -0,27 | 85,15 | -2.601.670 | 960.468.143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.692 | 1.766.037 | -0,26 | 85,15 | -399.510 | 150.372.929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337.870 | -0,24 | 85,15 | -68.884 | 28.768.651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212.927 | -0,22 | 85,15 | -40.019 | 18.130.117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53.551 | -0,07 | 85,15 | -3.150 | 4.559.712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233.030 | -0,22 | 85,15 | -44.447 | 19.841.829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36.174 | 11.310.659 | -0,32 | 85,78 | -3.102.970 | 970.217.018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.554 | 1.770.729 | -0,31 | 85,78 | -476.417 | 151.891.363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338.679 | -0,28 | 85,78 | -82.091 | 29.051.546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213.397 | -0,26 | 85,78 | -47.607 | 18.304.981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53.588 | -0,08 | 85,78 | -3.603 | 4.596.725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233.552 | -0,26 | 85,78 | -53.183 | 20.033.857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.663 | 11.346.833 | -0,03 | 87,30 | -319.780 | 990.579.656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1.776.283 | -0,03 | 87,30 | -49.063 | 155.069.684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339.636 | -0,03 | 87,30 | -8.468 | 29.650.257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213.952 | -0,03 | 87,30 | -4.889 | 18.678.031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53.630 | -0,01 | 87,30 | -349 | 4.681.904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234.172 | -0,03 | 87,30 | -5.500 | 20.443.239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.306 | 11.350.496 | -0,04 | 88,38 | -380.544 | 1.003.104.624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1.776.845 | -0,04 | 88,38 | -58.416 | 157.029.388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339.733 | -0,03 | 88,38 | -10.075 | 30.024.040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214.008 | -0,03 | 88,38 | -5.833 | 18.913.043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.634 | -0,01 | 88,38 | -442 | 4.739.926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234.235 | -0,03 | 88,38 | -6.540 | 20.700.612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.798 | 11.354.802 | -0,14 | 83,94 | -1.326.160 | 953.176.583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.425 | 1.777.506 | -0,14 | 83,94 | -203.566 | 149.212.386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339.847 | -0,12 | 83,94 | -35.089 | 28.528.388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214.074 | -0,11 | 83,94 | -20.315 | 17.970.399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53.639 | -0,03 | 83,94 | -1.511 | 4.502.715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234.309 | -0,12 | 83,94 | -22.749 | 19.669.022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3.660.993 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294.948 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4.627.208 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372.792 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.248.102 | 8.374.935 | 36,69 | 10,00 | 22.481.020 | 83.749.350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251.898 | 770.180 | 48,60 | 10,00 | 2.518.980 | 7.701.800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767.427 | 6.126.833 | 14,32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86.501 | 518.282 | 20,03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732.198 | 5.359.406 | 15,82 | 5,00 | 3.660.990 | 26.797.030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58.989 | 431.781 | 15,82 | 5,00 | 294.945 | 2.158.905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4.627.208 | 4.627.208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372.792 | 372.792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340.265 | 0,08 | 70,18 | 19.931 | 23.879.798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340.265 | 0,08 | 70,18 | 19.931 | 23.879.798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11.544.497 | 0,00 | 70,18 | 19.931 | 810.192.799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1.953.828 | 0,01 | 70,18 | 19.931 | 137.119.649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227.554 | 0,12 | 70,18 | 19.931 | 15.969.740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388.213 | 0,07 | 70,18 | 19.931 | 27.244.788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 81.414 | 2,96 | 8,71 | 20.381 | 709.116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 81.414 | 2,96 | 8,71 | 20.381 | 709.116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 4.280.212 | 0,05 | 8,71 | 20.381 | 37.280.647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810.564 | 0,03 | 69,08 | 18.997 | 55.993.761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810.564 | 0,03 | 69,08 | 18.997 | 55.993.761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1.269.837 | 0,02 | 69,08 | 18.997 | 87.720.340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131.007 | 24.798.117 | 0,53 | 19,09 | 2.501.238 | 473.455.569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14.555 | 3.151.020 | 0,46 | 19,09 | 277.890 | 60.160.534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38.207 | 24.667.110 | 0,16 | 19,01 | 726.353 | 468.946.428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.245 | 3.136.465 | 0,14 | 19,01 | 80.702 | 59.627.336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920.495 | 24.628.903 | 3,88 | 18,64 | 17.154.897 | 458.999.014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102.267 | 3.132.220 | 3,38 | 18,64 | 1.905.909 | 58.373.931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5.231.900 | 5.250.491 | 28.142,11 | 108,00 | 565.045.200 | 567.053.028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582.200 | 600.791 | 3.131,62 | 108,00 | 62.877.600 | 64.885.428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 632.599 | 2,66 | 1,32 | 21.626 | 835.031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 632.599 | 2,66 | 1,32 | 21.626 | 835.031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 34.222.983 | 0,05 | 1,32 | 21.626 | 45.174.338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1.953.544 | 0,02 | 50,40 | 19.958 | 98.458.618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227.270 | 0,17 | 50,40 | 19.958 | 11.454.408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387.929 | 0,10 | 50,40 | 19.958 | 19.551.622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34.884 | 34.884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18.580 | 73.180.602 | 0,03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18.580 | 73.180.602 | 0,03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14.658.102 | 14.658.102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14.658.102 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1.399.516 | 1.399.516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1.399.516 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3.284.771 | 7.018.874 | 87,97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3.284.771 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313.621 | 734.518 | 74,51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313.621 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3.734.103 | 3.734.103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3.734.103 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420.897 | 420.897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420.897 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2.700.597 | 2.700.597 | 18,00 | 48.610.746 | 48.610.746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299.403 | 299.403 | 18,00 | 5.389.254 | 5.389.254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3.734.103 | 3.734.103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420.897 | 420.897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 45.829.686 | 0,01 | 56,77 | 210.049 | 2.601.751.274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 45.829.686 | 0,01 | 56,77 | 210.049 | 2.601.751.274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.174 | 7.648.080 | 0,03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.174 | 7.648.080 | 0,03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126.399 | 45.825.986 | 0,28 | 54,02 | 6.828.339 | 2.475.615.998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129.715 | 45.699.587 | 0,28 | 53,70 | 6.966.305 | 2.454.282.610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204.537 | 45.569.872 | 0,45 | 52,68 | 10.775.582 | 2.400.748.453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.105 | 45.365.335 | 0,02 | 54,42 | 495.488 | 2.468.749.775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.442 | 45.356.230 | 0,05 | 52,26 | 1.120.576 | 2.370.352.865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.400 | 45.334.788 | 0,08 | 52,33 | 1.957.022 | 2.372.224.385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.000 | 45.297.388 | 0,00 | 51,88 | 103.750 | 2.349.802.002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.951 | 45.295.388 | 0,01 | 52,33 | 311.418 | 2.370.321.243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.963 | 45.289.437 | 0,08 | 52,06 | 1.976.213 | 2.357.600.519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.270 | 45.251.474 | 0,13 | 51,37 | 2.941.708 | 2.324.369.113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.500 | 45.194.204 | 0,02 | 51,36 | 539.280 | 2.321.174.317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.700 | 45.183.704 | 0,05 | 51,30 | 1.164.424 | 2.317.752.317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.533 | 45.161.004 | 0,16 | 51,26 | 3.717.693 | 2.314.736.292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.000 | 45.088.471 | 0,22 | 51,14 | 5.114.000 | 2.305.824.407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 44.988.471 | 0,02 | 10,08 | 100.800 | 453.483.788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 44.988.471 | 0,02 | 10,08 | 100.800 | 453.483.788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168.097 | 44.978.471 | 0,38 | 51,25 | 8.614.786 | 2.305.097.162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52.700 | 44.810.374 | 0,12 | 51,07 | 2.691.173 | 2.288.282.078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248.121 | 44.757.674 | 0,56 | 51,03 | 12.661.069 | 2.283.885.637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154.218 | 44.509.553 | 0,35 | 50,90 | 7.849.897 | 2.265.594.110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339.585 | 0,19 | 31,29 | 19.963 | 10.625.615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339.585 | 0,19 | 31,29 | 19.963 | 10.625.615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790.006 | 0,03 | 83,33 | 18.999 | 65.831.200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1.249.279 | 0,02 | 83,33 | 18.999 | 104.102.419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790.006 | 0,03 | 83,33 | 18.999 | 65.831.200 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999.514 | 7.480.182 | 15,42 | 4,50 | 4.497.813 | 33.660.819 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111.597 | 845.858 | 15,20 | 4,50 | 502.186 | 3.806.361 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439.036 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17.626.445 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2.250.846 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439.036 | 602.867 | 267,98 | 0,47 | 206.347 | 283.347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17.626.445 | 34.193.251 | 106,40 | 0,47 | 8.284.429 | 16.070.828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2.250.846 | 4.102.796 | 121,54 | 0,47 | 1.057.898 | 1.928.314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.456.543 | 44.355.335 | 8,45 | 52,00 | 179.740.236 | 2.306.477.420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389.610 | 5.278.174 | 7,97 | 52,00 | 20.259.720 | 274.465.048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.645.148 | 5.121.404 | 47,33 | 101,00 | 166.159.948 | 517.261.804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335.050 | 708.025 | 89,83 | 101,00 | 33.840.050 | 71.510.525 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4.136 | 58.131 | -6,64 | 7,91 | -32.715 | 459.799 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265.708 | 3.734.776 | -6,64 | 7,91 | -2.101.671 | 29.540.958 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25.517 | 358.671 | -6,64 | 7,91 | -201.832 | 2.836.980 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4.548 | 62.267 | -6,81 | 8,12 | -36.910 | 505.340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292.168 | 4.000.484 | -6,81 | 8,12 | -2.371.148 | 32.466.728 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28.058 | 384.188 | -6,81 | 8,12 | -227.710 | 3.117.955 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3.649 | 66.815 | -5,18 | 8,63 | -31.476 | 576.340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234.437 | 4.292.652 | -5,18 | 8,63 | -2.022.230 | 37.027.987 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22.514 | 412.246 | -5,18 | 8,63 | -194.204 | 3.555.993 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39.378 | 0 | -100,00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1.941 | 489.977 | -0,39 | 28,00 | -54.348 | 13.719.356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39.378 | 491.918 | 8,70 | 1,38 | 54.342 | 678.847 | |
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1.618.684 | 1.618.684 | 13,00 | 21.041.273 | 21.041.273 | ||
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304.392 | 304.392 | 13,00 | 3.956.792 | 3.956.792 | ||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5.996 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249.801 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24.466 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5.996 | 35.999 | 19,98 | 7,86 | 47.129 | 282.952 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249.801 | 2.372.218 | 11,77 | 7,86 | 1.963.436 | 18.645.633 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24.466 | 141.244 | 20,95 | 7,86 | 192.303 | 1.110.178 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.204.652 | 16.557.473 | 77,03 | 1,50 | 10.806.978 | 24.836.210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795.348 | 1.842.617 | 75,94 | 1,50 | 1.193.022 | 2.763.926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1.426.590 | 0 | -100,00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55.457 | 23.708.408 | -0,23 | 35,40 | -1.963.178 | 839.277.643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1.426.590 | 23.763.865 | 6,39 | 1,38 | 1.968.694 | 32.794.134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7.102 | 7.102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7.102 | 7.102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49.200 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9.913.242 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760.829 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797.191 | 1.878.242 | 73,74 | 17,00 | 13.552.247 | 31.930.114 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87.809 | 170.778 | 105,83 | 17,00 | 1.492.753 | 2.903.226 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1.081.051 | 1.081.051 | |||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82.969 | 82.969 | |||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.029 | 789.416 | 0,26 | 132,00 | 267.828 | 104.202.912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85.402 | 29.247.347 | 0,29 | 132,00 | 11.273.064 | 3.860.649.804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.569 | 4.386.818 | 0,29 | 132,00 | 1.659.108 | 579.059.976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158.279 | 3.476.256 | 4,77 | 71,00 | 11.237.809 | 246.814.176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17.777 | 372.975 | 5,00 | 71,00 | 1.262.167 | 26.481.225 | |
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3.109.063 | 3.109.063 | 8,50 | 26.427.036 | 26.427.036 | ||
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349.760 | 349.760 | 8,50 | 2.972.960 | 2.972.960 | ||
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329.491 | 0,19 | 32,55 | 19.986 | 10.724.932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1.246.660 | 0,01 | 125,91 | 18.886 | 156.966.961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1.246.660 | 0,01 | 125,91 | 18.886 | 156.966.961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787.387 | 0,02 | 125,91 | 18.886 | 99.139.897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22.560 | 7.317.906 | 0,31 | 117,95 | 2.660.914 | 863.134.572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.564 | 647.367 | 0,40 | 117,95 | 302.419 | 76.355.837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197.126 | 7.295.346 | 2,78 | 117,51 | 23.163.488 | 857.246.927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22.399 | 644.803 | 3,60 | 117,51 | 2.632.017 | 75.768.221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32.172 | 7.098.220 | 0,46 | 117,22 | 3.771.228 | 832.059.027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.656 | 622.404 | 0,59 | 117,22 | 428.559 | 72.958.695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65.264 | 7.066.048 | 0,93 | 117,01 | 7.636.802 | 826.826.541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.416 | 618.748 | 1,21 | 117,01 | 867.776 | 72.402.178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7.000.784 | 0,01 | 116,96 | 105.030 | 818.811.697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611.332 | 0,02 | 116,96 | 11.930 | 71.501.391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31.974 | 6.999.886 | 0,46 | 116,71 | 3.731.542 | 816.925.196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.634 | 611.230 | 0,60 | 116,71 | 424.108 | 71.333.903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12.726 | 6.967.912 | 0,18 | 116,37 | 1.480.897 | 810.840.590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.446 | 607.596 | 0,24 | 116,37 | 168.268 | 70.704.610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385.774 | 6.955.186 | 5,87 | 116,37 | 44.891.517 | 809.356.911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.835 | 606.150 | 7,80 | 116,37 | 5.100.965 | 70.536.100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.976 | 6.569.412 | 0,03 | 116,18 | 229.562 | 763.202.753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562.315 | 0,04 | 116,18 | 26.023 | 65.327.058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169.897 | 6.567.436 | 2,66 | 115,77 | 19.668.568 | 760.296.304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19.305 | 562.091 | 3,56 | 115,77 | 2.234.894 | 65.071.926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207.814 | 6.397.539 | 3,36 | 115,71 | 24.046.636 | 740.273.952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23.614 | 542.786 | 4,55 | 115,71 | 2.732.430 | 62.807.016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18.678 | 6.189.725 | 0,30 | 115,06 | 2.149.048 | 712.175.522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.122 | 519.172 | 0,41 | 115,06 | 244.152 | 59.734.736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64.455 | 6.171.047 | 1,06 | 114,33 | 7.369.301 | 705.551.231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.324 | 517.050 | 1,44 | 114,33 | 837.371 | 59.115.619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160.000 | 980.146 | 19,51 | 117,71 | 18.832.960 | 115.369.065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103.200 | 820.146 | 14,39 | 117,63 | 12.139.416 | 96.473.774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32.008 | 716.946 | 4,67 | 117,60 | 3.764.067 | 84.311.201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684.938 | 0,04 | 116,75 | 35.025 | 79.966.512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.747 | 7.645.906 | 0,05 | 116,75 | 437.462 | 892.659.526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684.638 | 0,06 | 116,75 | 49.736 | 79.931.486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44.898 | 7.642.159 | 0,59 | 117,50 | 5.275.484 | 897.948.333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.102 | 684.212 | 0,75 | 117,50 | 599.481 | 80.394.431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.373 | 7.597.261 | 0,07 | 117,21 | 629.790 | 890.504.591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679.110 | 0,09 | 117,21 | 71.618 | 79.601.132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217.305 | 7.591.888 | 2,95 | 117,05 | 25.434.638 | 888.598.604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.692 | 678.499 | 3,78 | 117,05 | 2.890.095 | 79.415.458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8.950 | 7.374.583 | 0,12 | 116,95 | 1.046.720 | 862.471.494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.017 | 653.807 | 0,16 | 116,95 | 118.940 | 76.463.971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39.473 | 7.365.633 | 0,54 | 116,65 | 4.604.506 | 859.197.407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.485 | 652.790 | 0,69 | 116,65 | 523.173 | 76.147.627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.310 | 7.326.160 | 0,06 | 116,54 | 502.277 | 853.773.836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648.305 | 0,08 | 116,54 | 57.103 | 75.551.974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.944 | 7.321.850 | 0,05 | 118,00 | 465.392 | 863.978.300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647.815 | 0,07 | 118,00 | 52.864 | 76.442.170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 328.877 | 2,57 | 18,13 | 149.572 | 5.962.540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 328.877 | 2,57 | 18,13 | 149.572 | 5.962.540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 40.898.792 | 0,01 | 66,60 | 246.420 | 2.723.859.547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 40.898.792 | 0,01 | 66,60 | 246.420 | 2.723.859.547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 40.895.092 | 0,02 | 10,20 | 102.000 | 417.129.938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 40.895.092 | 0,02 | 10,20 | 102.000 | 417.129.938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.030 | 6.559.338 | 0,03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.030 | 6.106.592 | 0,03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36.000 | 36.000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399.984 | 399.984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767.237 | 0,02 | 133,67 | 18.981 | 102.556.570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1.226.510 | 0,01 | 133,67 | 18.981 | 163.947.592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767.237 | 0,02 | 133,67 | 18.981 | 102.556.570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320.627 | 0,20 | 31,49 | 19.965 | 10.096.544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320.627 | 0,20 | 31,49 | 19.965 | 10.096.544 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151.177 | 4.527.089 | 3,45 | 12,00 | 1.814.124 | 54.325.068 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15.489 | 434.760 | 3,69 | 12,00 | 185.868 | 5.217.120 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6.050.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5.674.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243.450.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228.326.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25.000.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25.000.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121.672 | 767.095 | 18,85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111.514 | 645.423 | 20,89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4.896.067 | 29.141.653 | 20,19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4.487.412 | 24.245.586 | 22,71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502.779 | 4.353.957 | 13,06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491.338 | 3.851.178 | 14,62 | ||||
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32.051 | 9.764.459 | 0,33 | 17,76 | 569.226 | 173.416.792 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.389 | 1.169.695 | 0,29 | 17,76 | 60.189 | 20.773.783 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235.169 | 9.732.408 | 2,48 | 17,60 | 4.138.880 | 171.286.488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24.871 | 1.166.306 | 2,18 | 17,60 | 437.720 | 20.526.519 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35.360 | 9.497.239 | 0,37 | 16,31 | 576.555 | 154.855.331 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.739 | 1.141.435 | 0,33 | 16,31 | 60.966 | 18.611.440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.006 | 9.461.879 | 0,05 | 15,62 | 78.207 | 147.819.151 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1.137.696 | 0,05 | 15,62 | 8.264 | 17.773.770 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15.148 | 9.456.873 | 0,16 | 15,13 | 229.189 | 143.082.488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.602 | 1.137.167 | 0,14 | 15,13 | 24.238 | 17.205.337 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.143 | 9.441.725 | 0,10 | 16,20 | 148.089 | 152.927.620 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1.135.565 | 0,09 | 16,20 | 15.662 | 18.392.746 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8.671 | 9.432.582 | 0,09 | 15,35 | 133.078 | 144.766.552 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1.134.598 | 0,08 | 15,35 | 14.074 | 17.413.243 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.442 | 9.423.911 | 0,03 | 16,85 | 41.156 | 158.823.999 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1.133.681 | 0,02 | 16,85 | 4.348 | 19.106.266 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11.305 | 9.421.469 | 0,12 | 15,32 | 173.204 | 144.346.327 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.195 | 1.133.423 | 0,11 | 15,32 | 18.309 | 17.365.174 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.697 | 9.410.164 | 0,06 | 16,74 | 95.365 | 157.521.440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1.132.228 | 0,05 | 16,74 | 10.094 | 18.952.931 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993.182 | 0,02 | 100,27 | 18.951 | 99.586.359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993.182 | 0,02 | 100,27 | 18.951 | 99.586.359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533.909 | 0,04 | 100,27 | 18.951 | 53.535.055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1.363.375 | 0,05 | 29,39 | 19.985 | 40.069.591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319.993 | 0,21 | 29,39 | 19.985 | 9.404.594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.594.671 | 3.317.977 | 92,54 | 32,00 | 51.029.472 | 106.175.264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165.824 | 355.198 | 87,56 | 32,00 | 5.306.368 | 11.366.336 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664.259 | 6.480.668 | 11,42 | 6,00 | 3.985.554 | 38.884.008 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69.074 | 734.261 | 10,38 | 6,00 | 414.444 | 4.405.566 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294.178 | 40.885.092 | 0,72 | 59,46 | 17.493.177 | 2.431.215.642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.122 | 4.874.864 | 0,66 | 59,46 | 1.910.122 | 289.881.838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50.667 | 40.590.914 | 0,12 | 58,74 | 2.976.321 | 2.384.423.943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.533 | 4.842.742 | 0,11 | 58,74 | 325.024 | 284.476.225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.616 | 40.540.247 | 0,05 | 55,99 | 1.042.351 | 2.269.937.618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.039 | 4.837.209 | 0,04 | 55,99 | 114.168 | 270.845.974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.854 | 40.521.631 | 0,04 | 56,42 | 950.861 | 2.286.129.117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.846 | 4.835.170 | 0,04 | 56,42 | 104.147 | 272.788.203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143.016 | 40.504.777 | 0,35 | 56,48 | 8.078.001 | 2.287.839.420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.662 | 4.833.324 | 0,33 | 56,48 | 884.640 | 273.001.606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40.361.761 | 0,00 | 56,49 | 20.393 | 2.280.035.879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4.817.662 | 0,00 | 56,49 | 2.203 | 272.149.726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40.361.400 | 0,00 | 56,55 | 25.788 | 2.282.558.254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4.817.623 | 0,00 | 56,55 | 2.828 | 272.451.034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341.438 | 40.360.944 | 0,85 | 56,91 | 19.430.383 | 2.296.840.421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.392 | 4.817.573 | 0,78 | 56,91 | 2.127.885 | 274.156.035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95.280 | 40.019.506 | 0,24 | 55,84 | 5.320.673 | 2.234.789.264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.434 | 4.780.181 | 0,22 | 55,84 | 582.661 | 266.937.257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.335 | 39.924.226 | 0,01 | 55,87 | 186.336 | 2.230.686.279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4.769.747 | 0,01 | 55,87 | 20.394 | 266.500.074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.289 | 39.920.891 | 0,02 | 56,12 | 352.915 | 2.240.208.704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4.769.382 | 0,01 | 56,12 | 38.664 | 267.639.594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26.381 | 39.914.602 | 0,07 | 56,13 | 1.480.758 | 2.240.394.636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.889 | 4.768.693 | 0,06 | 56,13 | 162.159 | 267.665.307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289.278 | 39.888.221 | 0,73 | 56,26 | 16.274.202 | 2.244.031.537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.679 | 4.765.804 | 0,67 | 56,26 | 1.782.197 | 268.114.601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.884 | 39.598.943 | 0,01 | 51,83 | 149.479 | 2.052.425.095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4.734.125 | 0,01 | 51,83 | 16.378 | 245.371.119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.434 | 39.596.059 | 0,01 | 53,33 | 129.815 | 2.111.812.251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4.733.809 | 0,01 | 53,33 | 14.187 | 252.472.496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.717 | 39.593.625 | 0,08 | 53,66 | 1.755.578 | 2.124.574.121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.583 | 4.733.543 | 0,08 | 53,66 | 192.262 | 253.999.551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.332 | 39.560.908 | 0,10 | 54,37 | 2.192.976 | 2.151.049.207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.417 | 4.729.960 | 0,09 | 54,37 | 240.166 | 257.182.588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39.520.576 | 0,00 | 54,51 | 50.365 | 2.154.183.605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.725.543 | 0,00 | 54,51 | 5.505 | 257.579.425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.803 | 39.519.652 | 0,00 | 54,61 | 98.455 | 2.158.021.973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4.725.442 | 0,00 | 54,61 | 10.757 | 258.038.903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85.353 | 39.517.849 | 0,22 | 54,93 | 4.688.039 | 2.170.529.712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.347 | 4.725.245 | 0,20 | 54,93 | 513.387 | 259.535.499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.928.596 | 9.309.333 | 45,90 | 2,00 | 5.857.192 | 18.618.666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321.404 | 1.003.781 | 47,10 | 2,00 | 642.808 | 2.007.562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992.993 | 0,02 | 94,29 | 18.952 | 93.629.310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992.993 | 0,02 | 94,29 | 18.952 | 93.629.310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533.720 | 0,04 | 94,29 | 18.952 | 50.324.459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319.313 | 0,22 | 28,92 | 19.955 | 9.234.532 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12.550 | 1.131.625 | 1,12 | 13,15 | 165.029 | 14.880.529 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.476.348 | 9.404.467 | 35,74 | 12,25 | 30.335.263 | 115.204.721 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294.707 | 1.119.075 | 35,75 | 12,25 | 3.610.161 | 13.708.669 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.339 | 39.432.496 | 0,06 | 51,55 | 1.254.571 | 2.032.575.609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.730 | 4.715.898 | 0,06 | 51,55 | 140.720 | 243.084.264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58.541 | 39.408.157 | 0,15 | 51,41 | 3.009.341 | 2.025.803.896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.565 | 4.713.168 | 0,14 | 51,41 | 337.478 | 242.283.700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39.349.616 | 0,00 | 50,64 | 45.523 | 1.992.546.505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.706.603 | 0,00 | 50,64 | 5.114 | 238.328.256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.804 | 39.348.717 | 0,06 | 50,42 | 1.099.388 | 1.984.017.399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.445 | 4.706.502 | 0,05 | 50,42 | 123.280 | 237.308.420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.290 | 39.326.913 | 0,05 | 50,41 | 1.073.191 | 1.982.398.896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.388 | 4.704.057 | 0,05 | 50,41 | 120.375 | 237.123.046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39.305.623 | 0,00 | 50,00 | 4.500 | 1.965.281.150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4.701.669 | 0,00 | 50,00 | 500 | 235.083.450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39.305.533 | 0,00 | 49,84 | 44.802 | 1.958.791.237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.701.659 | 0,00 | 49,84 | 5.033 | 234.307.176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.380 | 39.304.634 | 0,02 | 50,99 | 427.266 | 2.004.001.791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4.701.558 | 0,02 | 50,99 | 47.927 | 239.715.517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.338 | 39.296.254 | 0,01 | 50,48 | 118.029 | 1.983.788.861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4.700.618 | 0,01 | 50,48 | 13.227 | 237.300.828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.241 | 39.293.916 | 0,08 | 51,25 | 1.703.751 | 2.013.990.018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.728 | 4.700.356 | 0,08 | 51,25 | 191.077 | 240.914.397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.440 | 39.260.675 | 0,06 | 50,33 | 1.179.656 | 1.975.856.286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.637 | 4.696.628 | 0,06 | 50,33 | 132.711 | 236.365.319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170.652 | 39.237.235 | 0,44 | 50,38 | 8.597.226 | 1.976.720.891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.201 | 4.693.991 | 0,41 | 50,38 | 967.321 | 236.477.164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.944 | 39.066.583 | 0,02 | 51,05 | 405.541 | 1.994.349.062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4.674.790 | 0,02 | 51,05 | 45.639 | 238.648.030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28.271 | 39.058.639 | 0,07 | 50,55 | 1.428.963 | 1.974.226.720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.181 | 4.673.896 | 0,07 | 50,55 | 160.784 | 236.243.008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.893 | 39.030.368 | 0,09 | 50,48 | 1.710.844 | 1.970.167.110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.813 | 4.670.715 | 0,08 | 50,48 | 192.472 | 235.767.418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48.036 | 38.996.475 | 0,12 | 50,10 | 2.406.829 | 1.953.906.681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.405 | 4.666.902 | 0,12 | 50,10 | 270.816 | 233.833.725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101.290 | 38.948.439 | 0,26 | 50,05 | 5.069.433 | 1.949.318.739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.397 | 4.661.497 | 0,25 | 50,05 | 570.405 | 233.301.865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.581 | 38.847.149 | 0,01 | 49,46 | 276.030 | 1.921.337.258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4.650.100 | 0,01 | 49,46 | 31.060 | 229.988.831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38.841.568 | 0,00 | 49,18 | 46.427 | 1.910.267.156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4.649.472 | 0,00 | 49,18 | 5.213 | 228.665.682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.825 | 38.840.624 | 0,04 | 48,61 | 672.033 | 1.888.042.733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.556 | 4.649.366 | 0,03 | 48,61 | 75.637 | 226.005.681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12.955 | 38.826.799 | 0,03 | 48,95 | 634.191 | 1.900.703.822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.457 | 4.647.810 | 0,03 | 48,95 | 71.325 | 227.526.102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38.813.844 | 0,00 | 47,27 | 25.904 | 1.834.718.762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4.646.353 | 0,00 | 47,27 | 2.931 | 219.631.712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.681 | 38.813.296 | 0,03 | 48,16 | 562.550 | 1.869.225.047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.314 | 4.646.291 | 0,03 | 48,16 | 63.281 | 223.762.587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.598 | 38.801.615 | 0,02 | 48,44 | 416.460 | 1.879.426.065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4.644.977 | 0,02 | 48,44 | 46.838 | 224.987.822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.930 | 38.793.017 | 0,02 | 48,29 | 286.332 | 1.873.132.464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4.644.010 | 0,01 | 48,29 | 32.206 | 224.237.416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84.331 | 4.643.343 | 1,85 | 46,17 | 3.893.638 | 214.387.325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.600 | 4.559.012 | 0,08 | 45,10 | 162.369 | 205.623.295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35.263 | 4.555.412 | 0,78 | 45,39 | 1.600.457 | 206.753.296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.360 | 4.520.149 | 0,19 | 46,10 | 385.414 | 208.388.813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.735 | 4.511.789 | 0,06 | 44,98 | 123.025 | 202.948.842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.074 | 4.509.054 | 0,20 | 45,80 | 415.623 | 206.531.357 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9.418.390 | -0,01 | 4,29 | -3.645 | 40.392.649 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1.551.387 | -0,01 | 4,29 | -600 | 6.653.433 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343.583 | 9.419.240 | -3,52 | 4,83 | -1.658.681 | 45.472.323 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56.417 | 1.551.527 | -3,51 | 4,83 | -272.359 | 7.490.152 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296.856 | 9.762.823 | -2,95 | 5,25 | -1.559.711 | 51.294.848 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48.744 | 1.607.944 | -2,94 | 5,25 | -256.106 | 8.448.299 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2.834.561 | 10.059.679 | -21,98 | 5,00 | -14.172.805 | 50.298.395 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465.439 | 1.656.688 | -21,93 | 5,00 | -2.327.195 | 8.283.440 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89.896 | 11.348.958 | 0,80 | 27,02 | 2.428.621 | 306.602.314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.104 | 1.758.289 | 0,58 | 27,02 | 272.969 | 47.501.760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.169.877 | 22.337.275 | 5,53 | 33,00 | 38.605.941 | 737.130.075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133.153 | 3.029.953 | 4,60 | 33,00 | 4.394.049 | 99.988.449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13.937.394 | 0,01 | 26,74 | 19.948 | 372.685.916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13.937.394 | 0,01 | 26,74 | 19.948 | 372.685.916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1.362.005 | 0,05 | 26,74 | 19.948 | 36.420.014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1.362.005 | 0,05 | 26,74 | 19.948 | 36.420.014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318.623 | 0,23 | 26,74 | 19.948 | 8.519.979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318.623 | 0,23 | 26,74 | 19.948 | 8.519.979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23.803.844 | 0,00 | 79,98 | 18.955 | 1.903.831.443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533.519 | 0,04 | 79,98 | 18.955 | 42.670.850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533.519 | 0,04 | 79,98 | 18.955 | 42.670.850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26.500 | 26.500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2.318 | 30.003 | -7,17 | 9,56 | -22.157 | 286.787 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158.684 | 2.122.417 | -6,96 | 9,56 | -1.516.797 | 20.287.335 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9.056 | 116.778 | -7,20 | 9,56 | -86.563 | 1.116.234 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5.111 | 32.321 | -13,65 | 9,40 | -48.043 | 303.817 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349.919 | 2.281.101 | -13,30 | 9,40 | -3.289.239 | 21.442.349 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19.970 | 125.834 | -13,70 | 9,40 | -187.718 | 1.182.840 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2.154 | 37.432 | -5,44 | 9,21 | -19.844 | 344.839 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147.529 | 2.631.020 | -5,31 | 9,21 | -1.359.096 | 24.238.009 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8.417 | 145.804 | -5,46 | 9,21 | -77.541 | 1.343.205 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4.201 | 39.586 | -9,59 | 9,44 | -39.648 | 373.605 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275.506 | 2.778.549 | -9,02 | 9,44 | -2.600.171 | 26.223.390 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16.493 | 154.221 | -9,66 | 9,44 | -155.658 | 1.455.507 | |
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 38.787.087 | 0,01 | 38,82 | 143.634 | 1.505.714.717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 38.787.087 | 0,01 | 38,82 | 143.634 | 1.505.714.717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 317.877 | 2,66 | 10,73 | 88.522 | 3.410.820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2.294 | 2.294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6.104.562 | 0,01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6.104.562 | 0,01 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1.232.130 | 0 | -100,00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101.204 | 0 | -100,00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179.531 | 976.214 | 22,53 | 18,00 | 3.231.558 | 17.571.852 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20.469 | 85.906 | 31,28 | 18,00 | 368.442 | 1.546.308 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796.683 | 796.683 | |||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65.437 | 65.437 | |||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 7.110.113 | 0,15 | 1,97 | 21.252 | 14.006.923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 89.673 | 13,68 | 1,97 | 21.252 | 176.656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 89.673 | 13,68 | 1,97 | 21.252 | 176.656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309.627 | 0,25 | 25,48 | 19.976 | 7.889.296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309.627 | 0,25 | 25,48 | 19.976 | 7.889.296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3.268.830 | 0,00 | 6,74 | 923 | 22.031.914 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3.479 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310.003 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3.479 | 43.787 | 8,63 | 6,74 | 23.448 | 295.124 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310.003 | 3.054.055 | 11,30 | 6,74 | 2.089.420 | 20.584.331 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6,74 | 923 | 923 | ||
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262.253 | 21.167.398 | 1,25 | 28,55 | 7.486.904 | 604.295.345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.647 | 2.896.800 | 1,00 | 28,55 | 817.826 | 82.699.005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10.818 | 20.905.145 | 0,05 | 27,82 | 300.959 | 581.585.315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.182 | 2.868.153 | 0,04 | 27,82 | 32.883 | 79.792.590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318.969 | 20.894.327 | 1,55 | 27,72 | 8.840.959 | 579.134.330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34.844 | 2.866.971 | 1,23 | 27,72 | 965.782 | 79.464.695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60.587 | 20.575.358 | 0,30 | 27,56 | 1.669.705 | 567.032.176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6.618 | 2.832.127 | 0,23 | 27,56 | 182.384 | 78.050.022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.433 | 20.514.771 | 0,14 | 26,55 | 755.024 | 544.759.487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.106 | 2.825.509 | 0,11 | 26,55 | 82.478 | 75.029.979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180.122 | 20.486.338 | 0,89 | 26,49 | 4.772.224 | 542.773.234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19.676 | 2.822.403 | 0,70 | 26,49 | 521.304 | 74.777.874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13.433 | 20.306.216 | 0,07 | 26,28 | 353.086 | 533.748.888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.467 | 2.802.727 | 0,05 | 26,28 | 38.560 | 73.669.679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14.775 | 20.292.783 | 0,07 | 25,61 | 378.343 | 519.637.294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.614 | 2.801.260 | 0,06 | 25,61 | 41.330 | 71.731.865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16.057 | 2.799.646 | 0,58 | 26,35 | 423.057 | 73.762.833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37.882 | 2.783.589 | 1,38 | 25,98 | 983.985 | 72.303.724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408.607 | 2.745.707 | 17,48 | 25,92 | 10.593.014 | 71.181.630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92.140 | 38.783.387 | 0,24 | 31,73 | 2.923.547 | 1.230.573.599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.034 | 4.496.280 | 0,22 | 31,73 | 318.373 | 142.664.267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.741 | 38.691.247 | 0,05 | 32,41 | 639.713 | 1.253.801.466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.150 | 4.486.246 | 0,05 | 32,41 | 69.671 | 145.378.148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 206.421.153 | 0,01 | 3,86 | 77.200 | 796.785.651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90.179 | 19.757.285 | 0,46 | 62,59 | 5.644.024 | 1.236.547.221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.821 | 3.358.951 | 0,29 | 62,59 | 614.666 | 210.226.330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127.964 | 19.667.106 | 0,65 | 61,38 | 7.854.149 | 1.207.123.699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13.936 | 3.349.130 | 0,42 | 61,38 | 855.361 | 205.562.231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24.431 | 19.539.142 | 0,13 | 61,03 | 1.490.975 | 1.192.434.758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.660 | 3.335.194 | 0,08 | 61,03 | 162.334 | 203.540.219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20.659 | 19.514.711 | 0,11 | 60,95 | 1.259.178 | 1.189.433.344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.250 | 3.332.534 | 0,07 | 60,95 | 137.139 | 203.119.947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97.484 | 19.494.052 | 0,50 | 60,85 | 5.931.960 | 1.186.224.761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10.616 | 3.330.284 | 0,32 | 60,85 | 645.990 | 202.649.780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 533.020 | 3,90 | 3,86 | 77.200 | 2.057.457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 533.020 | 3,90 | 3,86 | 77.200 | 2.057.457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.182 | 19.376.568 | 0,01 | 65,29 | 77.176 | 1.265.142.628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3.299.668 | 0,00 | 65,29 | 8.423 | 215.443.243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179.176 | 19.375.386 | 0,93 | 65,80 | 11.789.387 | 1.274.857.773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.513 | 3.299.539 | 0,59 | 65,80 | 1.283.912 | 217.102.407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180.358 | 19.196.210 | 0,95 | 67,15 | 12.110.607 | 1.288.979.431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.642 | 3.280.026 | 0,60 | 67,15 | 1.318.913 | 220.245.874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198.484 | 38.671.506 | 0,52 | 31,60 | 6.272.531 | 1.222.104.667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.616 | 4.484.096 | 0,48 | 31,60 | 683.113 | 141.707.299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.810 | 38.473.022 | 0,09 | 31,86 | 1.045.205 | 1.225.608.131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.573 | 4.462.480 | 0,08 | 31,86 | 113.823 | 142.158.102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.627 | 38.440.212 | 0,02 | 31,50 | 271.712 | 1.210.693.697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4.458.907 | 0,02 | 31,50 | 29.606 | 140.435.505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273.381 | 38.431.585 | 0,72 | 31,89 | 8.719.077 | 1.225.717.756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.772 | 4.457.967 | 0,67 | 31,89 | 949.533 | 142.180.171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145.272 | 38.158.204 | 0,38 | 31,74 | 4.611.296 | 1.211.236.790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.821 | 4.428.195 | 0,36 | 31,74 | 502.198 | 140.561.980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63.560 | 38.012.932 | 0,17 | 31,50 | 2.002.401 | 1.197.563.211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.922 | 4.412.374 | 0,16 | 31,50 | 218.071 | 139.007.872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387.336 | 37.949.372 | 1,03 | 32,31 | 12.514.051 | 1.226.068.311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.182 | 4.405.452 | 0,97 | 32,31 | 1.362.816 | 142.331.343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107.260 | 37.562.036 | 0,29 | 33,77 | 3.622.063 | 1.268.432.394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.681 | 4.363.270 | 0,27 | 33,77 | 394.456 | 147.343.265 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128.975 | 6.928.119 | 1,90 | 8,16 | 1.051.920 | 56.505.739 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14.046 | 824.368 | 1,73 | 8,16 | 114.559 | 6.723.545 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185.413 | 6.799.144 | 2,80 | 7,91 | 1.466.320 | 53.770.350 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20.192 | 810.322 | 2,56 | 7,91 | 159.686 | 6.408.351 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11.840 | 6.613.731 | 0,18 | 7,70 | 91.160 | 50.921.099 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.289 | 790.130 | 0,16 | 7,70 | 9.924 | 6.083.448 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68.132 | 6.601.891 | 1,04 | 8,03 | 546.807 | 52.984.797 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7.420 | 788.841 | 0,95 | 8,03 | 59.551 | 6.331.001 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30.986 | 6.533.759 | 0,48 | 7,88 | 244.126 | 51.476.874 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.374 | 781.421 | 0,43 | 7,88 | 26.582 | 6.156.503 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.874 | 37.454.776 | 0,01 | 32,34 | 157.646 | 1.211.448.511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4.351.589 | 0,01 | 32,34 | 17.692 | 140.749.100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147.831 | 37.449.902 | 0,40 | 33,15 | 4.900.997 | 1.241.565.366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.608 | 4.351.042 | 0,38 | 33,15 | 550.600 | 144.248.790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.289 | 37.302.071 | 0,06 | 32,96 | 767.582 | 1.229.438.958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.616 | 4.334.434 | 0,06 | 32,96 | 86.221 | 142.858.610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95.682 | 37.278.782 | 0,26 | 32,41 | 3.100.652 | 1.208.048.754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.749 | 4.331.818 | 0,25 | 32,41 | 348.330 | 140.376.028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165.237 | 37.183.100 | 0,45 | 32,30 | 5.337.915 | 1.201.185.172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.563 | 4.321.069 | 0,43 | 32,30 | 599.670 | 139.590.406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36.589 | 37.017.863 | 0,10 | 31,15 | 1.139.842 | 1.153.202.679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.111 | 4.302.506 | 0,10 | 31,15 | 128.068 | 134.034.248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97.272 | 36.981.274 | 0,26 | 32,12 | 3.124.484 | 1.187.879.200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.927 | 4.298.395 | 0,25 | 32,12 | 350.987 | 138.069.176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53.734 | 36.884.002 | 0,15 | 32,47 | 1.744.598 | 1.197.523.958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.037 | 4.287.468 | 0,14 | 32,47 | 196.005 | 139.202.510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 286.671.473 | 0,00 | 4,18 | 41.800 | 1.198.286.757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88.732 | 36.830.268 | 0,24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.968 | 4.281.431 | 0,23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48.996 | 36.741.536 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.504 | 4.271.463 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 36.692.540 | 0,03 | 4,18 | 41.800 | 153.374.817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.157 | 36.682.540 | 0,04 | 33,72 | 477.445 | 1.237.118.662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.590 | 4.255.959 | 0,04 | 33,72 | 53.623 | 143.532.217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.921 | 36.668.383 | 0,11 | 33,68 | 1.378.043 | 1.234.833.465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.597 | 4.254.369 | 0,11 | 33,68 | 154.807 | 143.268.854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218.550 | 36.627.462 | 0,60 | 32,49 | 7.101.280 | 1.190.125.135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.908 | 4.249.772 | 0,57 | 32,49 | 776.835 | 138.086.567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41.104 | 36.408.912 | 0,11 | 31,68 | 1.302.257 | 1.153.507.150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.496 | 4.225.864 | 0,11 | 31,68 | 142.442 | 133.883.823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.492 | 36.367.808 | 0,16 | 32,24 | 1.918.022 | 1.172.498.130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.508 | 4.221.368 | 0,15 | 32,24 | 209.818 | 136.096.904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301.066 | 36.308.316 | 0,84 | 32,76 | 9.862.139 | 1.189.366.031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.934 | 4.214.860 | 0,79 | 32,76 | 1.078.832 | 138.067.855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.814 | 36.007.250 | 0,06 | 31,24 | 681.563 | 1.125.021.321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.386 | 4.181.926 | 0,06 | 31,24 | 74.549 | 130.661.351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172.462 | 35.985.436 | 0,48 | 30,34 | 5.232.928 | 1.091.888.092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.866 | 4.179.540 | 0,45 | 30,34 | 572.442 | 126.817.692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54.439 | 35.812.974 | 0,15 | 30,55 | 1.663.024 | 1.094.029.055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.955 | 4.160.674 | 0,14 | 30,55 | 181.916 | 127.101.934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.022 | 19.015.852 | 0,03 | 74,00 | 445.628 | 1.407.173.048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3.260.384 | 0,02 | 74,00 | 50.172 | 241.268.416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20.492 | 19.009.830 | 0,11 | 69,70 | 1.428.282 | 1.324.975.646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.308 | 3.259.706 | 0,07 | 69,70 | 160.866 | 227.199.878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23.157 | 18.989.338 | 0,12 | 70,50 | 1.632.684 | 1.338.843.276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.608 | 3.257.398 | 0,08 | 70,50 | 183.877 | 229.662.846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.111 | 18.966.181 | 0,04 | 71,96 | 583.702 | 1.364.886.043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3.254.790 | 0,03 | 71,96 | 65.775 | 234.228.359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.815 | 35.758.535 | 0,11 | 30,13 | 1.199.793 | 1.077.554.845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.485 | 4.154.719 | 0,11 | 30,13 | 135.152 | 125.199.133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128.255 | 35.718.720 | 0,36 | 29,86 | 3.830.118 | 1.066.678.851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.447 | 4.150.234 | 0,35 | 29,86 | 431.435 | 123.939.683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67.407 | 35.590.465 | 0,19 | 28,52 | 1.922.670 | 1.015.157.510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.593 | 4.135.787 | 0,18 | 28,52 | 216.577 | 117.966.293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.134 | 35.523.058 | 0,01 | 28,46 | 117.674 | 1.011.163.846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4.128.194 | 0,01 | 28,46 | 13.265 | 117.509.042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.056 | 35.518.924 | 0,12 | 29,77 | 1.281.975 | 1.057.561.755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.850 | 4.127.728 | 0,12 | 29,77 | 144.407 | 122.901.450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218.768 | 35.475.868 | 0,62 | 30,21 | 6.610.053 | 1.071.899.804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.643 | 4.122.878 | 0,60 | 30,21 | 744.586 | 124.572.346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456.849 | 35.257.100 | 1,31 | 29,20 | 13.339.991 | 1.029.507.320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.677 | 4.098.235 | 1,23 | 29,20 | 1.450.568 | 119.668.462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226.865 | 34.800.251 | 0,66 | 29,94 | 6.791.816 | 1.041.839.474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.669 | 4.048.558 | 0,61 | 29,94 | 738.533 | 121.204.515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726.291 | 34.573.386 | 2,15 | 31,25 | 22.694.197 | 1.080.304.220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78.976 | 4.023.889 | 2,00 | 31,25 | 2.467.739 | 125.733.252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33.847.095 | 0,00 | 29,50 | 26.609 | 998.489.302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3.944.913 | 0,00 | 29,50 | 2.891 | 116.374.934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106.444 | 33.846.193 | 0,32 | 29,19 | 3.107.590 | 988.126.066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.575 | 3.944.815 | 0,29 | 29,19 | 337.927 | 115.167.296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151.144 | 33.739.749 | 0,45 | 30,27 | 4.574.645 | 1.021.194.235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.435 | 3.933.240 | 0,42 | 30,27 | 497.435 | 119.046.588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33.588.605 | 0,00 | 27,93 | 17.626 | 938.227.145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3.916.805 | 0,00 | 27,93 | 1.927 | 109.407.722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.073 | 33.587.974 | 0,22 | 27,28 | 1.966.043 | 916.229.549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.909 | 3.916.736 | 0,20 | 27,28 | 215.746 | 106.842.683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87.049 | 33.515.901 | 0,26 | 28,07 | 2.443.831 | 940.932.108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.551 | 3.908.827 | 0,24 | 28,07 | 268.137 | 109.737.191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15.187 | 18.958.070 | 0,08 | 69,45 | 1.054.742 | 1.316.643.649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.651 | 3.253.876 | 0,05 | 69,45 | 114.662 | 225.982.664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.250 | 18.942.883 | 0,04 | 70,86 | 584.597 | 1.342.296.478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3.252.225 | 0,03 | 70,86 | 63.562 | 230.453.314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67.373 | 18.934.633 | 0,36 | 69,54 | 4.684.923 | 1.316.659.468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.326 | 3.251.328 | 0,23 | 69,54 | 509.429 | 226.087.920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124.057 | 18.867.260 | 0,66 | 70,21 | 8.710.228 | 1.324.698.625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13.490 | 3.244.002 | 0,42 | 70,21 | 947.153 | 227.766.246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397.079 | 18.743.203 | 2,16 | 71,10 | 28.233.945 | 1.332.718.580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43.178 | 3.230.512 | 1,35 | 71,10 | 3.070.133 | 229.702.648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149.927 | 18.346.124 | 0,82 | 67,94 | 10.186.595 | 1.246.503.545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16.450 | 3.187.334 | 0,52 | 67,94 | 1.117.674 | 216.559.265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38.117 | 18.196.197 | 0,21 | 63,98 | 2.438.547 | 1.164.107.162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4.183 | 3.170.884 | 0,13 | 63,98 | 267.609 | 202.858.255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168.055 | 18.158.080 | 0,93 | 64,87 | 10.902.350 | 1.177.981.834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18.441 | 3.166.701 | 0,59 | 64,87 | 1.196.336 | 205.435.611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541.340 | 17.990.025 | 3,10 | 65,80 | 35.621.958 | 1.183.803.012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59.401 | 3.148.260 | 1,92 | 65,80 | 3.908.782 | 207.165.897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49.021 | 17.448.685 | 0,28 | 66,68 | 3.268.823 | 1.163.514.958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.379 | 3.088.859 | 0,17 | 66,68 | 358.683 | 205.971.605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72.894 | 17.399.664 | 0,42 | 67,68 | 4.933.706 | 1.177.666.678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.999 | 3.083.480 | 0,26 | 67,68 | 541.399 | 208.700.102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.939 | 17.326.770 | 0,04 | 60,85 | 422.220 | 1.054.288.905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3.075.481 | 0,02 | 60,85 | 46.305 | 187.135.023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57.865 | 17.319.831 | 0,34 | 61,73 | 3.572.047 | 1.069.165.292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.349 | 3.074.720 | 0,21 | 61,73 | 391.928 | 189.804.618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136.793 | 17.261.966 | 0,80 | 58,13 | 7.952.133 | 1.003.482.965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15.010 | 3.068.371 | 0,49 | 58,13 | 872.570 | 178.372.384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114.908 | 17.125.173 | 0,68 | 59,01 | 6.780.526 | 1.010.527.346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.609 | 3.053.361 | 0,41 | 59,01 | 744.036 | 180.173.642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65.309 | 17.010.265 | 0,39 | 60,40 | 3.944.513 | 1.027.380.882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.166 | 3.040.752 | 0,24 | 60,40 | 432.810 | 183.654.427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113.546 | 16.944.956 | 0,67 | 61,40 | 6.971.475 | 1.040.383.019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.459 | 3.033.586 | 0,41 | 61,40 | 764.955 | 186.255.507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289.755 | 16.831.410 | 1,75 | 62,56 | 18.126.986 | 1.052.967.960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31.795 | 3.021.127 | 1,06 | 62,56 | 1.989.086 | 189.000.799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176.647 | 16.541.655 | 1,08 | 63,37 | 11.194.368 | 1.048.267.836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.383 | 2.989.332 | 0,65 | 63,37 | 1.228.328 | 189.438.154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235.734 | 16.365.008 | 1,46 | 64,46 | 15.195.814 | 1.054.916.236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25.869 | 2.969.949 | 0,88 | 64,46 | 1.667.560 | 191.447.961 | |
| 2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45.000 | 12.894.240 | 0,35 | 6,33 | 284.656 | 81.565.094 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56.853 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2.296.890 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238.850 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26.292.961 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1.912.167 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582.747 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44.572.171 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4.382.118 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.723.306 | 1.723.306 | 24,00 | 41.359.344 | 41.359.344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189.374 | 189.374 | 24,00 | 4.544.976 | 4.544.976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56.853 | 639.600 | 9,76 | 0,68 | 38.376 | 431.730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2.296.890 | 73.162.022 | 3,24 | 0,68 | 1.550.401 | 49.384.365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238.850 | 6.533.135 | 3,79 | 0,68 | 161.224 | 4.409.866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26.292.961 | 70.865.132 | 58,99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1.912.167 | 6.294.285 | 43,64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582.747 | 582.747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44.572.171 | 44.572.171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4.382.118 | 4.382.118 | |||||
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.800 | 12.849.240 | 0,19 | 6,65 | 164.915 | 85.444.876 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91.187 | 12.824.440 | 0,72 | 6,29 | 573.311 | 80.629.819 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91.728 | 12.733.253 | 0,73 | 6,52 | 598.360 | 83.061.556 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.000 | 12.641.525 | 0,20 | 6,88 | 172.015 | 86.981.277 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63.345 | 12.616.525 | 0,50 | 6,98 | 441.971 | 88.028.018 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.581 | 6.502.773 | 0,06 | 11,00 | 39.377 | 71.504.492 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778.047 | 0,05 | 11,00 | 4.343 | 8.555.405 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66.345 | 6.499.192 | 1,03 | 10,80 | 716.745 | 70.212.721 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7.318 | 777.652 | 0,95 | 10,80 | 79.059 | 8.401.208 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.522 | 6.432.847 | 0,04 | 11,20 | 28.257 | 72.075.548 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770.334 | 0,04 | 11,20 | 3.115 | 8.631.053 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.503 | 6.430.325 | 0,07 | 10,98 | 49.423 | 70.576.032 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770.056 | 0,06 | 10,98 | 5.455 | 8.451.750 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.833 | 6.425.822 | 0,04 | 11,23 | 31.822 | 72.178.688 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769.559 | 0,04 | 11,23 | 3.505 | 8.644.148 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25.650 | 6.422.989 | 0,40 | 10,69 | 274.219 | 68.666.891 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.810 | 769.247 | 0,37 | 10,69 | 30.041 | 8.223.866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6.397.339 | 0,00 | 10,60 | 1.654 | 67.811.793 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766.437 | 0,00 | 10,60 | 180 | 8.124.232 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.021 | 6.397.183 | 0,06 | 10,69 | 42.999 | 68.409.556 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766.420 | 0,06 | 10,69 | 4.705 | 8.195.866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17.221 | 6.393.162 | 0,27 | 10,78 | 185.666 | 68.927.237 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.887 | 765.980 | 0,25 | 10,78 | 20.345 | 8.258.337 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.200 | 12.553.180 | 0,03 | 7,00 | 22.389 | 87.829.579 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103.600 | 12.549.980 | 0,83 | 7,29 | 755.368 | 91.504.414 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.734 | 6.375.941 | 0,03 | 8,90 | 15.433 | 56.745.875 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764.093 | 0,02 | 8,90 | 1.691 | 6.800.428 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27.996 | 6.374.207 | 0,44 | 8,96 | 250.766 | 57.095.047 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.067 | 763.903 | 0,40 | 8,96 | 27.472 | 6.842.432 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13.789 | 6.346.211 | 0,22 | 8,96 | 123.493 | 56.836.031 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.511 | 760.836 | 0,20 | 8,96 | 13.532 | 6.813.971 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57.453 | 6.332.422 | 0,92 | 9,89 | 567.934 | 62.597.258 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6.294 | 759.325 | 0,84 | 9,89 | 62.217 | 7.506.079 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14.313 | 6.274.969 | 0,23 | 9,15 | 131.017 | 57.439.184 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.568 | 753.031 | 0,21 | 9,15 | 14.353 | 6.893.020 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10.123 | 6.260.656 | 0,16 | 9,21 | 93.282 | 57.691.319 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.109 | 751.463 | 0,15 | 9,21 | 10.219 | 6.924.656 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45.903 | 6.250.533 | 0,74 | 9,08 | 416.602 | 56.727.962 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.029 | 750.354 | 0,67 | 9,08 | 45.642 | 6.809.988 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1.325 | 12.446.380 | 0,01 | 6,94 | 9.197 | 86.396.547 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51.370 | 12.445.055 | 0,41 | 6,87 | 352.974 | 85.512.462 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92.200 | 12.393.685 | 0,75 | 7,12 | 656.750 | 88.281.458 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.000 | 12.301.485 | 0,20 | 7,49 | 187.332 | 92.178.718 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175.000 | 12.276.485 | 1,45 | 7,45 | 1.303.890 | 91.469.634 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47.193 | 6.204.630 | 0,77 | 8,56 | 403.930 | 53.106.049 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.196 | 745.325 | 0,70 | 8,56 | 44.473 | 6.379.311 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.949 | 6.157.437 | 0,08 | 8,95 | 44.308 | 55.126.918 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740.129 | 0,07 | 8,95 | 4.879 | 6.626.301 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.279 | 6.152.488 | 0,05 | 8,82 | 28.937 | 54.295.091 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739.584 | 0,05 | 8,82 | 3.186 | 6.526.755 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20.851 | 6.149.209 | 0,34 | 8,10 | 168.891 | 49.807.978 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.296 | 739.223 | 0,31 | 8,10 | 18.597 | 5.987.632 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.998 | 6.128.358 | 0,05 | 8,08 | 24.213 | 49.495.071 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736.927 | 0,04 | 8,08 | 2.665 | 5.951.717 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12.706 | 6.125.360 | 0,21 | 7,91 | 100.517 | 48.457.723 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.399 | 736.597 | 0,19 | 7,91 | 11.067 | 5.827.219 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90.550 | 6.112.654 | 1,50 | 8,17 | 739.947 | 49.950.775 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.970 | 735.198 | 1,37 | 8,17 | 81.472 | 6.007.817 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47.193 | 6.204.630 | 0,77 | 8,56 | 403.930 | 53.106.049 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.196 | 745.325 | 0,70 | 8,56 | 44.473 | 6.379.311 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.949 | 6.157.437 | 0,08 | 8,95 | 44.308 | 55.126.918 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740.129 | 0,07 | 8,95 | 4.879 | 6.626.301 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.279 | 6.152.488 | 0,05 | 8,82 | 28.937 | 54.295.091 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739.584 | 0,05 | 8,82 | 3.186 | 6.526.755 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20.851 | 6.149.209 | 0,34 | 8,10 | 168.891 | 49.807.978 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.296 | 739.223 | 0,31 | 8,10 | 18.597 | 5.987.632 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.998 | 6.128.358 | 0,05 | 8,08 | 24.213 | 49.495.071 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736.927 | 0,04 | 8,08 | 2.665 | 5.951.717 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12.706 | 6.125.360 | 0,21 | 7,91 | 100.517 | 48.457.723 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.399 | 736.597 | 0,19 | 7,91 | 11.067 | 5.827.219 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90.550 | 6.112.654 | 1,50 | 8,17 | 739.947 | 49.950.775 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.970 | 735.198 | 1,37 | 8,17 | 81.472 | 6.007.817 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.801.161 | 20.278.008 | 9,75 | 29,00 | 52.233.669 | 588.062.232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785.045 | 2.337.100 | 50,58 | 29,00 | 22.766.305 | 67.775.900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.801.161 | 20.278.008 | 9,75 | 29,00 | 52.233.669 | 588.062.232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785.045 | 2.337.100 | 50,58 | 29,00 | 22.766.305 | 67.775.900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 78.885 | 9,86 | 3,00 | 21.246 | 236.655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 78.885 | 9,86 | 3,00 | 21.246 | 236.655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 6.348.612 | 0,11 | 3,00 | 21.246 | 19.045.836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513.020 | 0,03 | 108,45 | 18.979 | 55.637.019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513.020 | 0,03 | 108,45 | 18.979 | 55.637.019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666.111 | 0,03 | 108,45 | 18.979 | 72.239.738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308.843 | 0,18 | 35,20 | 19.994 | 10.871.274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308.843 | 0,18 | 35,20 | 19.994 | 10.871.274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482.740 | 0,12 | 35,20 | 19.994 | 16.992.448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11.423.179 | 0,00 | 35,20 | 19.994 | 402.095.901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196.132 | 0,29 | 35,20 | 19.994 | 6.903.846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356.791 | 0,16 | 35,20 | 19.994 | 12.559.043 | |
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150.000 | 33.428.852 | 0,45 | 44,00 | 6.600.000 | 1.470.869.488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.647 | 33.278.852 | 0,10 | 43,87 | 1.388.259 | 1.459.843.401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.461 | 33.247.205 | 0,17 | 43,93 | 2.524.015 | 1.460.406.753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75.612 | 33.189.744 | 0,23 | 43,93 | 3.321.363 | 1.457.905.971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.000 | 33.114.132 | 0,01 | 43,00 | 172.000 | 1.423.907.676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.638 | 33.110.132 | 0,03 | 43,84 | 466.321 | 1.451.395.880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.400 | 33.099.494 | 0,03 | 44,00 | 413.600 | 1.456.377.736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33.090.094 | 0,00 | 43,00 | 34.400 | 1.422.874.042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407.800 | 33.089.294 | 1,25 | 43,71 | 17.823.388 | 1.446.207.301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98.700 | 32.681.494 | 0,30 | 44,00 | 4.342.800 | 1.437.985.736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196.490 | 32.582.794 | 0,61 | 41,31 | 8.117.179 | 1.346.024.545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221.434 | 32.386.304 | 0,69 | 42,51 | 9.412.318 | 1.376.618.715 | |
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512.845 | 0,03 | 110,33 | 18.977 | 56.582.189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972.118 | 0,02 | 110,33 | 18.977 | 107.253.779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16.282.190 | 0,00 | 110,33 | 18.977 | 1.796.414.023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308.275 | 0,30 | 21,34 | 19.974 | 6.578.588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308.275 | 0,30 | 21,34 | 19.974 | 6.578.588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11.422.611 | 0,01 | 21,34 | 19.974 | 243.758.519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1.911.734 | 0,05 | 21,34 | 19.974 | 40.796.404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195.564 | 0,48 | 21,34 | 19.974 | 4.173.336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356.223 | 0,26 | 21,34 | 19.974 | 7.601.799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31.967.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7.587.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101.652 | 512.673 | 24,73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3.642.962 | 16.128.927 | 29,18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864.614 | 2.943.733 | 41,59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7.406 | 61.049 | 13,81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7.292 | 58.632 | 14,20 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100,00 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139.220 | 2.744.052 | 5,34 | 45,00 | 6.264.900 | 123.482.340 | |
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10.780 | 170.714 | 6,74 | 45,00 | 485.100 | 7.682.130 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346.000 | 32.164.870 | 1,09 | 48,44 | 16.761.728 | 1.558.204.612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50.000 | 31.818.870 | 0,16 | 47,40 | 2.370.000 | 1.508.214.438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160.453 | 31.768.870 | 0,51 | 48,60 | 7.798.690 | 1.544.100.511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.320 | 31.608.417 | 0,11 | 47,98 | 1.598.614 | 1.516.495.987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.386 | 31.575.097 | 0,05 | 47,54 | 683.847 | 1.500.941.181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.600 | 31.560.711 | 0,01 | 47,24 | 75.577 | 1.490.798.589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.500 | 31.559.111 | 0,06 | 46,31 | 949.351 | 1.461.496.119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.950 | 31.538.611 | 0,01 | 44,68 | 87.130 | 1.409.201.909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89.843 | 31.536.661 | 0,29 | 45,28 | 4.067.696 | 1.427.841.249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212.983 | 31.446.818 | 0,68 | 46,81 | 9.969.500 | 1.471.990.959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.818 | 31.233.835 | 0,03 | 46,74 | 458.905 | 1.459.906.929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.331 | 31.224.017 | 0,01 | 45,63 | 106.368 | 1.424.814.344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.513 | 31.221.686 | 0,01 | 45,43 | 159.601 | 1.418.448.028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.897 | 31.218.173 | 0,04 | 45,00 | 625.359 | 1.404.805.298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.649 | 31.204.276 | 0,13 | 42,14 | 1.713.148 | 1.315.101.092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.063 | 31.163.627 | 0,03 | 44,40 | 357.971 | 1.383.565.315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.391 | 31.155.564 | 0,05 | 40,67 | 625.950 | 1.267.093.672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191.321 | 31.140.173 | 0,62 | 41,06 | 7.856.214 | 1.278.708.924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88.640 | 30.948.852 | 0,29 | 42,44 | 3.761.802 | 1.313.441.425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183.073 | 30.860.212 | 0,60 | 43,28 | 7.923.253 | 1.335.605.287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274.814 | 30.677.139 | 0,90 | 44,63 | 12.265.553 | 1.369.188.203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.100 | 30.402.325 | 0,01 | 40,55 | 125.706 | 1.232.823.399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.300 | 30.399.225 | 0,04 | 41,13 | 464.823 | 1.250.466.041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.612 | 30.387.925 | 0,14 | 43,60 | 1.901.322 | 1.324.801.095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.338.927 | 30.344.313 | 12,36 | 41,00 | 136.896.007 | 1.244.116.833 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.213.469 | 6.022.104 | 58,12 | 15,50 | 34.308.770 | 93.342.612 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266.563 | 725.228 | 58,12 | 15,50 | 4.131.726 | 11.241.034 | |
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2.260 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2.260 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2.329 | 2.329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6.103.727 | 0,01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6.103.727 | 0,01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229.436 | 90.538 | -71,70 | 1,09 | -250.659 | 98.913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9.411.311 | 3.153.539 | -74,90 | 1,09 | -10.281.857 | 3.445.241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1.359.253 | 467.436 | -74,41 | 1,09 | -1.484.984 | 510.674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307.339 | 0,24 | 27,34 | 19.958 | 8.402.648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1.350.721 | 0,05 | 27,34 | 19.958 | 36.928.712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481.236 | 0,15 | 27,34 | 19.958 | 13.156.992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11.421.675 | 0,01 | 27,34 | 19.958 | 312.268.594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194.628 | 0,38 | 27,34 | 19.958 | 5.321.130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355.287 | 0,21 | 27,34 | 19.958 | 9.713.547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826.200 | 0,02 | 104,21 | 18.966 | 86.098.302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411.021 | 0,04 | 104,21 | 18.966 | 42.832.498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549.414 | 0,03 | 104,21 | 18.966 | 57.254.433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6.103.033 | 6.103.033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506.166 | 506.166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94.412 | 94.412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66.154 | 66.154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65.811 | 65.811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9.184.771 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680.187 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143.462 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200.526 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15.000 | 0 | -100,00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21.196 | 100.003 | 26,90 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211.614 | 12.250 | -94,53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 78.807 | 0,63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100.490 | 12.250 | -89,13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40.449 | 78.310 | 106,84 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1.068.128 | 680.187 | -61,09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5.543 | 37.861 | 17,15 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55.479 | 12.250 | -81,91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12.500 | 32.318 | 63,07 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165.213 | 12.250 | -93,10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19.318 | 19.818 | 3.863,60 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206.800 | 12.250 | -94,41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198.802 | 27.005.386 | 0,74 | 43,27 | 8.602.242 | 1.168.533.854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.202 | 26.816.266 | 0,21 | 43,29 | 2.476.343 | 1.160.908.335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.300 | 26.759.064 | 0,06 | 43,67 | 711.775 | 1.168.493.400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90.155 | 26.742.764 | 0,34 | 43,62 | 3.932.723 | 1.166.567.503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150.000 | 26.652.609 | 0,57 | 42,93 | 6.439.500 | 1.144.196.504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.200 | 26.492.927 | 0,03 | 40,95 | 376.718 | 1.084.821.778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52.381 | 26.483.727 | 0,20 | 41,54 | 2.176.038 | 1.100.200.229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139.683 | 26.431.346 | 0,53 | 42,68 | 5.961.908 | 1.128.134.781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13.352 | 26.291.663 | 0,05 | 42,97 | 573.749 | 1.129.779.051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2.300 | 26.278.311 | 0,01 | 42,15 | 96.949 | 1.107.675.482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.382 | 26.276.011 | 0,03 | 41,24 | 304.410 | 1.083.538.610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.500 | 26.268.629 | 0,02 | 41,07 | 184.815 | 1.078.852.593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89.100 | 26.264.129 | 0,34 | 40,57 | 3.614.475 | 1.065.443.789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120.529 | 26.175.029 | 0,46 | 41,09 | 4.951.958 | 1.075.406.301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 26.054.500 | 0,01 | 39,94 | 147.778 | 1.040.616.730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 26.054.500 | 0,01 | 39,94 | 147.778 | 1.040.616.730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 26.050.800 | 0,04 | 5,11 | 51.100 | 133.119.588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 26.050.800 | 0,04 | 5,11 | 51.100 | 133.119.588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.100 | 26.040.800 | 0,00 | 37,07 | 40.777 | 965.332.456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.617 | 26.039.700 | 0,18 | 37,15 | 1.732.013 | 967.481.618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.334 | 25.993.083 | 0,03 | 35,85 | 298.745 | 931.761.050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129.118 | 25.984.749 | 0,50 | 36,40 | 4.700.515 | 945.969.590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137.800 | 25.855.631 | 0,54 | 36,25 | 4.995.250 | 937.266.624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155.731 | 25.717.831 | 0,61 | 36,67 | 5.710.048 | 942.972.563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23.012 | 25.562.100 | 0,09 | 35,91 | 826.437 | 918.019.366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354.300 | 25.539.088 | 1,41 | 34,76 | 12.315.078 | 887.710.606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.973 | 25.184.788 | 0,24 | 34,61 | 2.075.833 | 871.716.030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.330 | 25.124.815 | 0,02 | 33,99 | 147.177 | 853.992.462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90.397 | 25.120.485 | 0,36 | 34,56 | 3.123.949 | 868.116.233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.952 | 25.030.088 | 0,09 | 34,52 | 757.888 | 864.158.782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306.609 | 0,21 | 30,43 | 19.962 | 9.330.112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306.609 | 0,21 | 30,43 | 19.962 | 9.330.112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.880 | 25.008.136 | 0,01 | 34,72 | 99.986 | 868.217.461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.439 | 25.005.256 | 0,03 | 34,47 | 221.935 | 861.863.660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158.771 | 24.998.817 | 0,64 | 34,69 | 5.507.401 | 867.151.464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116.946 | 24.840.046 | 0,47 | 34,62 | 4.049.208 | 860.076.657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.600 | 24.723.100 | 0,08 | 34,82 | 682.537 | 860.939.928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.021 | 24.703.500 | 0,02 | 34,79 | 139.882 | 859.380.417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213.820 | 24.699.479 | 0,87 | 34,76 | 7.432.169 | 858.529.191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211.400 | 24.485.659 | 0,87 | 34,92 | 7.382.532 | 855.090.632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.000 | 24.274.259 | 0,00 | 35,60 | 35.595 | 864.042.249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62.650 | 24.273.259 | 0,26 | 34,46 | 2.159.163 | 836.551.171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163.054 | 24.210.609 | 0,68 | 33,80 | 5.510.818 | 818.258.058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.995 | 24.047.555 | 0,02 | 33,60 | 167.830 | 807.985.824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.416 | 24.042.560 | 0,21 | 33,65 | 1.662.843 | 809.029.740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.898.409 | 6.323.855 | 343,64 | 3,75 | 18.369.034 | 23.714.456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434.924 | 625.495 | 228,22 | 3,75 | 1.630.965 | 2.345.606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390.935 | 2.604.832 | 17,66 | 20,00 | 7.818.700 | 52.096.640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34.065 | 159.934 | 27,06 | 20,00 | 681.300 | 3.198.680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1.000.000 | 9.184.771 | 12,22 | 94,19 | 94.190.000 | 865.113.580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21.441 | 345.074 | -5,85 | 3,86 | -82.762 | 1.331.986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859.988 | 12.589.950 | -6,39 | 3,86 | -3.319.554 | 48.597.207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118.571 | 1.851.789 | -6,02 | 3,86 | -457.684 | 7.147.906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21.548 | 366.515 | -5,55 | 3,81 | -82.130 | 1.396.972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863.100 | 13.449.938 | -6,03 | 3,81 | -3.289.706 | 51.264.439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118.652 | 1.970.360 | -5,68 | 3,81 | -452.242 | 7.510.027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4.554 | 388.063 | -1,16 | 3,55 | -16.184 | 1.379.059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182.454 | 14.313.038 | -1,26 | 3,55 | -648.387 | 50.864.243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25.092 | 2.089.012 | -1,19 | 3,55 | -89.169 | 7.423.722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 54.128 | 7,82 | 4,90 | 19.242 | 265.227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 54.128 | 7,82 | 4,90 | 19.242 | 265.227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 1.425.446 | 0,28 | 4,90 | 19.242 | 6.984.685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305.953 | 0,20 | 31,97 | 19.949 | 9.781.317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1.349.335 | 0,05 | 31,97 | 19.949 | 43.138.240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11.420.289 | 0,01 | 31,97 | 19.949 | 365.106.639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1.909.412 | 0,03 | 31,97 | 19.949 | 61.043.902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193.242 | 0,32 | 31,97 | 19.949 | 6.177.947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353.901 | 0,18 | 31,97 | 19.949 | 11.314.215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8.415 | 392.617 | -2,10 | 3,65 | -30.711 | 1.432.856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337.123 | 14.495.492 | -2,27 | 3,65 | -1.230.330 | 52.901.298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46.362 | 2.114.104 | -2,15 | 3,65 | -169.198 | 7.715.423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4.746 | 401.032 | -1,17 | 3,68 | -17.447 | 1.474.274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190.117 | 14.832.615 | -1,27 | 3,68 | -698.908 | 54.527.659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26.137 | 2.160.466 | -1,20 | 3,68 | -96.085 | 7.942.305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2.825 | 405.778 | -0,69 | 3,71 | -10.482 | 1.505.680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112.855 | 15.022.732 | -0,75 | 3,71 | -418.760 | 55.743.349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15.420 | 2.186.603 | -0,70 | 3,71 | -57.217 | 8.113.609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16.182 | 408.603 | -3,81 | 4,21 | -68.102 | 1.719.606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647.781 | 15.135.587 | -4,10 | 4,21 | -2.726.186 | 63.698.118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88.937 | 2.202.023 | -3,88 | 4,21 | -374.291 | 9.267.214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3.558 | 424.785 | -0,83 | 4,29 | -15.260 | 1.821.903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142.543 | 15.783.368 | -0,90 | 4,29 | -611.367 | 67.694.865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19.599 | 2.290.960 | -0,85 | 4,29 | -84.060 | 9.825.927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14.753 | 428.343 | -3,33 | 4,31 | -63.571 | 1.845.730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590.638 | 15.925.911 | -3,58 | 4,31 | -2.545.059 | 68.624.750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81.109 | 2.310.559 | -3,39 | 4,31 | -349.499 | 9.956.199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.900 | 23.993.144 | 0,02 | 31,97 | 124.679 | 767.036.821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23.989.244 | 0,00 | 30,80 | 15.400 | 738.868.715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.685 | 23.988.744 | 0,21 | 31,82 | 1.581.096 | 763.379.407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.855.894 | 23.939.059 | 8,40 | 31,94 | 59.276.698 | 764.606.363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597.000 | 22.083.165 | 2,78 | 31,75 | 18.954.631 | 701.136.072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305.532 | 21.486.165 | 1,44 | 31,68 | 9.680.415 | 680.763.355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70.867 | 21.180.633 | 0,34 | 31,41 | 2.226.244 | 665.376.877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6.874 | 443.096 | -1,53 | 4,27 | -29.358 | 1.892.419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274.734 | 16.516.549 | -1,64 | 4,27 | -1.173.361 | 70.540.529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37.592 | 2.391.668 | -1,55 | 4,27 | -160.552 | 10.214.575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9.908 | 449.970 | -2,15 | 4,45 | -44.093 | 2.002.456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396.496 | 16.791.283 | -2,31 | 4,45 | -1.764.486 | 74.724.568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54.396 | 2.429.260 | -2,19 | 4,45 | -242.073 | 10.810.693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5.457 | 459.878 | -1,17 | 4,71 | -25.724 | 2.167.865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218.383 | 17.187.779 | -1,25 | 4,71 | -1.029.457 | 81.023.190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29.960 | 2.483.656 | -1,19 | 4,71 | -141.231 | 11.707.954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8.429 | 465.335 | -1,78 | 4,62 | -38.907 | 2.147.940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337.541 | 17.406.162 | -1,90 | 4,62 | -1.558.056 | 80.345.103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46.383 | 2.513.616 | -1,81 | 4,62 | -214.099 | 11.602.600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.000 | 21.109.766 | 0,48 | 34,95 | 3.495.000 | 737.786.322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354.000 | 21.009.766 | 1,71 | 34,27 | 12.131.651 | 720.008.883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.772 | 20.655.766 | 0,07 | 34,53 | 510.114 | 713.295.239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185.378 | 20.640.994 | 0,91 | 34,33 | 6.364.935 | 708.706.465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30.507 | 107.504 | 39,62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30.507 | 3.993.087 | 0,77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399.208 | 0 | -100,00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.500 | 20.455.616 | 0,03 | 33,90 | 186.438 | 693.400.380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80.430 | 20.450.116 | 0,39 | 34,64 | 2.786.393 | 708.467.684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.500 | 20.369.686 | 0,21 | 33,28 | 1.414.515 | 677.958.148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185.528 | 20.327.186 | 0,92 | 33,31 | 6.180.420 | 677.151.416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216.284 | 20.141.658 | 1,09 | 32,56 | 7.043.267 | 655.911.079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38.614 | 19.925.374 | 0,19 | 33,00 | 1.274.254 | 657.533.357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.890 | 19.886.760 | 0,13 | 33,06 | 822.744 | 657.360.829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28.086 | 473.764 | -5,60 | 4,55 | -127.671 | 2.153.589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1.122.584 | 17.743.703 | -5,95 | 4,55 | -5.102.930 | 80.657.551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153.618 | 2.559.999 | -5,66 | 4,55 | -698.301 | 11.636.987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11.965 | 501.850 | -2,33 | 4,84 | -57.913 | 2.429.054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486.800 | 18.866.287 | -2,52 | 4,84 | -2.356.209 | 91.316.602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69.153 | 2.713.617 | -2,49 | 4,84 | -334.714 | 13.134.449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10.534 | 513.815 | -2,01 | 5,36 | -56.453 | 2.753.586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428.583 | 19.353.087 | -2,17 | 5,36 | -2.296.819 | 103.715.129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60.883 | 2.782.770 | -2,14 | 5,36 | -326.278 | 14.913.143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98.076 | 19.861.870 | 0,50 | 36,57 | 3.586.737 | 726.368.448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.639 | 19.763.794 | 0,05 | 36,75 | 390.999 | 726.349.075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69.397 | 19.753.155 | 0,35 | 35,88 | 2.490.291 | 708.836.041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63.137 | 19.683.758 | 0,32 | 36,74 | 2.319.502 | 723.134.028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.505 | 19.620.621 | 0,13 | 35,91 | 915.851 | 704.550.993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.839 | 19.595.116 | 0,12 | 35,55 | 811.963 | 696.637.726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.116 | 19.572.277 | 0,07 | 35,56 | 466.413 | 696.001.913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17.098 | 19.559.161 | 0,09 | 34,91 | 596.816 | 682.724.250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104.140 | 19.542.063 | 0,54 | 35,98 | 3.746.947 | 703.121.473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.006 | 19.437.923 | 0,15 | 35,28 | 1.023.471 | 685.863.225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.500 | 19.408.917 | 0,07 | 34,26 | 462.530 | 664.978.610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.769 | 19.395.417 | 0,13 | 34,58 | 890.989 | 670.615.938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866.669 | 19.369.648 | 4,68 | 33,79 | 29.287.172 | 654.554.641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.394 | 18.502.979 | 0,02 | 33,71 | 148.139 | 623.807.584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38.166 | 18.498.585 | 0,21 | 34,83 | 1.329.390 | 644.339.013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252.474 | 18.460.419 | 1,39 | 34,41 | 8.686.949 | 635.173.175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 50.201 | 21,59 | 2,16 | 19.254 | 108.434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 50.201 | 21,59 | 2,16 | 19.254 | 108.434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 1.421.519 | 0,63 | 2,16 | 19.254 | 3.070.481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305.329 | 0,23 | 28,54 | 19.978 | 8.714.090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305.329 | 0,23 | 28,54 | 19.978 | 8.714.090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1.348.711 | 0,05 | 28,54 | 19.978 | 38.492.212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11.419.665 | 0,01 | 28,54 | 19.978 | 325.917.239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192.618 | 0,36 | 28,54 | 19.978 | 5.497.318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353.277 | 0,20 | 28,54 | 19.978 | 10.082.526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7.000 | 7.000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 41.287 | 17,61 | 2,83 | 17.495 | 116.842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 41.287 | 17,61 | 2,83 | 17.495 | 116.842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 1.412.605 | 0,44 | 2,83 | 17.495 | 3.997.672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304.629 | 0,24 | 27,86 | 19.948 | 8.486.964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1.348.011 | 0,05 | 27,86 | 19.948 | 37.555.586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11.418.965 | 0,01 | 27,86 | 19.948 | 318.132.365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1.908.088 | 0,04 | 27,86 | 19.948 | 53.159.332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191.918 | 0,37 | 27,86 | 19.948 | 5.346.835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352.577 | 0,20 | 27,86 | 19.948 | 9.822.795 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 257.722 | 1,68 | 60,45 | 256.912 | 15.579.295 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 1.893.297 | 0,22 | 60,45 | 256.912 | 114.449.804 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 212.711 | 2,04 | 60,45 | 256.912 | 12.858.380 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 322.445 | 1,34 | 60,45 | 256.912 | 19.491.800 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416.208 | 0,16 | 39,80 | 26.668 | 16.566.494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27.046 | 18.207.945 | 0,15 | 39,80 | 1.076.523 | 724.738.118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.471 | 415.538 | 0,36 | 39,93 | 58.731 | 16.590.770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.400 | 18.180.899 | 0,33 | 39,93 | 2.371.604 | 725.890.573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.938 | 414.067 | 0,47 | 39,99 | 77.503 | 16.559.036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78.262 | 18.121.499 | 0,43 | 39,99 | 3.129.791 | 724.700.491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.155 | 412.129 | 0,28 | 39,84 | 46.021 | 16.421.239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.653 | 18.043.237 | 0,26 | 39,84 | 1.858.884 | 718.930.974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.534 | 410.974 | 1,36 | 38,96 | 215.578 | 16.009.574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223.466 | 17.996.584 | 1,26 | 38,96 | 8.705.163 | 701.060.529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405.440 | 0,13 | 38,56 | 20.591 | 15.633.847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.559 | 17.773.118 | 0,12 | 38,56 | 831.319 | 685.334.985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404.906 | 0,12 | 37,52 | 17.895 | 15.190.413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.223 | 17.751.559 | 0,11 | 37,52 | 721.168 | 665.965.712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.757 | 404.429 | 0,94 | 37,40 | 140.504 | 15.124.795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151.530 | 17.732.336 | 0,86 | 37,40 | 5.666.904 | 663.152.128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.411 | 400.672 | 0,61 | 37,67 | 90.826 | 15.093.995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97.254 | 17.580.806 | 0,56 | 37,67 | 3.663.724 | 662.298.849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398.261 | 0,12 | 37,63 | 18.667 | 14.988.274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.011 | 17.483.552 | 0,11 | 37,63 | 753.100 | 657.981.241 | |
| 2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 397.765 | 0,39 | 36,04 | 55.281 | 14.334.377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.878 | 17.463.541 | 0,36 | 36,04 | 2.229.916 | 629.338.866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396.231 | 0,14 | 36,39 | 20.817 | 14.419.995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.058 | 17.401.663 | 0,13 | 36,39 | 839.147 | 633.296.981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395.659 | 0,00 | 35,27 | 670 | 13.956.001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17.378.605 | 0,00 | 35,27 | 27.548 | 612.992.058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.137 | 395.640 | 0,54 | 34,38 | 73.479 | 13.603.725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86.201 | 17.377.824 | 0,50 | 34,38 | 2.963.944 | 597.520.838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393.503 | 0,07 | 35,11 | 9.481 | 13.817.386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.896 | 17.291.623 | 0,06 | 35,11 | 382.600 | 607.174.592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.809 | 393.233 | 0,46 | 34,05 | 61.604 | 13.391.196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.980 | 17.280.727 | 0,42 | 34,05 | 2.485.268 | 588.479.605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391.424 | 0,12 | 34,21 | 16.421 | 13.391.046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.348 | 17.207.747 | 0,11 | 34,21 | 661.916 | 588.695.953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.151 | 390.944 | 0,30 | 34,08 | 39.232 | 13.325.287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.460 | 17.188.399 | 0,27 | 34,08 | 1.583.584 | 585.864.861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.921 | 389.793 | 0,76 | 34,03 | 99.415 | 13.266.449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117.879 | 17.141.939 | 0,69 | 34,03 | 4.011.965 | 583.419.037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 386.872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 386.872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 17.178.061 | 0,02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383.372 | 0,13 | 34,26 | 17.304 | 13.136.012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.395 | 17.020.560 | 0,12 | 34,26 | 698.822 | 583.199.276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382.867 | 0,00 | 34,10 | 239 | 13.055.765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17.000.165 | 0,00 | 34,10 | 9.991 | 579.705.626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372.860 | 0,20 | 34,60 | 25.815 | 12.902.522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30.122 | 16.989.872 | 0,18 | 34,60 | 1.042.348 | 587.920.929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372.114 | 0,20 | 33,73 | 24.964 | 12.553.191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.865 | 16.959.750 | 0,18 | 33,73 | 1.007.490 | 572.133.774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.069 | 371.374 | 0,29 | 34,31 | 36.673 | 12.740.319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.131 | 16.929.885 | 0,26 | 34,31 | 1.479.648 | 580.794.942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370.305 | 0,21 | 33,92 | 26.559 | 12.560.486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.617 | 16.886.754 | 0,19 | 33,92 | 1.072.427 | 572.786.875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369.522 | 0,09 | 34,74 | 11.430 | 12.837.564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.271 | 16.855.137 | 0,08 | 34,74 | 461.048 | 585.564.315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.933 | 369.193 | 0,80 | 33,77 | 99.060 | 12.469.235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118.389 | 16.841.866 | 0,71 | 33,77 | 3.998.506 | 568.822.235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366.260 | 0,23 | 33,72 | 28.295 | 12.352.009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.868 | 16.723.477 | 0,20 | 34,72 | 1.176.056 | 580.717.722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 365.421 | 0,42 | 33,98 | 52.118 | 12.415.252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.892 | 16.689.609 | 0,37 | 33,98 | 2.102.793 | 567.032.804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363.887 | 0,17 | 34,01 | 21.190 | 12.376.779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.156 | 16.627.717 | 0,15 | 34,01 | 855.623 | 565.553.550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.228 | 363.264 | 0,34 | 33,40 | 41.020 | 12.134.580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.553 | 16.602.561 | 0,30 | 33,40 | 1.655.283 | 554.596.928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362.036 | 0,27 | 33,54 | 33.007 | 12.143.991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.710 | 16.553.008 | 0,24 | 33,54 | 1.332.016 | 555.247.479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372.860 | 0,20 | 34,60 | 25.815 | 12.902.522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30.122 | 16.989.872 | 0,18 | 34,60 | 1.042.348 | 587.920.929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372.114 | 0,20 | 33,73 | 24.964 | 12.553.191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.865 | 16.959.750 | 0,18 | 33,73 | 1.007.490 | 572.133.774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.069 | 371.374 | 0,29 | 34,31 | 36.673 | 12.740.319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.131 | 16.929.885 | 0,26 | 34,31 | 1.479.648 | 580.794.942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370.305 | 0,21 | 33,92 | 26.559 | 12.560.486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.617 | 16.886.754 | 0,19 | 33,92 | 1.072.427 | 572.786.875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369.522 | 0,09 | 34,74 | 11.430 | 12.837.564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.271 | 16.855.137 | 0,08 | 34,74 | 461.048 | 585.564.315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.933 | 369.193 | 0,80 | 33,77 | 99.060 | 12.469.235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118.389 | 16.841.866 | 0,71 | 33,77 | 3.998.506 | 568.822.235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366.260 | 0,23 | 33,72 | 28.295 | 12.352.009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.868 | 16.723.477 | 0,20 | 34,72 | 1.176.056 | 580.717.722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 365.421 | 0,42 | 33,98 | 52.118 | 12.415.252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.892 | 16.689.609 | 0,37 | 33,98 | 2.102.793 | 567.032.804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363.887 | 0,17 | 34,01 | 21.190 | 12.376.779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.156 | 16.627.717 | 0,15 | 34,01 | 855.623 | 565.553.550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.228 | 363.264 | 0,34 | 33,40 | 41.020 | 12.134.580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.553 | 16.602.561 | 0,30 | 33,40 | 1.655.283 | 554.596.928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362.036 | 0,27 | 33,54 | 33.007 | 12.143.991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.710 | 16.553.008 | 0,24 | 33,54 | 1.332.016 | 555.247.479 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 253.472 | 3,26 | 65,10 | 520.800 | 16.501.027 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 1.889.047 | 0,43 | 65,10 | 520.800 | 122.976.960 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 208.461 | 3,99 | 65,10 | 520.800 | 13.570.811 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 318.195 | 2,58 | 65,10 | 520.800 | 20.714.494 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303.913 | 0,25 | 26,57 | 19.981 | 8.074.968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303.913 | 0,25 | 26,57 | 19.981 | 8.074.968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1.347.295 | 0,06 | 26,57 | 19.981 | 35.797.628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11.418.249 | 0,01 | 26,57 | 19.981 | 303.382.876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1.907.372 | 0,04 | 26,57 | 19.981 | 50.678.874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191.202 | 0,39 | 26,57 | 19.981 | 5.080.237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80.000 | 80.000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60.000 | 60.000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9.031 | 211.614 | 4,46 | 105,75 | 955.028 | 22.378.180 | |
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365.969 | 8.172.521 | 4,69 | 105,75 | 38.701.222 | 864.244.096 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.738 | 452.540 | 2,66 | 28,50 | 334.533 | 12.897.390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475.644 | 18.476.847 | 2,64 | 28,50 | 13.555.854 | 526.590.140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38.934 | 1.552.055 | 2,57 | 28,50 | 1.109.619 | 44.233.568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303.161 | 0,23 | 29,27 | 19.962 | 8.873.522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303.161 | 0,23 | 29,27 | 19.962 | 8.873.522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11.243.600 | 0,01 | 29,27 | 19.962 | 329.100.172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1.732.723 | 0,04 | 29,27 | 19.962 | 50.716.802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16.553 | 4,30 | 29,27 | 19.962 | 484.506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177.212 | 0,39 | 29,27 | 19.962 | 5.186.995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361.052 | 0,18 | 39,91 | 25.504 | 14.410.344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.596 | 16.513.298 | 0,16 | 39,91 | 1.021.590 | 659.080.401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.280 | 360.413 | 0,36 | 39,92 | 51.100 | 14.388.372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51.244 | 16.487.702 | 0,31 | 39,92 | 2.045.758 | 658.220.390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.063 | 359.133 | 0,30 | 39,65 | 42.153 | 14.241.383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.646 | 16.436.458 | 0,26 | 39,65 | 1.691.123 | 651.786.098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.486 | 358.070 | 0,70 | 39,70 | 98.694 | 14.215.379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99.775 | 16.393.812 | 0,61 | 39,70 | 3.961.068 | 650.834.336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.377 | 355.584 | 0,39 | 39,54 | 54.442 | 14.058.725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55.256 | 16.294.037 | 0,34 | 39,54 | 2.184.656 | 644.217.341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.056 | 354.207 | 0,87 | 39,53 | 120.798 | 14.001.201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122.660 | 16.238.781 | 0,76 | 39,53 | 4.848.541 | 641.891.407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.492 | 351.151 | 1,59 | 43,98 | 241.512 | 15.441.935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219.958 | 16.116.121 | 1,38 | 43,98 | 9.672.697 | 708.709.644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345.659 | 0,16 | 44,00 | 24.332 | 15.208.823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.147 | 15.896.163 | 0,14 | 44,00 | 974.457 | 699.423.224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.863 | 345.106 | 0,84 | 44,05 | 126.102 | 15.200.366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114.663 | 15.874.016 | 0,73 | 44,05 | 5.050.389 | 699.178.972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342.243 | 0,05 | 43,42 | 7.382 | 14.861.800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.814 | 15.759.353 | 0,04 | 43,42 | 295.896 | 684.345.176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.512 | 342.073 | 0,74 | 42,95 | 107.883 | 14.691.043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.626 | 15.752.539 | 0,64 | 42,95 | 4.321.595 | 676.525.868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339.561 | 0,10 | 43,72 | 14.864 | 14.845.233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.632 | 15.651.913 | 0,09 | 43,72 | 595.976 | 684.284.419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.011 | 339.221 | 0,30 | 43,01 | 43.479 | 14.588.403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.471 | 15.638.281 | 0,26 | 43,01 | 1.740.480 | 672.533.657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.818 | 338.210 | 0,54 | 43,20 | 78.547 | 14.612.329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.807 | 15.597.810 | 0,47 | 43,20 | 3.145.619 | 673.901.821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336.392 | 0,14 | 43,64 | 19.858 | 14.681.829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.232 | 15.525.003 | 0,12 | 43,64 | 795.736 | 677.588.756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335.937 | 0,09 | 42,65 | 12.369 | 14.328.721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.617 | 15.506.771 | 0,07 | 42,65 | 495.500 | 661.410.303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.551 | 335.647 | 1,07 | 42,56 | 151.129 | 14.284.968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142.220 | 15.495.154 | 0,93 | 42,56 | 6.052.812 | 659.466.007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.632 | 332.096 | 0,80 | 42,41 | 111.631 | 14.085.188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105.414 | 15.352.934 | 0,69 | 42,41 | 4.470.924 | 651.163.990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.816 | 329.464 | 0,86 | 42,31 | 119.144 | 13.939.556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112.797 | 15.247.520 | 0,75 | 42,31 | 4.772.419 | 645.119.522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127.000 | 892.000 | -12,46 | 432,60 | -54.940.390 | 385.880.538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4.567.000 | 31.967.000 | -12,50 | 432,60 | -1.975.691.050 | 13.828.972.150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1.084.000 | 7.587.000 | -12,50 | 432,60 | -468.940.026 | 3.282.147.580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2.459.000 | 1.019.000 | -70,70 | 425,88 | -1.047.233.756 | 433.969.580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88.153.000 | 36.534.000 | -70,70 | 425,88 | -37.542.414.519 | 15.559.023.199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20.922.000 | 8.671.000 | -70,70 | 425,88 | -8.910.217.424 | 3.692.787.271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170.000 | 6.050.000 | 2,89 | 104,52 | 17.768.043 | 632.333.295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6.830.000 | 243.450.000 | 2,89 | 104,52 | 713.857.257 | 25.444.882.755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242.000 | 5.880.000 | 4,29 | 104,25 | 25.228.500 | 612.990.000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9.758.000 | 236.620.000 | 4,30 | 104,25 | 1.017.271.500 | 24.667.635.000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61.000 | 5.638.000 | 1,09 | 103,75 | 6.328.750 | 584.942.500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2.439.000 | 226.862.000 | 1,09 | 103,75 | 253.046.250 | 23.536.932.500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121.000 | 5.577.000 | 2,22 | 104,75 | 12.674.750 | 584.190.750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4.879.000 | 224.423.000 | 2,22 | 104,75 | 511.075.250 | 23.508.309.250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5.456.000 | 5.456.000 | 100,00 | 545.600.000 | 545.600.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5.456.000 | 5.456.000 | 100,00 | 545.600.000 | 545.600.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219.544.000 | 219.544.000 | 100,00 | 21.954.400.000 | 21.954.400.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219.544.000 | 219.544.000 | 100,00 | 21.954.400.000 | 21.954.400.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25.000.000 | 25.000.000 | 100,00 | 2.500.000.000 | 2.500.000.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25.000.000 | 25.000.000 | 100,00 | 2.500.000.000 | 2.500.000.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133.000 | 5.674.000 | 2,40 | 104,09 | 13.844.090 | 590.611.767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5.367.000 | 228.326.000 | 2,41 | 104,09 | 558.655.860 | 23.766.658.833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85.000 | 5.541.000 | 1,56 | 104,12 | 8.850.625 | 576.956.625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3.415.000 | 222.959.000 | 1,56 | 104,12 | 355.586.875 | 23.215.605.875 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8.721 | 40.308 | 27,61 | 17,50 | 152.618 | 705.390 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346.965 | 2.213.897 | 18,58 | 17,50 | 6.071.888 | 38.743.198 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44.314 | 125.869 | 54,34 | 17,50 | 775.495 | 2.202.708 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302.479 | 0,22 | 30,33 | 19.957 | 9.174.188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11.242.918 | 0,01 | 30,33 | 19.957 | 340.997.703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1.732.041 | 0,04 | 30,33 | 19.957 | 52.532.804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15.871 | 4,33 | 30,33 | 19.957 | 481.367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176.530 | 0,37 | 30,33 | 19.957 | 5.354.155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196.794 | 0,34 | 30,33 | 19.957 | 5.968.762 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25.663 | 202.583 | 14,51 | 56,63 | 1.453.296 | 11.472.275 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1.024.337 | 7.806.552 | 15,10 | 56,63 | 58.008.204 | 442.085.040 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21.410 | 510.449 | 4,38 | 3,62 | 77.504 | 1.847.825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1.854.058 | 19.767.770 | 10,35 | 3,62 | 6.711.690 | 71.559.327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882.323 | 2.829.753 | 45,31 | 3,62 | 3.194.009 | 10.243.706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21.410 | 510.449 | 4,38 | 3,62 | 77.504 | 1.847.825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1.854.058 | 19.767.770 | 10,35 | 3,62 | 6.711.690 | 71.559.327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882.323 | 2.829.753 | 45,31 | 3,62 | 3.194.009 | 10.243.706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.705 | 145.533 | 20,45 | 4,40 | 108.702 | 640.345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991.161 | 4.832.285 | 25,80 | 4,40 | 4.361.108 | 21.262.054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120.498 | 1.642.513 | 7,92 | 4,40 | 530.191 | 7.227.057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81.555 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1.866.932 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31.587 | ||||||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1.731.383 | 0,04 | 32,85 | 19.907 | 56.875.932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15.213 | 4,15 | 32,85 | 19.907 | 499.747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175.872 | 0,35 | 32,85 | 19.907 | 5.777.395 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 380.839 | 2,70 | 4,44 | 44.400 | 1.690.925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 380.839 | 2,70 | 4,44 | 44.400 | 1.690.925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 12.455.783 | 0,08 | 4,44 | 44.400 | 55.303.677 | |
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5.437 | 440.802 | 1,25 | 14,46 | 78.641 | 6.375.804 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217.986 | 18.001.203 | 1,23 | 14,46 | 3.152.971 | 260.371.200 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26.577 | 1.513.121 | 1,79 | 14,46 | 384.412 | 21.885.933 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3.790 | 435.365 | 0,88 | 14,55 | 55.145 | 6.334.648 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151.980 | 17.783.217 | 0,86 | 14,55 | 2.211.339 | 258.749.364 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18.530 | 1.486.544 | 1,26 | 14,55 | 269.615 | 21.629.513 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4.312 | 431.575 | 1,01 | 14,58 | 62.885 | 6.294.003 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172.893 | 17.631.237 | 0,99 | 14,58 | 2.521.437 | 257.130.434 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21.080 | 1.468.014 | 1,46 | 14,58 | 307.427 | 21.409.223 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5.437 | 427.263 | 1,29 | 14,46 | 78.600 | 6.176.728 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217.986 | 17.458.344 | 1,26 | 14,46 | 3.151.315 | 252.386.550 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26.577 | 1.446.934 | 1,87 | 14,46 | 384.210 | 20.917.601 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.775 | 421.826 | 0,66 | 14,42 | 40.004 | 6.081.001 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111.266 | 17.240.358 | 0,65 | 14,42 | 1.604.000 | 248.535.277 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13.566 | 1.420.357 | 0,96 | 14,42 | 195.566 | 20.475.724 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.552 | 419.051 | 2,83 | 14,45 | 166.955 | 6.056.335 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463.197 | 17.129.092 | 2,78 | 14,45 | 6.694.355 | 247.558.202 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56.475 | 1.406.791 | 4,18 | 14,45 | 816.205 | 20.331.647 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407.499 | 0,22 | 14,50 | 12.903 | 5.907.798 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35.702 | 16.665.895 | 0,21 | 14,50 | 517.597 | 241.617.146 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.353 | 1.350.316 | 0,32 | 14,50 | 63.108 | 19.576.476 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.189 | 406.609 | 1,29 | 14,00 | 72.641 | 5.692.119 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208.063 | 16.630.193 | 1,27 | 14,00 | 2.912.674 | 232.806.072 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.368 | 1.345.963 | 1,92 | 14,00 | 355.127 | 18.842.136 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.511 | 401.420 | 2,95 | 14,08 | 162.100 | 5.652.877 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461.548 | 16.422.130 | 2,89 | 14,08 | 6.499.611 | 231.259.719 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56.274 | 1.320.595 | 4,45 | 14,08 | 792.462 | 18.596.883 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.735 | 301.215 | 1,60 | 35,82 | 169.584 | 10.788.015 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189.886 | 11.241.654 | 1,72 | 35,82 | 6.800.767 | 402.619.838 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.152 | 1.730.777 | 1,36 | 35,82 | 829.189 | 61.987.778 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.558 | 296.480 | 1,21 | 36,62 | 130.294 | 10.857.098 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142.702 | 11.051.768 | 1,31 | 36,62 | 5.225.747 | 404.715.744 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.399 | 1.707.625 | 1,03 | 36,62 | 637.151 | 62.533.228 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.790 | 292.922 | 0,96 | 36,69 | 102.356 | 10.746.400 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111.907 | 10.909.066 | 1,04 | 36,69 | 4.105.521 | 400.219.813 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.644 | 1.690.226 | 0,81 | 36,69 | 500.556 | 62.009.152 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.114 | 290.132 | 0,39 | 36,75 | 40.942 | 10.662.989 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44.627 | 10.797.159 | 0,42 | 36,75 | 1.640.140 | 396.819.347 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.501 | 1.676.582 | 0,33 | 36,75 | 202.174 | 61.618.077 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.021 | 289.018 | 0,35 | 36,82 | 37.595 | 10.642.105 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.933 | 10.752.532 | 0,38 | 36,82 | 1.507.219 | 395.925.432 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.046 | 1.671.081 | 0,30 | 36,82 | 185.802 | 61.531.876 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.613 | 287.997 | 0,56 | 36,93 | 59.574 | 10.636.852 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64.679 | 10.711.599 | 0,61 | 36,93 | 2.388.848 | 395.621.126 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.974 | 1.666.035 | 0,48 | 36,93 | 294.511 | 61.533.170 | |
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 489.039 | 1,75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 489.039 | 1,75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 1.947.430 | 0,43 | ||||
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.358 | 286.384 | 0,48 | 36,93 | 50.154 | 10.576.877 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54.399 | 10.646.920 | 0,51 | 36,93 | 2.009.091 | 393.217.373 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6.760 | 1.658.061 | 0,41 | 36,93 | 249.664 | 61.236.338 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285.026 | 0,12 | 36,99 | 12.280 | 10.542.371 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.313 | 10.592.521 | 0,13 | 36,99 | 492.413 | 391.789.811 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.655 | 1.651.301 | 0,10 | 36,99 | 61.214 | 61.077.331 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284.694 | 0,01 | 36,18 | 1.266 | 10.300.969 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.392 | 10.579.208 | 0,01 | 36,18 | 50.366 | 382.783.251 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1.649.646 | 0,01 | 36,18 | 6.260 | 59.688.481 | |
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.184 | 389.909 | 12,45 | 12,50 | 539.800 | 4.873.862 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.730.970 | 15.960.582 | 12,16 | 12,50 | 21.637.125 | 199.507.275 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218.846 | 1.264.321 | 20,93 | 12,50 | 2.735.575 | 15.804.012 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284.659 | 0,15 | 36,54 | 15.273 | 10.401.212 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.768 | 10.577.816 | 0,16 | 36,54 | 612.689 | 386.504.934 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.120 | 1.649.473 | 0,13 | 36,54 | 77.463 | 60.270.424 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.129 | 284.241 | 0,40 | 36,41 | 41.111 | 10.350.295 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45.279 | 10.561.048 | 0,43 | 36,41 | 1.648.780 | 384.567.890 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.725 | 1.647.353 | 0,35 | 36,41 | 208.469 | 59.986.383 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283.112 | 0,21 | 35,53 | 20.928 | 10.059.507 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.610 | 10.515.769 | 0,23 | 35,53 | 838.908 | 373.645.253 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.985 | 1.641.628 | 0,18 | 35,53 | 106.063 | 58.330.162 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.516 | 282.523 | 1,26 | 34,02 | 119.609 | 9.610.980 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140.962 | 10.492.159 | 1,36 | 34,02 | 4.795.302 | 356.926.462 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.822 | 1.638.643 | 1,10 | 34,02 | 606.276 | 55.744.013 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.104 | 279.007 | 0,40 | 34,74 | 38.358 | 9.694.098 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44.244 | 10.351.197 | 0,43 | 34,74 | 1.537.258 | 359.652.340 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.594 | 1.620.821 | 0,35 | 34,74 | 194.364 | 56.315.426 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277.903 | 0,26 | 27,99 | 19.985 | 7.778.505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277.903 | 0,26 | 27,99 | 19.985 | 7.778.505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10.306.953 | 0,01 | 27,99 | 19.985 | 288.491.614 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1.615.227 | 0,04 | 27,99 | 19.985 | 45.210.204 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14.607 | 5,14 | 27,99 | 19.985 | 408.850 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175.266 | 0,41 | 27,99 | 19.985 | 4.905.695 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277.189 | 0,22 | 27,63 | 16.912 | 7.659.813 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.508 | 10.306.239 | 0,24 | 27,64 | 677.325 | 284.832.497 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.080 | 1.614.513 | 0,19 | 27,64 | 85.122 | 44.620.134 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276.577 | 0,16 | 27,97 | 12.672 | 7.736.744 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18.151 | 10.281.731 | 0,18 | 27,97 | 507.742 | 287.612.918 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.281 | 1.611.433 | 0,14 | 27,97 | 63.807 | 45.076.938 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276.124 | 0,28 | 28,43 | 21.551 | 7.850.509 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30.102 | 10.263.580 | 0,29 | 28,43 | 855.833 | 291.804.869 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.940 | 1.609.152 | 0,25 | 28,43 | 112.019 | 45.749.961 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275.366 | 0,14 | 28,58 | 10.718 | 7.870.098 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14.878 | 10.233.478 | 0,15 | 28,58 | 425.221 | 292.477.918 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.947 | 1.605.212 | 0,12 | 28,58 | 55.646 | 45.877.762 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.742 | 274.991 | 0,64 | 28,23 | 49.180 | 7.763.463 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69.187 | 10.218.600 | 0,68 | 28,23 | 1.953.267 | 288.488.450 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.055 | 1.603.265 | 0,57 | 28,23 | 255.638 | 45.262.897 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273.249 | 0,29 | 27,96 | 22.033 | 7.640.288 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31.584 | 10.149.413 | 0,31 | 27,96 | 883.117 | 283.786.722 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.004 | 1.594.210 | 0,25 | 27,96 | 111.955 | 44.575.546 | |
| 2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20.099 | 176.920 | 12,82 | 47,53 | 955.305 | 8.409.008 | |
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839.621 | 6.782.215 | 14,13 | 47,53 | 39.907.186 | 322.358.679 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272.461 | 0,13 | 27,24 | 9.997 | 7.421.838 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 272.461 | 0,13 | 27,24 | 9.997 | 7.421.838 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 10.117.829 | 0,00 | 27,24 | 9.997 | 275.609.662 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 1.590.206 | 0,02 | 27,24 | 9.997 | 43.317.211 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 13.893 | 2,71 | 27,24 | 9.997 | 378.445 | |
| 2013-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 367 | 174.552 | 0,21 | 27,24 | 9.997 | 4.754.796 | |
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
1.045.475 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
14.229.612 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
346.725 | ||||||||
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271.806 | 0,00 | 27,54 | 165 | 7.485.537 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10.117.174 | 0,00 | 27,54 | 7.381 | 278.626.972 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1.589.551 | 0,00 | 27,54 | 716 | 43.776.235 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.859 | 271.800 | 1,82 | 26,83 | 130.352 | 7.291.551 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202.311 | 10.116.906 | 2,04 | 26,83 | 5.427.377 | 271.405.226 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21.830 | 1.589.525 | 1,39 | 26,83 | 585.631 | 42.642.028 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.223 | 266.941 | 0,84 | 27,32 | 60.725 | 7.291.894 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92.592 | 9.914.595 | 0,94 | 27,32 | 2.529.289 | 270.832.034 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.352 | 1.567.695 | 0,54 | 27,32 | 228.147 | 42.823.940 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.231 | 264.718 | 0,85 | 27,99 | 62.450 | 7.409.960 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92.917 | 9.822.003 | 0,96 | 27,99 | 2.600.923 | 274.936.526 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.691 | 1.559.343 | 0,56 | 27,99 | 243.278 | 43.648.973 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.298 | 262.487 | 1,66 | 27,94 | 120.075 | 7.333.204 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178.978 | 9.729.086 | 1,87 | 27,94 | 5.000.180 | 271.805.367 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.724 | 1.550.652 | 1,09 | 27,94 | 467.225 | 43.321.185 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258.189 | 0,06 | 27,86 | 3.983 | 7.192.010 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258.046 | 0,01 | 26,68 | 640 | 6.884.693 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258.022 | 0,03 | 27,16 | 2.146 | 7.008.187 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.905 | 257.943 | 3,99 | 27,84 | 275.793 | 7.182.113 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248.038 | 0,26 | 26,91 | 17.516 | 6.673.735 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247.387 | 0,13 | 25,83 | 8.367 | 6.388.868 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.972 | 9.550.108 | 0,06 | 27,86 | 166.354 | 266.023.988 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9.544.136 | 0,01 | 26,68 | 26.146 | 254.638.503 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.298 | 9.543.156 | 0,03 | 27,16 | 89.578 | 259.203.569 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412.596 | 9.539.858 | 4,52 | 27,84 | 11.488.241 | 265.625.898 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27.125 | 9.127.262 | 0,30 | 26,91 | 729.828 | 245.579.024 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.447 | 9.100.137 | 0,15 | 25,83 | 347.274 | 235.014.678 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1.533.928 | 0,04 | 27,86 | 16.296 | 42.728.485 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1.533.343 | 0,01 | 26,68 | 2.561 | 40.909.745 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1.533.247 | 0,02 | 27,16 | 8.773 | 41.644.828 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.412 | 1.532.924 | 2,71 | 27,84 | 1.125.224 | 42.682.429 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.657 | 1.492.512 | 0,18 | 26,91 | 71.490 | 40.157.677 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.316 | 1.489.855 | 0,09 | 25,83 | 33.986 | 38.476.101 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103.608 | 463.839 | 28,76 | 3,00 | 310.824 | 1.391.517 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4.282.419 | 17.888.512 | 31,47 | 3,00 | 12.847.257 | 53.665.536 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336.639 | 1.922.230 | 21,23 | 3,00 | 1.009.917 | 5.766.690 | |
| 2012-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 288 | 288 | 35,89 | 10.336 | 10.336 | ||
| 2012-07-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Stock Options (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21.082 | 156.821 | 15,53 | 41,20 | 868.578 | 6.461.025 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864.918 | 5.942.594 | 17,03 | 41,20 | 35.634.622 | 244.834.873 | |
| 2012-06-29 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy) |
A - Award | 7.500 | 7.500 | |||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12.500 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12.500 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -25.000 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -4.023 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -147.292 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -46.195 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -998 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -205 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -116.454 | 0 | -100,00 | 32,00 | -3.726.528 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -4.922.226 | 0 | -100,00 | 32,00 | -157.511.232 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -1.646.964 | 0 | -100,00 | 32,00 | -52.702.848 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -99.636 | 0 | -100,00 | 32,00 | -3.188.352 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -65.882 | 0 | -100,00 | 32,00 | -2.108.224 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -60.827 | 0 | -100,00 | 32,00 | -1.946.464 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -2.302 | 0 | -100,00 | 32,00 | -73.664 | ||
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 380 | 247.063 | 0,15 | 32,94 | 12.518 | 8.138.922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.026 | 9.086.690 | 0,19 | 32,94 | 560.882 | 299.340.103 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.732 | 246.683 | 1,12 | 32,21 | 87.992 | 7.945.166 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 546 | 243.951 | 0,22 | 32,04 | 17.493 | 7.815.922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 122.268 | 9.069.664 | 1,37 | 32,21 | 3.938.008 | 292.115.738 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.454 | 8.947.396 | 0,27 | 32,04 | 783.479 | 286.664.726 | |
| 2012-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 17.500 | 17.500 | |||||
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 517 | 243.405 | 0,21 | 34,46 | 17.815 | 8.387.176 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.104 | 8.922.942 | 0,26 | 34,46 | 796.111 | 307.464.059 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.972 | 242.888 | 0,82 | 34,25 | 67.541 | 8.318.914 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 540 | 240.916 | 0,22 | 33,11 | 17.882 | 7.977.668 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 555 | 240.376 | 0,23 | 34,47 | 19.129 | 8.285.160 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 88.028 | 8.899.838 | 1,00 | 34,25 | 3.014.959 | 304.819.452 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.136 | 8.811.810 | 0,27 | 33,11 | 799.237 | 291.793.395 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.769 | 8.787.674 | 0,28 | 34,47 | 853.726 | 302.889.154 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.212 | 239.821 | 1,36 | 33,92 | 108.951 | 8.134.728 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 897 | 236.609 | 0,38 | 33,67 | 30.198 | 7.965.513 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 370 | 235.712 | 0,16 | 32,59 | 12.058 | 7.681.501 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 175 | 235.342 | 0,07 | 31,53 | 5.517 | 7.419.863 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143.388 | 8.762.905 | 1,66 | 33,92 | 4.863.721 | 297.237.738 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.073 | 8.619.517 | 0,47 | 33,67 | 1.349.070 | 290.178.626 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.526 | 8.579.444 | 0,19 | 32,59 | 538.558 | 279.591.211 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.797 | 8.562.918 | 0,09 | 31,53 | 245.824 | 269.971.679 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 627 | 235.167 | 0,27 | 30,22 | 18.946 | 7.105.877 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26.033 | 8.555.121 | 0,31 | 30,22 | 786.621 | 258.504.103 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 214 | 234.540 | 0,09 | 29,98 | 6.415 | 7.030.829 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.867 | 8.529.088 | 0,10 | 29,98 | 265.807 | 255.677.324 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.402 | 234.326 | 0,60 | 29,86 | 41.861 | 6.996.599 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 58.198 | 8.520.221 | 0,69 | 29,86 | 1.737.699 | 254.400.167 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 460 | 232.924 | 0,20 | 29,90 | 13.752 | 6.963.379 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19.087 | 8.462.023 | 0,23 | 29,90 | 570.615 | 252.976.409 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 116 | 232.464 | 0,05 | 28,50 | 3.306 | 6.624.620 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.737 | 232.348 | 0,75 | 28,90 | 50.196 | 6.714.416 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 172 | 230.611 | 0,07 | 28,41 | 4.886 | 6.550.529 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.811 | 8.442.936 | 0,06 | 28,50 | 137.101 | 240.601.724 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 72.073 | 8.438.125 | 0,86 | 28,90 | 2.082.773 | 243.845.780 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.124 | 8.366.052 | 0,09 | 28,41 | 202.358 | 237.638.544 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 536 | 230.439 | 0,23 | 28,28 | 15.159 | 6.517.184 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 754 | 229.903 | 0,33 | 28,25 | 21.300 | 6.494.530 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22.241 | 8.358.928 | 0,27 | 28,28 | 629.011 | 236.403.858 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31.273 | 8.336.687 | 0,38 | 28,25 | 883.431 | 235.503.071 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 722 | 1.488.539 | 0,05 | 28,28 | 20.419 | 42.098.265 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.014 | 1.487.817 | 0,07 | 28,25 | 28.644 | 42.029.342 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 | 229.149 | 0,00 | 28,00 | 140 | 6.416.172 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 369 | 229.144 | 0,16 | 27,99 | 10.330 | 6.414.863 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 935 | 228.775 | 0,41 | 28,03 | 26.208 | 6.412.540 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 188 | 8.305.414 | 0,00 | 28,00 | 5.264 | 232.551.592 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14.078 | 8.305.226 | 0,17 | 27,99 | 394.112 | 232.503.971 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35.727 | 8.291.148 | 0,43 | 28,03 | 1.001.424 | 232.400.049 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7 | 1.486.803 | 0,00 | 28,00 | 196 | 41.630.484 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 514 | 1.486.796 | 0,03 | 27,99 | 14.389 | 41.622.705 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.305 | 1.486.282 | 0,09 | 28,03 | 36.579 | 41.660.336 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 910 | 57.704 | 1,60 | 3,01 | 2.735 | 173.429 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1.482 | 56.794 | 2,68 | 2,99 | 4.430 | 169.763 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4.186 | 55.312 | 8,19 | 2,96 | 12.383 | 163.618 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15.076 | 51.126 | 41,82 | 2,55 | 38.444 | 130.371 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 8.628 | 36.050 | 31,46 | 2,34 | 20.186 | 84.343 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1.170 | 27.422 | 4,46 | 1,87 | 2.188 | 51.279 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 430 | 26.252 | 1,67 | 1,89 | 811 | 49.506 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
25.822 | ||||||||
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 34.544 | 3.540.015 | 0,99 | 3,01 | 103.822 | 10.639.515 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56.294 | 3.505.471 | 1,63 | 2,99 | 168.268 | 10.478.203 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 159.015 | 3.449.177 | 4,83 | 2,96 | 470.382 | 10.203.010 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 572.737 | 3.290.162 | 21,08 | 2,55 | 1.460.479 | 8.389.913 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 327.769 | 2.717.425 | 13,72 | 2,34 | 766.848 | 6.357.688 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 44.467 | 2.389.656 | 1,90 | 1,87 | 83.153 | 4.468.657 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 16.326 | 2.345.189 | 0,70 | 1,89 | 30.788 | 4.422.557 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
2.328.863 | ||||||||
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4.592 | 232.011 | 2,02 | 3,01 | 13.801 | 697.309 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 7.484 | 227.419 | 3,40 | 2,99 | 22.370 | 679.778 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15.599 | 219.935 | 7,63 | 2,96 | 46.143 | 650.590 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56.187 | 204.336 | 37,93 | 2,55 | 143.277 | 521.057 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 32.155 | 148.149 | 27,72 | 2,34 | 75.230 | 346.609 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4.363 | 115.994 | 3,91 | 1,87 | 8.159 | 216.909 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1.601 | 111.631 | 1,46 | 1,89 | 3.019 | 210.514 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
110.030 | ||||||||
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 516 | 227.840 | 0,23 | 30,36 | 15.668 | 6.918.088 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 583 | 227.324 | 0,26 | 29,88 | 17.420 | 6.792.259 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19.513 | 8.255.421 | 0,24 | 30,36 | 592.489 | 250.665.952 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22.071 | 8.235.908 | 0,27 | 29,88 | 659.464 | 246.082.342 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.162 | 1.484.977 | 0,15 | 30,36 | 65.647 | 45.089.545 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.346 | 1.482.815 | 0,16 | 29,88 | 70.097 | 44.305.326 | |
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
360.231 | ||||||||
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
1.585.591 | ||||||||
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
13.606.093 | ||||||||
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.845 | 226.741 | 0,82 | 30,07 | 55.477 | 6.817.830 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.254 | 224.896 | 1,01 | 29,96 | 67.521 | 6.737.007 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.419 | 222.642 | 1,10 | 29,52 | 71.410 | 6.572.503 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 405 | 220.223 | 0,18 | 29,47 | 11.936 | 6.490.060 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69.783 | 8.213.837 | 0,86 | 30,07 | 2.098.291 | 246.980.222 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 85.231 | 8.144.054 | 1,06 | 29,96 | 2.553.188 | 243.964.096 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91.459 | 8.058.823 | 1,15 | 29,52 | 2.699.915 | 237.900.484 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 15.288 | 7.967.364 | 0,19 | 29,47 | 450.543 | 234.801.404 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.372 | 1.480.469 | 0,57 | 30,07 | 251.736 | 44.515.926 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.225 | 1.472.097 | 0,70 | 29,96 | 306.301 | 44.098.285 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.972 | 1.461.872 | 0,76 | 29,52 | 323.899 | 43.155.192 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.763 | 1.450.900 | 0,12 | 29,47 | 51.956 | 42.758.603 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.149 | 219.818 | 1,92 | 29,06 | 120.562 | 6.387.493 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.353 | 215.669 | 0,63 | 29,11 | 39.384 | 6.277.801 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 974 | 214.316 | 0,46 | 29,03 | 28.276 | 6.221.722 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 156.902 | 7.952.076 | 2,01 | 29,06 | 4.559.274 | 231.072.220 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 51.248 | 7.795.174 | 0,66 | 29,11 | 1.491.752 | 226.905.822 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 36.881 | 7.743.926 | 0,48 | 29,03 | 1.070.678 | 224.810.818 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19.552 | 1.449.137 | 1,37 | 29,06 | 568.144 | 42.109.168 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.934 | 1.429.585 | 0,42 | 29,11 | 172.730 | 41.613.075 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.270 | 1.423.651 | 0,30 | 29,03 | 123.961 | 41.329.443 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.639 | 213.342 | 0,77 | 28,12 | 46.095 | 5.999.988 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 145 | 211.703 | 0,07 | 27,98 | 4.057 | 5.923.683 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.238 | 211.558 | 0,59 | 27,98 | 34.635 | 5.918.737 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 62.098 | 7.707.045 | 0,81 | 28,12 | 1.746.432 | 216.751.392 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.511 | 7.644.947 | 0,07 | 27,98 | 154.204 | 213.914.027 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 46.909 | 7.639.436 | 0,62 | 27,98 | 1.312.368 | 213.727.737 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.477 | 1.419.381 | 0,53 | 28,12 | 210.282 | 39.918.387 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 638 | 1.411.904 | 0,05 | 27,98 | 17.852 | 39.506.627 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.217 | 1.411.266 | 0,37 | 27,98 | 145.955 | 39.482.848 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.419 | 210.320 | 1,16 | 29,85 | 72.219 | 6.279.062 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.460 | 207.901 | 1,20 | 29,61 | 72.842 | 6.156.073 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10 | 205.441 | 0,00 | 28,96 | 290 | 5.950.085 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 849 | 205.431 | 0,41 | 28,88 | 24.517 | 5.932.272 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.475 | 204.582 | 0,73 | 28,44 | 41.945 | 5.817.698 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91.543 | 7.592.527 | 1,22 | 29,85 | 2.732.998 | 226.673.375 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 93.088 | 7.500.984 | 1,26 | 29,61 | 2.756.392 | 222.108.637 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 349 | 7.407.896 | 0,00 | 28,96 | 10.108 | 214.551.188 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 32.125 | 7.407.547 | 0,44 | 28,88 | 927.680 | 213.909.216 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 55.804 | 7.375.422 | 0,76 | 28,44 | 1.586.898 | 209.734.875 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.838 | 1.406.049 | 0,78 | 29,85 | 323.566 | 41.977.312 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 11.021 | 1.395.211 | 0,80 | 29,61 | 326.338 | 41.313.035 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 41 | 1.384.190 | 0,00 | 28,96 | 1.187 | 40.089.603 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.944 | 1.384.149 | 0,29 | 28,88 | 113.892 | 39.970.348 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.341 | 1.380.205 | 0,53 | 28,44 | 208.756 | 39.248.890 | |
| 2012-02-14 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 150.000 | 557.211 | 36,84 | 20,85 | 3.128.040 | 11.619.855 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 753 | 203.107 | 0,37 | 26,52 | 19.967 | 5.385.666 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 492 | 202.354 | 0,24 | 26,62 | 13.098 | 5.387.048 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.980 | 201.862 | 1,50 | 26,60 | 79.278 | 5.370.195 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 102 | 198.882 | 0,05 | 26,24 | 2.676 | 5.217.868 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.312 | 198.780 | 0,66 | 26,33 | 34.540 | 5.233.162 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64 | 197.468 | 0,03 | 26,27 | 1.681 | 5.187.208 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.594 | 197.404 | 0,81 | 26,26 | 41.851 | 5.182.921 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.585 | 195.810 | 1,87 | 26,18 | 93.840 | 5.125.464 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 161 | 192.225 | 0,08 | 26,17 | 4.213 | 5.029.586 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 28.469 | 7.319.618 | 0,39 | 26,52 | 754.895 | 194.089.919 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18.628 | 7.291.149 | 0,26 | 26,62 | 495.913 | 194.104.240 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 112.735 | 7.272.521 | 1,57 | 26,60 | 2.999.123 | 193.473.058 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.883 | 7.159.786 | 0,05 | 26,24 | 101.874 | 187.844.145 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 49.670 | 7.155.903 | 0,70 | 26,33 | 1.307.632 | 188.389.165 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.441 | 7.106.233 | 0,03 | 26,27 | 64.122 | 186.670.792 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 60.315 | 7.103.792 | 0,86 | 26,26 | 1.583.594 | 186.512.900 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 135.681 | 7.043.477 | 1,96 | 26,18 | 3.551.545 | 184.367.941 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6.093 | 6.907.796 | 0,09 | 26,17 | 159.424 | 180.743.173 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.378 | 1.372.864 | 0,32 | 26,52 | 116.089 | 36.403.411 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.865 | 1.368.486 | 0,21 | 26,62 | 76.272 | 36.431.697 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.339 | 1.365.621 | 1,29 | 26,60 | 461.275 | 36.330.025 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 615 | 1.348.282 | 0,05 | 26,24 | 16.135 | 35.373.527 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.858 | 1.347.667 | 0,59 | 26,33 | 206.873 | 35.479.221 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 387 | 1.339.809 | 0,03 | 26,27 | 10.166 | 35.194.907 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.891 | 1.339.422 | 0,74 | 26,26 | 259.692 | 35.167.060 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22.251 | 1.329.531 | 1,70 | 26,18 | 582.436 | 34.801.405 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 999 | 1.307.280 | 0,08 | 26,17 | 26.139 | 34.205.112 | |
| 2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 23.172 | 116.454 | 24,84 | 17,00 | 393.924 | 1.979.718 | |
| 2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 876.828 | 4.922.226 | 21,67 | 17,00 | 14.906.076 | 83.677.842 | |
| 2012-01-31 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -59.340 | 0 | -100,00 | 0,22 | -13.156 | ||
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12.907 | 407.211 | 3,27 | 17,89 | 230.942 | 7.286.145 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 28.966 | 394.304 | 7,93 | 17,95 | 519.960 | 7.078.033 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3.018 | 365.338 | 0,83 | 18,43 | 55.629 | 6.734.093 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 18.547 | 362.320 | 5,40 | 18,55 | 343.997 | 6.720.058 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 14.629 | 343.773 | 4,44 | 18,01 | 263.424 | 6.190.320 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7.926 | 329.144 | 2,47 | 17,86 | 141.534 | 5.877.491 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.944 | 195.858 | 1,00 | 17,89 | 34.784 | 3.504.448 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4.360 | 193.914 | 2,30 | 17,95 | 78.265 | 3.480.892 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 454 | 189.554 | 0,24 | 18,43 | 8.368 | 3.493.954 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2.792 | 189.100 | 1,50 | 18,55 | 51.784 | 3.507.294 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2.202 | 186.308 | 1,20 | 18,01 | 39.651 | 3.354.848 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.193 | 184.106 | 0,65 | 17,86 | 21.303 | 3.287.562 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 75.149 | 8.574.445 | 0,88 | 17,89 | 1.344.626 | 153.420.829 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 168.641 | 8.499.296 | 2,02 | 17,95 | 3.027.224 | 152.568.313 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 17.571 | 8.330.655 | 0,21 | 18,43 | 323.877 | 153.554.798 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 107.980 | 8.313.084 | 1,32 | 18,55 | 2.002.737 | 154.185.263 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 85.169 | 8.205.104 | 1,05 | 18,01 | 1.533.638 | 147.749.308 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 46.142 | 8.119.935 | 0,57 | 17,86 | 823.953 | 144.996.867 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7.925 | 321.218 | 2,53 | 16,84 | 133.456 | 5.409.279 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12.694 | 313.293 | 4,22 | 16,88 | 214.254 | 5.287.885 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7.590 | 300.599 | 2,59 | 16,90 | 128.252 | 5.079.372 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -16 | 0 | -100,00 | 1,50 | -24 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -28 | 16 | -63,64 | 1,25 | -35 | 20 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 16 | 44 | 57,14 | 1,50 | 24 | 66 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 1.600 | 293.009 | 0,55 | 15,00 | 24.000 | 4.395.135 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 2.800 | 291.409 | 0,97 | 15,00 | 42.000 | 4.371.135 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12.041 | 288.609 | 4,35 | 16,44 | 197.940 | 4.744.386 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 31.115 | 276.568 | 12,68 | 16,41 | 510.585 | 4.538.370 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 28 | 28 | 1,25 | 35 | 35 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 426 | 245.453 | 0,17 | 15,81 | 6.735 | 3.880.391 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.795 | 245.027 | 0,74 | 16,07 | 28.843 | 3.937.241 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3.839 | 243.232 | 1,60 | 16,07 | 61.686 | 3.908.300 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.201 | 182.913 | 0,66 | 16,84 | 20.225 | 3.080.237 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.923 | 181.712 | 1,07 | 16,88 | 32.457 | 3.067.008 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.149 | 179.789 | 0,64 | 16,90 | 19.415 | 3.037.985 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -2 | 0 | -100,00 | 1,50 | -3 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -5 | 2 | -71,43 | 1,25 | -6 | 2 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 2 | 7 | 40,00 | 1,50 | 3 | 10 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 200 | 178.640 | 0,11 | 15,00 | 3.000 | 2.679.600 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 500 | 178.440 | 0,28 | 15,00 | 7.500 | 2.676.600 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.824 | 177.940 | 1,04 | 16,44 | 29.984 | 2.925.120 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4.712 | 176.116 | 2,75 | 16,41 | 77.322 | 2.889.993 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 5 | 5 | 1,25 | 6 | 6 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 66 | 171.404 | 0,04 | 15,81 | 1.043 | 2.709.743 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 278 | 171.338 | 0,16 | 16,07 | 4.467 | 2.753.162 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 594 | 171.060 | 0,35 | 16,07 | 9.545 | 2.748.626 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 45.574 | 8.073.793 | 0,57 | 16,84 | 767.462 | 135.961.867 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 72.997 | 8.028.219 | 0,92 | 16,88 | 1.232.073 | 135.503.492 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 43.644 | 7.955.222 | 0,55 | 16,90 | 737.474 | 134.423.364 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -87 | 0 | -100,00 | 1,50 | -130 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -162 | 87 | -65,06 | 1,25 | -202 | 109 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 87 | 249 | 53,70 | 1,50 | 130 | 373 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 8.700 | 7.911.578 | 0,11 | 15,00 | 130.500 | 118.673.670 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 16.200 | 7.902.878 | 0,21 | 15,00 | 243.000 | 118.543.170 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 69.245 | 7.886.678 | 0,89 | 16,43 | 1.137.958 | 129.608.089 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 178.921 | 7.817.433 | 2,34 | 16,41 | 2.936.022 | 128.280.949 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 162 | 162 | 1,25 | 202 | 202 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2.449 | 7.638.512 | 0,03 | 15,81 | 38.716 | 120.758.000 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 10.327 | 7.636.063 | 0,14 | 16,07 | 165.940 | 122.700.842 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 22.081 | 7.625.736 | 0,29 | 16,07 | 354.802 | 122.531.851 | |
| 2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -20.000 | 59.340 | -25,21 | 0,20 | -4.000 | 11.868 | |
| 2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -118.800 | 79.340 | -59,96 | 0,21 | -25.233 | 16.852 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.122 | 355.839 | 0,32 | 16,62 | 18.648 | 5.914.115 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.965 | 354.717 | 0,56 | 16,58 | 32.576 | 5.880.463 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.769 | 352.752 | 0,79 | 16,46 | 45.570 | 5.805.345 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.919 | 349.983 | 1,72 | 16,21 | 95.924 | 5.671.859 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.850 | 344.064 | 0,84 | 16,38 | 46.691 | 5.636.697 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 41.677 | 12.430.783 | 0,34 | 16,62 | 692.680 | 206.602.100 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72.978 | 12.389.106 | 0,59 | 16,58 | 1.209.822 | 205.385.360 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 102.856 | 12.316.128 | 0,84 | 16,46 | 1.692.732 | 202.690.213 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 219.881 | 12.213.272 | 1,83 | 16,21 | 3.563.413 | 197.929.507 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 105.847 | 11.993.391 | 0,89 | 16,38 | 1.734.060 | 196.484.127 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 29.089 | 135.739 | 27,28 | 25,18 | 732.461 | 3.417.908 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 1.077.225 | 5.077.676 | 26,93 | 25,18 | 27.124.526 | 127.855.882 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 187.576 | 1.736.065 | 12,11 | 25,18 | 4.723.164 | 43.714.117 | |
| 2012-01-05 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Options (Right to Buy) |
A - Award | 12.500 | 12.500 | |||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -355.143 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 355.143 | 15.131.223 | 2,40 | 6,25 | 2.219.644 | 94.570.144 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -49.563 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 49.563 | 450.461 | 12,36 | 6,25 | 309.769 | 2.815.381 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -68.006 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 68.006 | 539.130 | 14,43 | 6,25 | 425.038 | 3.369.562 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -339.788 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 339.788 | 4.966.001 | 7,34 | 6,25 | 2.123.675 | 31.037.506 | |
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -186.272 | 0 | -100,00 | 4,25 | -791.656 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -6.669.338 | 0 | -100,00 | 4,25 | -28.344.686 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -12.679 | 0 | -100,00 | 4,25 | -53.886 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -79.054 | 0 | -100,00 | 4,25 | -335.980 | ||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | 284.115 | 284.115 | |||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -34.385 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -249.730 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | 355.143 | 355.143 | |||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -42.981 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -312.162 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 448.047 | 682.908 | 190,77 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -45.090 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -49.807 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -353.150 | 0 | -100,00 |
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)
